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Inflammation, as a subject, has dominated the history of 
medicine as far back as Hippocrates (about 460-377 B.C.) who saw a |
close connection between it and fever (Menkin, I96I). It was, #
however, not until the nineteenth century that serious investigation 
of this phenomenon started with the pioneering endeavours of 
Cohnheim (I889). Inflammation has been defined by Menkin (1950) as 
the vascular lymphatic and local tissue reaction elicited in higher 
animals by the presence of viable or non-viable irritants. It is a 
protective and quite normal response to a stimulus that threatens /
the well-being of the host. An inflammatory process is initiated 
by a disturbance in the local fluid exchange which is manifested by \
increased capillary permeability (Cohnheim, I889). With this 
enhanced passage of plasma protein, fibrinogen accumulates in the 
area of injury. Thrombi then occlude the draining lymphatics, the 
site of the inflammation is circumscribed and the phagocytic ]^
capacity of leukocytes proceeds to dispose of the irritant. This 
inflammatory response may be beneficial. Thus, a thermal or 
chemical burn triggers off the inflammatory and reparative process 
which proceeds smoothly from injury to healing. However, when 
tissue injury is caused by a self-replicating parasite (bacterium, 
virum, or neoplasm) the ensuing inflammatory response becomes more 
complex as the inflammatory process seeks to isolate the noxius 
agents from the rest of the organism. This may lead to chronic 
disabling conditions that affect single or multiple organ systems 
of the body. Examples of these disease conditions include gout, 
tetanus, serum sickness and rheumatoid arthritis.
When a patient presents with any of the conditions mentioned
a
above, clinicians usually direct treatment at two therapeutically 
independent aspects of his disease firstly to relieve the pain 
resulting from inflammation and, secondly, to destroy the 
etiological factor. One of the most effective groups of therapeutic 
agents against inflammation are the corticosteroids and their 
synthetic analogues. Corticosteroids are secreted by the adrenal 
cortex and the essential features of their biosynthesis, summarised 
in Fig. 1, involve the transformation of acetyl-GoA by several 
enzyme-catalysed conversions and through several intermediaries to 
Pregnenolone, the 21-carbon compound from which corticosteroids, 
as well as androgens and estrogens are derived (Schulster et al. 
1976).
Corticosteroids were first isolated from adrenal cortical 
tissue by Mason et al, (1938) and it soon became obvious that 
various corticosteroids differed in their biological activity; some, 
like aldosterone, showed mineralooorticoid effects and influenced 
sodium retention while others, like cortisol, had minimal impact on 
salt and water metabolism but protected against stress and showed 
effects on carbohydrate metabolism (increased glucose production 
and glycogen deposition). Clinical interest in the isolation and, 
particularly, synthesis of adrenal steroids arose from the rumours, 
during World War II, that German airmen were receiving compound E 
(cortisone) to minimise fatigue and give them extra stamina. It 
was not long before this compound was synthesised from desoxycholic 
acid, obtained from ox bile (Sarett, 1946). Soon, additional uses 
were found for this steroid, its anti-inflammatory powers became 
recognised and, by 1950, hydrocortisone, the physiologically active
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form of cortisone, had been chemically synthesised. However, it 
was evident that, despite dramatic clinical responses, prolonged 
administration of cortisone or hydrocortisone exaggerated the 
physiological effects of the steroids leading to untoward effects, 
the most frequent and troublesome of which was excessive retention 
of salt and water. Hiese * side-effects* limited the usefulness of 
these steroids end prompted the search for synthetic analogues. 
Prednisolone -hydrocortisone) was developed and was found to 
possess four times the anti-inflammatory potency (as measured by 
its ability to prevent granuloma formation, induced by the presence 
of cotton wool, in experimental animals) of cortisone or 
hydrocortisone (Piddle and Pox, I96I), Furthermore, the new steroid 
produced less retention of sodium and water while still retaining 
strong glucocorticoid properties (as measured by the ability to 
deposit glycogen in the liver). Thus, by modifying the steroid 
nucleus, at least partial dissociation of mineralooorticoid and 
glucocorticoid activities had been achieved and efforts aimed at 
eliminating side-effects by further modification of the steroid 
nucleus (Pig, 2) increased. The introduction of a halogen atom at 
the position of hydrocortisone produced -fluorohydrocortisone 
which possessed a greatly enhanced anti-inflammatory power; the 
addition of a hydroxyl group at the position, to produce 
triamcinolone, appeared to cancel out the sodium-retaining effects 
inherent in -fluorohydrocortisone; méthylation at the same 
position produced dexamethasone which, in addition to its powerful 
anti-inflammatory properties, enhanced sodium excretion rather than 
its retention.
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FIG, 2 Various corticosteroid analogues (significant 
alterations from the hydrocortisone molecule are shov/n in thicker lines)
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The reason for the enhanced biological activity of these 
hydrocortisone analogues is not clear but it has been suggested 
(Jailer, I960) that the substituted compounds are not easily 
degraded by hepatic enzymes. Consequently, they remain intact, 
in circulation and, perhaps, in target tissues for longer periods 
thus exerting a more prolonged effect. Also, there appears to be 
no general agreement on the anti-inflammatory mechanism of these 
steroids, Menkin (1950) suggested that corticosteroids repressed 
protein synthesis in the target cells causing a suppression of 
cellular activity and, finally, cell lysis ; Allison et al (1955) 
found that these steroids inhibited leukocyte accumulation; Grant 
et al (i960) concluded that corticosteroids inhibited the adhesion 
of white blood cells to blood vessel walls ; and Mason and Reid 
(1971) demonstrated that platelet aggregation was inhibited by the 
steroids. Despite the failure to explain their mode of action in 
combatting inflammation, corticosteroids remain high on the 
clinician's prescription list because they promptly suppress many 
forms of inflammation and are life-saving in conditions in which 
the inflammatory process per se is life-threatening. There is, 
however, considerable concern over the medical complications which 
are known to arise from prolonged corticosteroid therapy. These 
complications include a decreased ability to resist bacterial or 
viral infections, appearance of oedema and related changes in 
electrolyte balance, interference with adrenal-pitiutary 
relationship, occurrence of peptic ulcers, mental stimulation, 
diabetes, alterations in glucose metabolism and development of 
osteoporosis, to mention but a few. Prednisolone, in particular.
V.
7causes severe muscle wasting in patients (Paludi et al. I964) • The 
elimination of these undesirable effects can only be achieved 
through a better understanding of the biochemical events following 
the administration of corticosteroids.
Possible Mechanisms of Corticosteroid Action
The general lack of success in eliminating the side-effects 
resulting from corticosteroid therapy may be reflective of the fact 
that both their anti-inflammatory action and side-effects could be 
only different biological expressions of a common mechanism of 
corticosteroid action. There have been several suggestions that a 
single activity may account for the entire spectrum of biologic 
response. Munck (l97l) claimed that corticosteroids decrease 4
glucose utilisation by peripherial tissue by blocking its transport 
into the cell, presumably by preventing phosphorylation and Schayer 
(1964) had previously suggested that both the physiological and the 
pharmacological actions of corticosteroids result from the passive 
attachment to microvascular smooth muscle cells causing interference 
with the dilation of small blood vessels. This effect on blood flow 
could presumably decrease the available substrates and lead to the 
onset of catabolic action. Munck and Wira (1971 and 1972) take the 
view that the events which precede the phenotypic response of 
respective target tissues begin with the rapid entry of the 
corticosteroids into the cell and proceed via an initial binding of d
Ithe hormone to specific cytoplasmic receptors which constitute a d
carrier system designed to transport the steroids to their ultimate 
site of action. This primary interaction serves in some way, 
possibly throu^ an aliosteric mechanism to direct the
J
■ÿ
hormone-receptor complex to the nucleus at which level the action 
of the steroid may govern the specific responses observed in the 
target tissue. Munck*s hypothesis is illustrated in Fig. 3 in 
relation to the atrophying effect of glucocorticoids on rat thymus 
cells.
Another mechanism through which a hormone can act is a 
membrane-mediated process involving cyclic AMP. This is the 
* secondary messenger* theory proposed by Sutherland (1965) from i
his studies of the stimulation of glycogenolysis by epinephrine 
and glucagon. Although this theory is broad enough to embrace 
the possibility that corticosteroids too may act by altering 
intracellular cAMP levels, there is no evidence for oAMP 
involvement in corticosteroid action (Granner et al. I968; Soifer 
and Hechter, 1971; Szego 1971» Bakken et al, 1972). However, as 
a consequence of the observation that there is a dose-related 
effect of added prostaglandins on cAMP levels in mouse ovary 
(Kuehl, 1973) it has been suggested (Ramay, 1975) that 
corticosteroids may act by controlling prostaglandin formation.
There is however no experimental support, at the present time, for v
'4this hypothesis,
Corticosteroid Actions at the Transcriptional Level
Although they were thought of initially as inhibitors of 
protein synthesis and stimulators of protein breakdown (Long et al.
I96O; Mayer et al. 1976; Millward et al. 1976) corticosteroids have 
also been shown to cause elevation of liver weight, protein, and 
RHA content in rats and mice (Amaral and Moriba 1967» Ottolenghi 
and Barnabei, I970)• Are there then significant differences
I
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FIG, 3 Interaction of glucocorticoids with rat thymus cells and its relationship with effects on target cells (Munck and Wira, 1971) .
(Dashed lines and parentheses indicate relationships for which evidence is still circumstancial)•
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between catabolic and anabolic sites of corticosteroid action in 
terms of events which precede the response of respective tissues 
or are there unifying principles underlying the preliminary steps 
prior to these responses? The answer to this question is still 
elusive despite the extensive investigative work in this field#
A full biochemical understanding of these responses would require 
elucidation of each step leading up to the observed response, a 
task which, at the present time, does not seem to have been 
accomplished for any corticosteroid.
It has been known for some time (Long et al, 1940) that 
adreno-cortical hormones stimulate hepatic gluconeogenesis at the 
expense of protein derived from other tissues, principally skeletal 
muscle. Since then. Smith and Long (1967) have demonstrated an 
increased mobilisation of amino-acids from skeletal muscle and a 
decreased incorporation of these amino-acids into muscle protein 
following the treatment of rats with cortisol. This decreased 
incorporation of amino-acids into protein occurs in spite of the 
enrichment of the intracellular and plasma concentrations of free 
amino-acids a few hours after corticosteroid treatment (Kaplan and 
Shimizu, I963; Betheil et al# I969) and cannot, therefore, be 
attributed to some corticosteroid-mediated inhibition of amino-acid 
transport (Manchester et al, 1959» Kostyo and Redmond, I966; Makman 
et al. 1968)# If, on the other hand, corticosteroids acted to 
reduce the rate of muscle protein synthesis, such an action would . 
explain the intracellular accuiimlation of free amino-acids and 
their subsequent passage into the plasma could lead to increased 
levels of free amino-acids. Amino-acid metabolism can be
11
simplified by writing;
. (1) (2)Protein ' C Amino-acid  >■ ÏÏrea + Co^ + H^O
where (l) is the anabolic fate and (2) the catabolic fate of the 
amino-acid. The increased urea formation in the liver following 
corticosteroid treatment (Smith and Long, I967) would suggest, 
therefore, that in the liver, as in the muscle, corticosteroids 
have a catabolic effect causing some loss of protein., The 
question then must be whether the increased incorporation (anabolic 
fate) of amino-acids into liver protein following corticosteroid 
treatment (Komer, I960) is due to increased availability of 
amino-acid from other tissues and whether this anabolic fate is 
secondary to a general catabolic effect of corticosteroids on all
tissues. An alternative view, that the catabolic action of a
corticosteroid on muscle or other extra-hepatic tissue was due to 
a primary stimulation of protein synthesis in the liver and a 
resultant hepatic demand for muscle-derived metabolites, has been
suggested by Dunn et al. (1971)* In an investigation of this
possibility, Mayer and Rosen (1975) established the presence of 
corticosteroid receptors in muscle tissue. Other workers had 
previously demonstrated the presence of such receptors in the 
liver (Litwack et al. 1973)* It would appear, therefore, that the 
muscle and the liver are independent and direct targets for 
corticosteroid action and that attention should novf be concentrated 
on finding out how corticosteroids affect protein synthesis and 
breakdown in each of these tissues independently.
Could a corticosteroid exert selective effects on gene
12
transcription? In experiments with actinClmycin D, Garren et al 
(1964) showed that the hydrocortisone-induced synthesis of 
trytophan pyrmLase and tyrosine transaminase in rat liver did not 
occur when actinomycin D was administered together with the 
hormone. Actinpmycin D inhibits ENA synthesis by binding 
selectively to DNA (Barnabei et al. 19&5) and these findings of 
Garren and his co-workers are, therefore, consistent with hormonal 
regulation at a transcriptional level. Given the present 
understanding of the process of genetic transcription to form 
messenger RNA and the role of this RNA in polysome formation and 
coding of amino-acid sequences, hormonal regulation of protein 
synthesis at this level, by a gene,^ hormone interaction, is an 
attractive proposition (Monod et al. 1963; Beato et al. 1973; 
Rousseau et al, 1975; Simons et al, 1976). It is now accepted 
that DNA binds steroid hormone-receptor complexes (Rousseau et al. 
1975) and that there are different nuclear- and DNA- binding forms 
of the hormone^receptor complexes (Simons et al. 1977)* If 
corticosteroids do control biological responses at this level, 
the different responses in the liver and muscle may reflect the 
ability of the hormone to cause induction and repression at 
different regions of the same genome. In this regard it is of 
interest that administration of cortisol was shown to induce 
formation of new messenger RNA and to stimulate synthesis of 
primary transcription products of the ribosomal RNA gene, in general, 
in livers of control rats and rats which had undergone partial 
hepatectomy (Drews and Brawerman, I967).
In the lymphoid cells there are indications that
13
glucocorticoids act initially to initiate nuclear synthesis of a 
specific protein that causes cell atrophy hy inhibiting glucose 
transport (Munck et al, 1972)• A selective inhibition of the 
synthesis of RNA molecules as well as an inhibition of RNA 
polymerase (B.C. 2.7.7*6) activity has been demonstrated in rat 
thymus cells (Abraham and Sekeris, 1971). The view that 
corticosteroids exert their primary action within the confines of 
the thymus cell nucleus is also supported by Drews and Wagner 
(1970) who showed that prednisolone decreased the ability of rat 
thymic nuclei to synthesise ribosomal ENA.
It has been known for some time that a rise in liver ENA 
polymerase is an early response to corticosteroid administration 
(Barnabei and Florin!, I964; Barnabei et al. 1965» Yu and 
Feigelson, 1971). There is evidence too that RNA polymerase 
activities in the rat thymus are altered following corticosteroid 
treatment (Drews and Wagner, 1970; Bell and Borthwick 1976). It 
would seem a reasonable assumption, therefore, that alterations in 
this enzyme may be involved in the corticosteroid control of ENA 
synthesis.
A major advance in the understanding of the mechanism of 
transcription control in nuclei of eukaryotes has been the discovery 
of multiple forms of nuclear DNA- dependent RNA polymerase which 
differ in their structure, location and function (Jacob 1973» 
Chambon, 1975). Widnell and Tata (1964 and I966) described two 
different ENA polymerase reactions in rat liver nuclei, an Mg'*'^- 
activated enzyme reaction resulting in rRNA- like RNA production 
and an Mn**"^ +(NH^ ) ^SO -^ activated enzyme producing messenger-like
14
ENA. Other workers have identified classes of ENA polymerase 
using methods based on the order of their elution from DEAE-Sephadex 
(Boeder and Rutter, I969) and on their resistance to inhibition by 
«C-arnanitin (Kedinger et al, 1970). °(-Amanitin is a poison 
isolated from toadstools and, in vitro, it inhibits the RNA 
polymerase involved in the synthesis of DNA-like RNA whereas the 
enzyme transcribing the ribosomal genes is not affected (Kedinger 
et al, 1970) • Eukaryotic RNA polymerases are now usually 
classified with respect to their response to this substance and 
studies by high-resolution autoradiographic (Maul and Hamilton,
1967) and cell fractionation (Yu and Feigelson, 1971; Barbiroli 
et al. 1975) techniques have established that the amanitin-resistant 
enzyme is preferentially located in the nucleolus while the 
amanitin-sensitive enzymes are found in the nucleoplasm. This 
would suggest that the synthesis of ribosomal RNA occurs in the 
nucleolus while messenger-like RNA is produced in the nucleoplasm. 
The existence of multiple RNA polymerase forms with distinct 
subcellular localisation and with specific functions strengthens 
the hypothesis that these enzymes may regulate gene expression by 
specific recognition and transcription of different genes or 
different classes of genes. Several lines of biochemical, 
autoradiographic and electron microscopic evidence (Jacob et al.
1970 ; Tata et al. 1972; Has tie and Mahy, 1973) support this view. 
Although there is, at present, no evidence that eukaryotic genomes 
contain regulatory sites similar to the prokaryotic promoter and 
termination regions (Losick, 1972; Chamberlain, 1974)» the 
similarity between the polymeric molecular structure of the
15
prokaryotic and eukaryotic RM polymerases (Chambon, 1975) 
suggest that regulatory mechanisms in prokaryotes might have 
their counterparts in eukaryotic cells. The different eukaryotic 
E M  polymerases could, therefore play a positive role in 
regulating the expression of genetic information. Corticosteroids 
might control these processes by causing alterations in the number 
of DNA sites available to the enzyme for transcription (Dahmus and 
Bonner, 1965), by acting directly on the enzyme and possibly causing 
allosteric alterations to change the enzymic activity (Sadjel and 
Jacob, 1971) or by a combination of both of these factors (Yu and 
Feigelson, 1971)•
In an effort to localise the site of cortisol action, in vivo, 
in rat thymus cells, Nakagawa and White (1970) investigated some 
properties of ‘aggregate* ENA polymerase preparations from 
cortisol-treated animals. ‘Aggregate* ENA polymerase is a 
polymerase-DNA-protein complex, obtained by lysing the isolated 
nuclei with hypotonic buffer, selectively precipitating the complex 
with MgCl2 and, finally, collecting the complex by centrifugation.
In preparations from hormone-treated animals there was a general 
depression of RNA polymerase activities associated with a 
depression of synthesis of all types of ENA. From investigations 
of the ability of E. Coli RNA polymerase to utilise the DNA 
template in the ‘aggregate* enzyme preparations for RNA synthesis, 
Nakagawa and White (I970) concluded that cortisol altered the 
efficiency of the DNA template through alterations in the nuclear 
ionic environment. In the soleus muscle of rats in which 
compensatory hypertrophy had been induced by tenotomy of the
16
gastrocnemius and plantaris muscles, Sobel and Kaufman (1970) 
reported a biphasic alteration of KNA metabolism; an early 
activation of ENA polymerase caused by some yet unidentified but 
possibly ionic change in the intracellular environment preceded 
an increased synthesis of the enzyme after 24 h. It would appear 
therefore that in the muscle, as in the thymus and liver, RNA 
synthesis may be regulated by varying levels of ENA polymerase 
activity. Two separate studies of BNA and protein synthesis in 
dystrophic chick muscle reported apparently conflicting findings 
(Baieve and Plorini, 1970; Battelle and Florin!, 1973). This 
discrepancy has since been attributed to artefactual alterations 
in activated EM polymerase activity caused by changes in
the integrity of the endogeneous DKA template (Neal and Florini, 
1975). More rapid degradation of the template was believed to 
occur in the dystrophic animal and there was, therefore, 
differential mechanical damage of nuclei during isolation 
procedures. The results with these isolated nuclei were, 
therefore, critically dependent on the ENA polymerase assay 
method and the length of the incubation time in these assays 
(Neal and Florini, 1975)*
Corticosteroid Control of Translational Processes
There are strong indications that, at least in certain specific 
cases, corticosteroids may also exert control of protein synthesis 
at the translational level. Bullock et al (I968) showed that the 
capacity of isolated preparations of muscle ribosomes to synthesize 
proteins was reduced following the injection of corticosteroids 
into rats and rabbits. A corticosteroid could influence cellular
17
protein synthesis by modulating initiation (Young et al. I968).
This view is not, however, supported by the work of Peters et al 
(1970) who showed no apparent difference in polysomal profiles 
isolated from normal or triamcinolone-treated rats, although the 
latter polysomes showed a much decreased capacity for protein 
synthesis. Furthermore, Clark and Goodlad (1975) have shown, from 
a study of the translational process in the gastrocnemius muscle 
of normal and tumour-bearing rats that, where a tissue suffers a 
preferential depletion of protein, protein synthesis could be 
affected at some post-initiation stage of translation, possibly 
translocation. It would seem, therefore, that corticosteroids 
might control factors other than the free/bound ribosome ratio to 
elicit the responses they produce in target organs. When 
actinomycin I) was administered to rats 5 ~ 9 h after hydrocortisone 
injection, there was an increased synthesis of tyrosine 
transaminase in the liver. This increase was not observed in the 
absence of the antibiotic and this observation supported the view 
that, following steroid treatment, a repressor appears which 
inhibits further protein synthesis by inhibiting the function of 
messenger BNA (Garren et al, I964). Actinomycin D presumably 
blocked the transcription of the message for this repressor.
These findings are in accordance with the model proposed by 
Tomkins et al (I969 and 1972). This model acknowledges that the 
eukaryotic cell does not express its full genetic potential and 
that different cell types may express different portions of their 
genome. In all cases DNA remains the primary genetic material 
and genetic information is expressed by DNA transcription into
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BNA. According to this model, illustrated in Pig. 4» the hormonal 
regulation of the synthesis of a specific protein entails two 
genes, a structural gene for the specific protein and a regulatory 
gene whose protein product (repressor) inhibits translation and 
promotes the degradation of messenger ENA. For the synthesis of 
a specific protein, the structural gene is transcribed and its 
messenger (M) translated to produce the protein. The regulatory 
gene is similarly transcribed and its messenger translated to 
produce a labile protein, the repressor, which combines reversibly 
with M to produce an inactive messenger^repressor complex. A 
steroid can act as an inducer which, by an unknown mechanism, 
inactivates the repressor preventing the conversion of the 
messenger to a repressed form. Thus the steroid inhibits the 
degradation of the messenger allowing its concentrations to 
increase and thereby augmenting the rate of synthesis of the 
specific protein. In principle, the Tomkins model relates the 
hormonal control of gene expression to a post-transcriptional 
repressor mechanism.
Corticosteroid Effects on Ribosomal BNA Turnover
Some attention has been focussed on the possibility that 
corticosteroids may exert their effects by interfering with BNA 
synthesis (Makraan et al. I966 and 1968; Abraham and Sekeris,
1971 ; Bell and Borthwick, 1976). In particular, it has been shown 
that an alteration in ribosomal BNA synthesis is one of the 
earliest responses to corticosteroids in rat liver (Yu and 
Feigelson, 1971) and in rat thymus cells (Drews and Wagner, 1970)•
In eukaryotic cells, ribosomal ENA, like other cytoplasmic
19
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M A  species originates from the transcription of nuclear D M  (Maden, 
1971) and is transcribed from D M  sequences located in the 
nucleolus (Evans, 1973). The primary transcription product is a 
45s-sedimenting species which undergoes a series of * tailoring* 
and base modifications to yield the 28S and 18S M A  found in 
eukaryotic cytoplasmic ribosomes (Adams et al, 1976). It is 
generally agreed that the bulk of mammalian cellular ribonucleic 
acid is ribosomal (Hirsch, 1967; Millward et al. 1973) and the high 
complexity of the architecture of eukaryotic ribosomes supports the 
idea that expression of genetic information in animal cells can be 
controlled at the ribosomal level (Sielka, 1978; Rogers, 1978).
The activity and turnover of ribosomes and ribosomal MA are, 
therefore, important considerations in the study of the expression 
of genetic information in eukaryotes.
There is increasing evidence that dietary manipulations of 
mammalian cells play an important role in regulating ribosomal MA 
synthesis. Hela cells starved for lysine showed decreased 
ribosomal M A  synthesis (Malden, I969) and the lack of amino-acid 
inhibited the transport, from nucleus to cytoplasm, of ribosomal 
R M  of Ascites tumour cells (Shields and Komer, 1970) « Dietary 
protein intake (Clark et al. 1957» Shaw and Pilios, I968; 
Wannemacher et al. 1971) and food deprivation (Bnwonwu et al. 1971) 
have also been shown to affect ribosomal M A  turnover in the rat 
liver. Such changes in the rat liver may be due to changes in the 
rate of M A  synthesis (Hirsch and Hiatt, I966; Kawada et al. 1977; 
Lewis and Winick, 1978) or to changes in the translation of MA 
(Enwonwu and Munro, 1970). Dietary conditions have also been shown
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to alter the rate of total ENA synthesis in the rat gastrocnemius 
muscle (Howarth and Baldwin, 1971) * If it is accepted that more 
than 8C^ of muscle ENA is ribosomal (Manchester, 1967; Young, 1970), 
a change in total BNA serves as a good indication of a change in 
ribosome content. There is also evidence that the activity of 
muscle polyribosomes are altered by dietary conditions (Young and 
Alexis, 1968; Van der Beken and Olmstedt, I970).
Corticosteroids too can alter ribosomal activity and both 
corticosterone and hydrocortisone have been shown to restore to 
normal, the decreased turnover rate of ribosomes and polysomes in 
the liver of adrenalectomised rats (Mishra and Peltham, 1973).
These workers concluded that these hormones acted to increase 
ribosomal ENA synthesis, a view which is supported by the findings 
of Schmid and Sekeris (1975) who showed that nucleolar ENA 
synthesis in rat liver was significantly enhanced 4 b. after cortisol 
administration. Izawa and Ichii (1972 and 1973)» however, hold the 
view that the increase half-life of free and membrane-bound 
ribosomes of rat liver, following cortisol treatment, was due to a 
decreased degradation of ribosomal ENA. Ottolenghi and Barnabei 
(1970) had attributed the cortisone-mediated increase in rat liver 
ribosomal ENA to decreases in both the synthesis and the 
degradation of this ENA. There are no comparable results of the 
effects of corticosteroids on muscle tissue but hormonal influence 
on muscular ribosomal ENA metabolism has been demonstrated by King 
and King (l97&) from studies of thyroid hormone effects in the 
chick embryo. Previously, Peters et al (1970) had shown that 
ribosomal activity in rat gastrocnemius muscle was decreased by
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treatment with triamcinolone acetonide. These workers attributed 
this alteration to a decreased ENA synthesis, a finding which 
agreed with that of Drews (1969) who investigated the effect of 
the same steroid on rat thymus cells. Ferguson and Wool (1962) 
had, however, reported no change in ENA synthesis in isolated 
diaphragm muscle in rats given cortisol for four days.
It would appear, therefore, that glucocorticoids can affect 
different tissues in different manners (Werthamer et al. I969,
Izawa and Ichii, 1972) and that the effects of the hormones on 
ribonucleic acid turnover and on the turnover of ribosomal ENA in 
particular might be important factors in this respect.
Corticosteroid Action on Eibonuclease Activities
Several workers (Barnabei and Ottolenghi, I968; Kraft and 
Shortman, 1970; Eosso et al, 1973; Goodlad and Ma, 1974) have 
demonstrated a relationship between the level of tissue ENA and 
the level of ribonuclease activity in the tissue. Some (Wiemick 
and Macleod, 1965; Barnabei and Ottolenghi, I968; Groves and Sells, 
1971) have shown that, where alterations in ENA levels occur in 
response to steroid treatment, there are related changes in the 
activity of ribonucleases, A steroid might therefore control ENA 
metabolism by regulating ribonuclease activity.
Although mammalian ribonucleases have been studied 
extensively, their physiological roles are still poorly understood. 
Here the term ’ribonuclease* will be used to describe an enzyme 
which degrades macromolecular ENA but will not include enzymes 
which have the general capability to split phoj^ hodiester bonds 
(phosphodiesterases) or enzymes which hydrolyse both ENA and DNA.
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Three main types of ribonucleases have been reported in rat liver 
subcellular particles and some of their properties have been 
studied. Acid ribonuclease':' (E,C, 3,1,4*23) is predominantly 
located in lysosomes although Roth (1957) found a similar enzymic 
activity in the rat liver mitochondria. It has a pH optimum at 
5*8, is generally believed to have a purely digestive function and 
is released under conditions of injury or stress or by dead or 
dying cells to degrade ENA to products which can be re-utilised. 
Two types of alkaline, ribonucleases (E.G. 3,1,4*-) with pH 
optimas between 7*0 - 8,0 and 9*0 - 9*5» respectively, have been 
isolated although controversy persists about their subcellular 
location. The mitochondria (Eoth, 1965; Baudhuin et al. 1975) the 
post-mitochondrial supernatant (Roth, 1967; Baudhuin et al. 1975) 
and a ribosomal subunit (Krechetova et al, 1975) have all been 
cited as locations for alkaline ribonuclease activity. It seems 
clear, however, that most of the alkaline ribonuclease activity 
is found predominantly in the post-mitochondrial fraction (Rahman, 
1967), that the enzyme has no particular metal requirement and 
that it can withstand a temperature of 70^ 0 for five minutes. An 
enzyme which shows optimal activity at pH 9*0 has been shown to 
occur mostly in the mitochondrial membrane, is strongly inhibited 
by Na^ and and is very heat-labile.
The existence of a ribonuclease inhibitor which depresses the 
activity of the pH 7*8 enzyme has been reported (Shortman, I96I; 
Eoth, 1962), This inhibitor has been shown to be a labile protein 
readily inactivated by heat and extremes of pH, It is dependent 
for its activity on the integrity of one or more -SH groups and
/
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shows optimal inhibition in the pH 8,0 region. It would appear, 
therefore, that although the pH 7.8 ribonuclease is readily 
available to digest cellular ENA, an effective and controllable 
means of regulating its activity is also present in the inhibitor. 
The practical details of ENA se estimation in the presence of the 
inhibitor have been described by Shortman (I96I). By performing 
the enzyme assays in the presence or absence of 
p-chloromercuribenzoate (PCMB), a reagent which inactivates the 
inhibitor by destroying its sulphydryl groups, he was able to 
quantitate the free ENAse activity in the cell as well as the 
* latent* enzyme activity which was released only when the 
inhibitor had been inactivated by PCMB, In regenerating rat liver 
Shortman (1962) noted increasing levels of this inhibitor. High 
levell5 of the inhibitor activity were found in a variety of 
circumstances where cell proliferation or protein synthesis were 
increased and these levels dropped during ageing (Kraft and 
Shortman, 1970), Ma (1973) also noted decreased alkaline 
ribonuclease activity and increased ENAse inhibitor activity in 
the liver of the pregnant rat. These reports along with those of 
Brewer et al (I969) suggest that increased catabolic activity in 
cell could be associated with a decreased inhibitor/ENAse ratio 
and that a high ratio is observed in increased anabolism.
In summary, it seems that RNAse activity is detectable in 
most subcellular fractions, that this activity varies with the 
level of inhibitor activity present, and that the 
ribonuclease/inhibitor system may be a means of controlling 
cellular ENA and hence protein, metabolism. Various relationships
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between hormone administration and ribonuclease activities have 
been demonstrated (Temer et al, 196?» Barnabei and Ottolenghi, 
1968; Groves and Sells, 1971» Maor et al, 1973) and direct hormone 
effects on mitochondrial concentrations of RNAses have been 
suggested (Allard et al, 1956)• It is conceivable too that there 
might be a tissue specificity about the hormonal control of 
ribonuclease activity. Cortisone has been shown to increase 
alkaline ribonuclease activity in the thymus, spleen and lymph 
nodes of mouse but not in the liver (Maor et al, 1973Band 1976) and 
a wide variety of glucocorticoids, including prednisolone, have 
been shown to decrease the activities of neutral ribonuclease in 
mouse liver and skeletal muscle (Kershner and Mayer, 1976), Thus, 
variation of ribonuclease activity must be considered as a possible 
factor in the action of corticosteroids on muscle and liver ENA,
Eole of Eeceptors in Corticosteroid Action
If corticosteroids do interact directly with target tissues, 
they must first be carried to these tissues, a function which for 
cortisol in human plasma is known to be fulfilled by transcortin, 
a specific alpha globulin (Sanberg and Slaunwhite, I963),
Werthamer et al (1969 and 1971) who examined the in vitro effects 
of cortisol and prednisolone on separate populations of 
lymphocytes and leukocytes have demonstrated the dependence of 
these hormones on the presence of transcortin. It would seem 
reasonable, therefore, to suggest a mediatory role for this carrier 
protein in the action of a corticosteroid. However, dexamethasone, 
a potent glucocorticoid, does not bind to transcortin (Eousseau 
et al. 1972) and there are no reports of prednisolone binding to
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the protein in vivo. Therefore, the evidence that the biologic 
activity of a corticosteroid is regulated by transcortin is by 
no means unequivocal. '
As a result of the increasing evidence for the existence of 
specific binding sites for hormones in their target tissues 
(Hackney et al. 1970; Munck et al. 1972; Simons, 1977) considerable 
attention is now being focussed on the interaction of a hormone 
with receptors located in the target tissue. Classical 
pharmacology defines a receptor as a transducer which converts 
input information (i.e. the circulating hormone) into biological 
response. Some of these receptors have been isolated and their 
structure shown to be protein. Thus hormone-binding activity was 
destroyed by extreme pH, by proteolytic enzyme and by -SH 
group-inactivating reagents (Munck et al. 1972; Thompson and 
Lippman, 1974)• Receptors appear to be the determinants of target 
tissue specificity (Gorski et al. I968) and the hormone-receptor 
interaction is believed to be the initial event in the sequence of 
changes leading up to the observed biological response (Lippman 
et al. 1973; Baxter and Porsham, 1974; Kondo et al, 1975; Yamamoto 
and Alberts, 1976; 0*Malley and Buller, 1977). Since the receptors 
are not retained by nuclei in the absence of the hormone (Buller 
et al. 1975) it is probable that the hormone induces some 
alteration in the conformation of the receptor which facilitates 
the translocation of the hormone-receptor complex to the nuclear 
compartment where it is believed to act directly on the genetic 
apparatus of the cell (Baxter and Porsham, 1974; Yamamoto and 
Alberts, 1971; O'Malley and Buller, 1977).
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Over the past decade, many experimental data relating to 
these theoretical considerations have accumulated (Munck et al,
1972; Buller et al, 1975» Mayer et al. 1976; O'Malley and Buller, 
1977)• In particular, the experimental data on estrogen and 
progesterone activities in the rat uterus and chick oviduct, 
respectively, (O'Malley and Means, 1974; O'Malley and Buller,
1977) have improved current understanding of the action of steroid 
hormones and their receptors, in general. It was accepted that 
(a), the proteins which hind these hormones were limited to their 
respective target tissues and attracted only the biological active 
hormone, either naturally occurring or synthetic; (b), the 
cytoplasmic hormone-receptor complex had a sedimentation coefficient 
of about 48 but was capable of association with other binding 
entities, in conditions of low ionic strength, to form an 8S 
complex; (c), an estrogen-induced conformational change occurred 
in the uterine cytoplasmic receptor protein and this was followed 
by the translocation of the hormonelreceptor complex to the 
nucleus were it induced changes in gene expression; (d) , the 
translocation process was temperature dependent (37°C) and 
required the alteration of the hormone-receptor complex to a 
5S-sedimenting form; (e), in the nucleus, the hormone-receptor 
complex interacted with nuclear chromatin binding firmly but 
non-covalently in two parts, to the chromatin BNA and to 
non-histone (acidic) acceptor proteins of the chromatin; (f), the 
binding to the genome induced alterations in the composition, 
steric conformation, or both of the chromatin resulting in the 
changes which constitute the hormone-mediated biologic response.
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The conceptual relationship vrhich might exist between the hormone, 
its receptor and the genetic apparatus is illustrated in Pig. 5* 
This sequence of events, although largely derived from work with 
oestrogens, is believed to apply to steroid hormones in general.
It has not been demonstrated directly that the binding of the 
hormone-receptor complex to chromatin resulted in alterations of 
rates of nuclear transcription but indirect evidence (Hamilton 
et al, 1968; Luck and Hamilton, 1972; Glasser et al, 1972) support 
the view that synthesis of ENA plays a major role in the 
subsequent events which culminate in the biological response.
Scope of the Present Work
The present work constitutes an attempt to explain the diverse 
effects which corticosteroids elicit in manmalian tissues and, in 
particular, the action of prednisolone on skeletal muscle ENA, It 
seems unlikely that a single biochemical alteration in all tissues 
can conclusively explain all these effects. However, all 
phenotypic expression require some generation of ENA and protein. 
Since the events leading up to the formation of ENA and protein is 
common to all target tissues, this work will concentrate on these 
transcriptional and translational events. In an attempt to 
understand how prednisolone elicits its opposite effects on 
mammalian liver and muscle, the effect of treatment with this 
steroid or ENA metabolism in these two tissues in the rat, will 
be examined. The influence of prednisolone on various aspects of 
ENA synthesis and breakdown in these tissues will be investigated 
and information will be sought on how prednisolone receptors in the 
cytosols of these tissues may confer organ specificity to 
prednisolone-mediated responses.
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A B S T R A C T
It has been demonstrated that administration of prednisolone to 
rats causes loss of RFA and protein in the gastrocnemius muscle and 
increases in RFA and protein levels in the liver.
These changes have been shown to involve alterations iii RFA 
turnover in the two tissues. In liver, rate of synthesis of ribosomal 
RFA was shown to be increased and its rate of breakdown decreased 
following administration of prednisolone. In muscle, the steroid 
caused net decreases in rates of synthesis and breakdown of ribosomal 
RFA. These prednisolone-induced alterations in RFA turnover were not 
the result of changes in the RFA precursor pool in the tissues.
Prednisolone treatment was shown to cause an increase in the 
activity of the RFA polymerase believed to be responsible for ribosomal 
RFA synthesis in the liver. This enzyme activity in the muscle was 
decreased following administration of prednisolone. Ribonuclease 
activity was decreased in the liver and muscle of prednisolone-treated 
animals. These alterations of enzymic activities could explain the 
observed changes in RFA turnover in prednisolone-treated animals.
More prednisolone binding occurred in the liver cytosol than 
occurred in the muscle cytosol. Prednisolone receptors in the muscle 
appeared to be of a smaller molecular size than receptors in the liver.
The prednisolone-receptor complexes from muscle were less stable in a
low ionic environment than complexes from the liver. These 
quantitative and qualitative differences may have dictated the 
response of each tissue to prednisolone.
In the course of this work conditions have been established for
isolating cytoplasmic RFA from rat gastrocnemius muscle in an 
essentially undegraded form and in good yield.
2. MATERIALS AND METHODS
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CHEMICALS MB REAGMTS
Wherever possible ’Analar' grade chemicals and reagents were 
used in these studies.
Sodium dodeovi:,' sulphate (SDS)
Sodium dodecyi':' sulphate was obtained as a white powder from 
British Drug Houses (Poole, England). Before use it was purified 
by extraction in boiling ethanol, lOOg of the powder were poured 
into 3 1 of boiling ethanol and boiled for 10 min, with continuous 
stirring. Thereafter it was filtered, hot, through a J-inch thick 
Hyflo supercel pad supported on a Whatmanh' Fo, 1 filter paper on 
a Buchner funnel. The filtrate was allowed to stand overnight at 
4°C to allow crystallisation of SDS. The crystals were collected 
by filtration and the material dried by washing with diethyl ether, 
filtering again^  and finally dried at 37^ 0 overnight. The yield was
% of the starting material,
Hyflo supercel
Hyflo supercel was obtained as a white powder from Koch Light 
Laboratories (Bucks, England). Before use it was washed with 2 vol 
of l.OM FaOH and collected on Whatman' Fo, 1 filter paper by 
vacuum filtration. Thereafter the material was washed with 3 vol 
of l.OM FaOH followed by several washes with distilled water until 
the filtrate was neutral with respect to pH, The preparation was 
next washed with 5 vol l.OM HCl and then with distilled water to a 
neutral pH, The material was dried at 37^ C and stored at 20°C 
until required.
Bentonite
Technical grade bentonite was obtained as a brown powder from
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British Drug Houses (Poole, England), Before use it was purified 
by suspending ^g in 100ml of distilled water. The suspension 
was stirred vigorously for 20 min, at 20°C and coarse particles 
were sediraented by centrifugation at lOOg on the MSE 6L centrifuge 
for 10 min, at 1 0 and discarded. The fine clay suspension was 
decanted off and centrifuged at 9000g for 20 min, at lO^ C, The 
supernatant was discarded and the sediment was resuspended in 40ml 
of 0,01M sodium acetate buffer, pH 6,0, After the suspension was 
stirred vigorously for 20 min, at 20°G, it was centrifuged at 9000g 
for 10 min, and the supernatant was discarded. This buffer wash 
cycle was repeated until the supernatant liquid registered a 
negligible optical density (< 0,04) at 260nm, Finally the material 
was dried at 37^ 0 and stored at 20°G,
Activated charcoal
Animal charcoal was obtained as a black powder from British 
Drug Houses (Poole, England) . Before use it was activated by 
washing l80g successively with 5 1 of 0,1M HGl, 2 1 5/^ (w/v) KGl, 
200ml O.IM Ba(0H)2 and 2 1 5^ (w/v) KGl. After each wash the 
material was sucked dry over a Whatman'; No, 42 filter paper in a 
Buchner funnel. Following the last wash, the material was 
incubated at 100°G overnight. The activated charcoal was stored 
in an air-tight jar at 20^ G,
DE-52 Gellulose
DE-52 cellulose is the anion exchange resin diethylaminoethyl 
cellulose whose active group is of the following composition ;
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where R represents a glucose unit in the cellulose chain.
The resin was obtained from Whatman Biochemicals Ltd,
(Maidstone, England) and before use freed of 'fines* by suspending 
the desired quantity in 10 vol of distilled water and pouring off 
particles which did not settle under gravity after the suspension 
had stood for 1 h at The resin was then washed with gentle
stirring in 10 vol 2.0M NaOH and, thereafter, in 10 vol 4»0M HCl,
Each wash was maintained for 30 min. The resin was finally washed 
repeatedly with O.OOIM sodium phosphate buffer, pH 7*4 until the 
pH of the supernatant liquid rose to 7*4. The resin was 
equilibrated with the buffer overnight at 4°G before use,
Girrasol
Girrasol was a gift from Imperial Chemical Industries Ltd, 
(Manchester, England), It was stored at 20°G and used without 
further purification,
Folin and Ciocalteau phenol reagent
Folin and Ciocalteau phenol reagent was obtained from British 
Drug Houses (Poole, England), It was stored in a dark bottle at 4°0.
Bovine Serum Albumin
Bovine serum albumin (Fraction Y powder) was obtained from 
Sigma Chemical Go, Ltd. (London, England), It was stored at -15°G 
in an airtight jar containing granules of silica gel and was used 
without further purification.
Desoxyribonucleic Acid (DNA) standard
DNA from calf thymus was obtained from Sigma Chemical Go. Ltd. 
(London, England) . It was stored at -15^ G and was used as an aqueous
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solution at a concentration of 40/*^  per ml.
Ribonucleic Acid (RNA) Standard
RFA isolated from bakers' yeast (Saccharomyces cerevisiae) 
was used as the standard RFA in this study. The choice of bakers' 
yeast RFA as a suitable standard was based on its easy extraction 
in essentially pure form from this readily-available source. 
Significant differences in purine/pyrimidine ratios have been shown 
to exist between RFAs from different sources (Adams et al. 1976) 
and it is acknowledged that in colorimetric determinations of RFA 
which measure only purine-bound ribose (as in Orcinol reaction) 
considerable error is introduced if the base ratio of the standard 
differs markedly from that of the material being assayed. However, 
in this study, such errors affect RFA levels in 'control' and 
'test' animals to the same extent and should not influence any 
differences detected between these two groups.
The extraction procedure was that described by Grestfield 
et al, (1955)» This method depends on the ability of SDS to 
dissociate RFA from its accompanying protein without depolymerising 
the nucleic acid. The detergent-protein complex is salted out and 
removed by centrifugation. The RFA is then subjected to further 
purification steps,
300g of bakers* yeast purchased from a local bakery were cut 
into fine pieces which were then poured into 1,0 1 of an aqueous 
solution, at lOO^ G, containing 2^ (w/v) SDS, 4*5% (v/v) ethanol, 
12,5 mM FaHgPO^ and 12,5 mM Fa H^PO^ , The mixture was stirred 
constantly with an overhead motor-driven stirrer for 2 min, during 
which the temperature was maintained between 85° and 90®c, To
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reduce foaming the beaker and its contents were transferred to a 
boiling water bath and heating and stirring were continued for a 
further 5 min. This combination of heat and detergent treatment 
is believed to inactivate completely any ribonucleases which could 
cause enzymic degradation of the RFA (Grestfield et al. 1955)• At 
the end of the heating period the hot mixture was poured into a 
2-1 beaker cooled in ice. The suspension was stirred in the cold 
room until the temperature dropped to after which the mixture 
was centrifuged at 600g ave. for 30 min. at 2°G to sediment the 
debris. Crude RFA was precipitated from the supernatant fractions 
by pouring the pooled fractions into 2 vol of ice-cold ethanol.
The precipitate was collected by centrifugation at 600g ave, for 
15 min, at 2^ G and washed twice with 300ml portions of ice-cold 
675^  (v/v) ethanol containing 2ml 2.0M FaGl, Maximal removal of 
SDS and protein material during this washing was ensured by stirring 
the precipitate continuously with a glass rod while the wash 
solution was added slowly. FaOl was necessary to facilitate 
floculation and recovery of RFA, The crude RFA was suspended in 
300ml of 80^  (v/v) ethanol and the mixture kept overnight at 4^ 0,
The crude RFA was then sedimented by centrifugation at 600g ave, 
for 15 min. at 2°G and dissolved in 300ml of distilled water. The 
turbid solution was titrated to a neutral pH with l.OM acetic acid 
and clarified by centrifugation at 35»OOOg ave, for 1 h at 2°G on 
the MSE super 18 centrifuge. Sufficient solid FaGl was added to 
the pooled supernatant fraction to make the medium l.OM with respect 
to the salt in order to dissociate histones from the RFA (Marko and 
Butler, 1951)• The mixture was kept in ice for 1 h during which
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time a gel of RFA was formed. The yellow supernatant fluid was 
separated by centrifugation at 600g ave. for 1 h at 2°C and 
discarded. The gel was washed 3 times with 200ml portions of 
ice-cold 679^ (v/v) ethanol containing 2ml 2.0M FaGl and dissolved 
in 200ml of ice-cold distilled water by stirring. This solution 
was transferred to a dialysis bag and dialysed against 6 changes 
of distilled water in the cold room at 4^ 0 for 36 h. The turbid 
solution was filtered by vacuum through a i-inch thick pad of 
Hyflo supercel. This filtration step removed any residual protein 
leaving a clear colourless filtrate which was lyophilised, l,9g 
of EFA was obtained from 300g of the bakers* yeast and the white 
fluffy material was stored at 0°G in an airtight glass bottle inside 
a plastic container containing granules, of silica gel. The protocol 
for the isolation of RFA from bakers* yeast is presented in Pig, 6,
Water-saturated phenol reagent
Water-saturated phenol reagent was prepared from phenol 
crystals obtained from British Drug Houses (Poole, England), 300g 
of the crystals were dissolved in 600ml of distilled water by 
stirring the mixture at 20°G for 45 min. The cloudy solution was 
allowed to stand at 4°G in the dark for 18 h. The lower phenol 
phase which separated out during this time was made 0.19^ (w/v) with 
respect to 8-hydroxyquinoline (British Drug Houses, Poole, England) 
to prevent atmospheric oxidation of the phenol (Kirby, I964), The 
reagent was stored in a dark bottle at 4°C.
2-methoxyethanol
2-methoxyethanol was obtained from British Drug Houses (Poole, 
England) as a technical grade solvent and was freed of contaminating
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BAKERS* YEAST
Heat treatment in the presence of SDS
COOLED TO 0 0 and GEÈÎTRIMJGED
SUPERHATAÊTT
precipitate of cell debris discarded
supernatantdiscarded
Precipitation of 
RHA gel by addition of HaCl followed by centrifugation
Cold ethanol precipitation of crude RNA followed by 
centrifugation
PRECIPITATE dissolved in 
water and solution 
neutralised with acetic acid
supernatantdiscarded PRECIPITATE washed in 67%(v/v) ethanol and dissolved in water
Dialysed against water for 36 h
PIG. 6
PILTRATIOF through Hyflo super-cell and RHA 
freeze-dried
Protocol followed for the isolation of RNA from bakers* yeast. Experimental details are 
described on page 34*
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peroxides by distillation at 124°G, For this process, an aqueous 
solution containing 30g hydrated ferrous sulphate and 3ml cone 
H^SO^ was added to 3 1 of the solvent. The mixture was distilled 
and the first $ml of the distillate and the last 100ml of the 
solvent were not collected. The material collected showed no 
absorption at 280nm and had a negligible absorption (<0,05) at 
260nm. It was stored in a dark bottle at to minimise oxidation,
RADIOISOTOPES
All radioisotopes used in this study were obtained from the 
Radiochemical Centre (Amersham, England) and they were stored in 
borosilicate vials shielded with polythene. Radioactivity was 
counted in glass vials with aluminium-lined cork caps. These vials 
contained 5ml of the scintillation fluid and gave background counts 
ranging from 18 to 23cpm in the pre~&et window. The scintillation 
fluids used were obtained from British Drug Houses (Poole, England) 
and were toluene- or dioxane-based*0,6/^  (w/v) 2, 5-diphenyloxazole 
(PPO) was the primary scintillator in these fluids and 0,02% (w/v)
1, 4 di-2-(5~phenyloxazolyl benzene) (POPOP) served as the secondary 
scintillator necessary to shift the wavelength of photon emission 
from around 370nm to 420nm, where the photomultiplier tubes were 
more responsive,
[5-%] Orotic Acid
Orotic Acid was obtained as an aqueous solution in 
borosilicate multidose vials ("Duoseal" vial) and was stored at 
O^ C, Portions withdrawn with a sterile needle and syringe and 
diluted as desired just before use. Specific activities of the 
material showed batchwise variation ranging from I9 to 25 Ci per 
mmol.
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The stability and the radioohemical purity of the material on 
storage was tested by paper chromatography. 20^ 1 of a sample which 
had been stored for 9 months vters spotted onto the chromatography 
paper (Whatmam; No. 33 cut into a square 19 x 19cm) and dried 
immediately with an air drier. As a marker 20^ 1 of freshly-prepared 
unlabelled Orotic acid (lOOmg/ml in distilled water) were spotted on 
the same horizontal line as the ^-labelled sample and similarly 
dried. Ascending chromatography using a mixture of isopropanol/ 
water/HCl (130:37:33) as developing solvent was allowed to proceed 
for 7 h at 20^ 0 in a sealed chromatography unit. At the end of this 
period the paper was removed and dried in a hot air chamber. The 
position of the marker was detected by examination under ultraviolet 
light and its distance from the origin was measured. For the sample, 
strips, each 0,5cm wide, were cut sequentially along the direction of 
development from the origin to the solvent front. The radioactivity 
on each strip was counted in a toluene-based scintillation fluid 
(NE 233) using an Intertechnique liquid scintillation spectrometer 
(Model SL30), The highest radioactivity count was obtained from the 
strip cut 7*5cm from the origin which coincided with the position of 
the marker (Fig, 7) • It was therefore concluded that almost all the 
tritium label was present as orotic acid and that the material had 
not undergone any significant deterioration,
7(n) - h^ ] Prednisolone
[ô, 7(n)Prednisolone was obtained in a toluene/ethanol 
(9:1) mixture. It was stored at -15^ 0 and, after each use was 
resealed under nitrogen. The specific activity of the material was 
46 Ci per mmol.
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FIG, 7 Paper Chromatography of %-Orotio Acid
Ascending chromatography was carried out on Whatman No, 33 filter paper for 7 h at 20°C. Moving liquid phase was an 
isopropanol/water/HCl mixture (130:37:33). Strips were cut out and counted for radioactivity as described on page 98 • The 
arrow indicates the position of non-radioactive orotic acid applied on the same horizontal level as the radioactive sample 
and developed in parallel with the radioactive sample.
41
[b. 6-&j Uridine 5 -triphosnhate ( &4JTP")
%-UTP was obtained as the ammonium salt in 50^ (v/v) aqueous 
ethanol. The specific activity of the material ranged from 40 - 60
Ci per mmol. It was stored at -15°C,
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Treatment of Animals
Male Wister rats of body weight ranging between I40 and 190g 
were used in this study. They were housed individually in wire 
mesh cages in a windowless room in which lighting was regulated to 
provide a 12-h light and 12-h dark cycle (light on from 07.00 h), 
Temperature in this room was maintained at 70°F - l^ F. As a 
pretreatment before commencement of any experiments, the animals 
were fasted overnight. Thereafter each animal was fed daily, at 
16,00 h, 12g *Diet 4TB* containing 14^  (w/w) dried skimmed milk 
(North Eastern Agricultural Co-operative Ltd,, Burksbum, U,K,).
The animals consumed their daily allowance of food throughout the 
experimental period and were allowed water ad libitum. Experimental 
animals and their controls were paired on the basis of initial 
fasted body weight.
Preparation of rat liver cell san
Liver, freshly excised from the animal, was washed in 0,85%
(w/v) saline to remove blood. Thereafter it was chopped into fine 
pieces with scissors and suspended in 20 vol 0,05M Tris-HCl buffer, 
pH 7,5 (at 20°C), containing 0,001M MgCl '6E 0, 0.025M ECl and 
O.25M sucrose. The suspension was homogenised using a Potter-EWhjem 
(1936) homogeniser with a close fitting pestle and was centrifuged 
at 40,000g ave, for 90 min, at 3°C in the MSE superspeed 65 
centrifuge. The supernatant fluid was carefully withdrawn using a 
pasteur pipette to avoid contamination from the white lipid layer 
which formed a plug at the top of the supernatant layer. This 
supernatant fluid was taken as the cell sap. It was stored frozen 
in small portions and, for use, was thawed out and diluted ten-fold
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with distilled water.
Methods employed for the estimation of ribonucleic acid (RNA)
RNA was estimated either by the orcinol method or by the 
ultraviolet absorbance of the nucleic acid at 260nm.
The orcinol method (Schneider, 1957) depends on the reaction 
of pentose sugars with hot strong acid to form the heterocyclic 
furfural which condenses with orcinol to yield a green-coloured 
product the absorbance of which is measured at 660nm.
HOCH —  CHOÏÏ GH— CH OH
I I II II . (Orcinol)
OEg GH-GHO HCl at 100°0 qH C OHO O H ^ O H ______ ^ Green-
I I -3E 0 colouredOH OH  ^ Complex
Pentose Furfural
The conversion of the ribose units of ENA to furfural depends on the 
prior removal of the associated base. Purine bases are effectively 
removed by the acid used in the orcinol reagent but pyrimidine bases 
persist to some extent and render pyrimidine-bound ribose unreactive. 
This could lead to serious errors where the purine/pyrimidine ratio 
differs from that of the ENA used as standard. The molar proportions 
of these bases in yeast ENA (Crestfield et al, 1955) are however 
closely equivalent to those in rat liver ENA (Adams et al, 1976) and 
any errors arising from purine/pyrimidine ratios are therefore 
minimal. The orcinol method was used to measure ENA where 
ultraviolet measurements were liable to interference from cellular 
materials (e,g, protein and ENA) or reagents (e.g. trichloracetic 
acid),
Orcinol reagent was prepared by dissolving 0.5g FeCl^ in 100ml
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of cpric HCl and adding orcinol to a final concentration of 1% (w/v).
For assay, 3ml of a suitable dilution of the sample in l.OM 
perchloric acid was mixed with 3ml of the orcinol reagent. This 
mixture was heated in a boiling water for exactly 20 min. Thereafter 
it was cooled in ice and its absorbance measured at 660nm against 
a reagent blank prepared by subjecting 3ml 0,5M perchloric acid to 
t^he assay procedure, A standard calibration plot (Fig, 8) was 
Obtained by assaying serial dilutions of yeast EM,
The green colour developed in the orcinol reaction was 
proportional to ENA concentration only when the final ENA concentration 
in the assay mixture was less than 300/Jg, Care was taken to use 
exact quantities of FeCl^  (to keep blank readings constant) and HCl 
(which governs the rate of furfural release from ribose) in the 
preparation of the orcinol reagent. Heating time and temperature 
were also found to be critical factors in the development of the 
green colour.
The second method employed to estimate ENA utilised the 
characteristic absorption of ultraviolet light by purine and pyrimidine 
bases in the region of 260nm, This method was used in situations 
where the presence of traces of sucrose would interfere with the 
orcinol assay method. In extracting ENA which was to be measured by 
this method, the period of alkali digestion was limited to 1 h. This 
was necessary to avoid errors arising from the release of proteins 
and peptides into solution as well as avoiding deamination of 
cytidylio acid. to yield uridylic acid-; which absorbs light maximally 
around 260nm (Fleck and Munro, I962).
Extracts containing ENA were suitably diluted with 0,2M
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method. Yeast RNA was used as the standard* Details of the assay procedure are described on page 43.
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perchloric acid. The ultraviolet absorption of the solution was 
then measured at 260nm against a blank containing only 0,2M 
perchloric acid. A 1^ (w/v) solution of yeast RNA in this acid 
was found to have an of 230 and calculation of RNA measured
by this method was based on this factor. The optical properties 
of a mixture of nucleotides is believed to be those of their 
component nucleotides (Munro and Fleck, 1^ 66) and it is 
acknowledged that yeast RNA may have quite a different absorbance 
from that of similar amounts of rat liver or muscle RNA. However, 
any such difference would be expected to affect control and 
prednisolone-treated rats to a similar extent and, it was felt, 
would not invalidate these studies which were aimed solely at 
detecting the difference in RNA content between the two groups of 
animals.
Method employed for the estimation of ideoxyribonucleic acid (DNA)
DNA was assayed as described by Burton (1955)• Mild acid 
hydrolysis transforms sugar residues originally combined with purine 
bases in DNA into #-hydroxy laevulinic aldehyde. This labile 
aldehyde and some of its derivatives are believed to be responsible 
for the blue colour formed with diphenylamine (Stacey et al, 1946). 
Acetaldehyde acts to potentiate this colour development presumably 
by also reacting with the aromatic amine and bringing about ring 
closure. The concentration of perchloric acid in the DNA sample 
is critical to linear colour development and a perchloric acid 
concentration of 0.5M is believed to be optimal (Burton, 1955)*
The diphenylamine reagent was prepared by dissolving 1.5g 
diphenylamine in 100ml of glacial acetic acid and adding 1,5ml cone
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HgSO^ to the solution. This reagent was stored in the dark.
Before use, 0.1ml of an aqueous solution containing l6mg acetaldehyde 
per ml (stored in the dark) was added to every 20ml of the 
diphenylamine solution.
Samples, containing 20 - 4P/*g BNA, were made up to 2ml with 
0.5M perchloric acid. 4ml of the diphenylamine reagent containing 
aldehyde were added and the blue colour was developed by incubating 
the solution for 16 - 20 h at 30°C. This colour was measured at 
600nm against a blank prepared by subjecting 2ml 0.5M perchloric 
acid to the assay procedure. Calf thymus DNA served as standard 
and was used as an aqueous solution at a concentration of 4Q/*g per 
ml, 1ml of the standard solution was mixed with 1ml l.OM perchloric 
acid and, along with samples containing DM, subjected to two 15-min. 
incubations at 'JO^ C in a water bath. The mixture was cooled in an 
ice bucket, the diphenylamine reagent added, and colour allowed to 
develop as described above. The calibration curve is shown in Pig. 9*
Methods employed for the estimation of proteins
Three methods of protein estimation were used in the course of 
these studies.
(a) Biuret method
Samples containing protein at concentrations above 25QMg per ml 
were assayed for protein using the * biuret* method described by 
Gornal et al. (1949) • This method measured the intensity of the 
violet colour produced by the reaction of cupric ions in the * biuret* 
reagent and protein peptide bonds under the alkaline conditions of 
the assay.
To prepare the *biuret* reagent 1.5g CuSO^'^HgO were dissolved
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FIG, 9 Calibration Curve for DNA estimation by the 
diphenylamine method. Calf thymus DNA was used as the standard. Details of the assay procedure are described on page 47.
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in lOOvol distilled water and mixed with 6g potassium tartro&e 
dissolved in water. This mixture was added, with swirling, to 
300ml 10^ (w/v) NaOH and the final volume was made up to l.Oll with 
distilled water. This reagent was stable and retained optical 
clarity for several weeks at 20°0.
For assay, 1,0ml of the test sample was mixed with 4»0ml of 
the * biuret* reagent and allowed to stand for 30 min at 20°G. 
Thereafter the absorption of the complex was measured at 540nm 
against a reagent blank containing water instead of the sample,
A standard calibration plot (Fig. lOA) was prepared by subjecting 
1.0ml of serial dilutions of a lOmg per ml aqueous solution of 
bovine albumin to the assay procedure.
(b) Micro-K.ieldahl method
The raicro-Kjeldahl method, as modified by Ma and Zuazago 
(1942) was used to measure the protein content of the commercial 
preparations of bovine albumin used as standards for protein 
assay. These preparations vary significantly in their water 
content, depending on storage conditions, and the Kjeldahl assay 
served to check and correct for any such errors,
1,5ml of an aqueous solution containing l.Omg of the bovine 
albujnin per ml were pipetted into a Kjeldahl digestion tube. 2,0ml 
nitrogen-free cone were added followed by a trace of
finely-ground copper-selenium catalyst and a few anti-bump granules. 
The tube was then transferred to the gas burners and acid digestion 
was allowed to proceed for I6 h. The digest was cooled and the 
contents along with washings transferred to the micro-Kjeldahl 
distillation apparatus. Protein nitrogen, novf present as (jNH^ )^ sO^
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was measured by adding 10ml àff/o (w/v) NaOH to the digest and 
steam-distilling the liberated ammonia into a 5*0ml aqueous 
solution of ^  (w/v) H^pO^ cooled in ice. The H^BO^ solution 
contained 5 drops of a mixed indicator prepared by mixing 5vol 
0,1^ (w/v) bromocresol green in 95^ (v/v) ethanol with Ivol 0,1^ 
(w/v) methyl red in 95?^  (v/v) ethanol. Complete recovery of the 
ammonia was obtained in about 10,0ml of distillate which turned 
the mauve H^BO^ solution blue, ^/l75 HCl was then used to titrate 
this blue solution back to a pink end-point,
1,0ml 1,0M HCl =: 14mg nitrogen 
12.5ml ^ 9175 HO i s  l.Omg nitrogen 
The nitrogen content was converted to protein content by multiplying 
the nitrogen content by 6,25» the assumption being made that 16$^  of 
the mass of protein is nitrogen. The result obtained was compared 
with the measured weight of the albumin and the ratio of these two 
values was used as a correction factor to allow for the water 
content of the albumin,
A comparative study in which protein extracts from rat liver 
and gastrocnemius muscle were analysed by both the ’biuret* and 
the Kjeldahl method was carried out, A close similarity was 
observed in the results obtained using the two methods (Table l),
Table 1, A comparison of ’biuret* and Kjeldahl methods of 
protein analysis
Sample Protein Concentration (mg/100ml)
Biuret assay Kjeldahl assay
Liver 1796 i 12 1809 t 19
Muscle 453 - 4 466 t 10
The results are the means from 4 experiments - S.E.M,
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(c) Folin-liOwry method
Assays of proteins at concentrations below 250/4g per assay 
were performed as described by Lowry et al (195I)* This method 
is based on the copper-Polin reaction in which copper-treated 
protein reduces phosphotungstic/phosphomolybdic acid (the active 
ingredients in the Polin-0 iocalteau phenol reagent) in alkaline 
conditions to give dark greenish blue-coloured complex the 
absorbance of which is read at 500jimn, Although the absorbance 
measured in this reaction has been reported to deviate slightly 
from linearity with protein concentration and its intensity varies 
with different proteins, the Polin-Lowry method is much more 
sensitive than the biuret method. It is therefore the preferred 
method for assays of small amounts of protein. Furthermore, the 
relative chromogenicity of mixed tissue proteins does not show too 
great a variability from tissue to tissue (Lowry et al, I951) •
For assay, 0.5ml of the sample was mixed with 5*0ml of an 
alkaline copper reagent prepared freshly each day by mixing 25ml of 
Reagent A (2^  (w/v) Na^CO^ in O.IM NaOH) with 0,5ml of Reagent B 
(prepared by dissolving l.Cg sodium pot^sium tartrate and 0,5g 
CuSO^ - 5Hg0 in 20ml distilled water, adding 10ml O.IM NaOH and making 
the volume up to 100ml with water). The mixture was allowed to 
stand at 20°0 for 10 min. Thereafter 0,5ml c'folln and Ciocalteau 
phenol reagent, diluted before use with 1,36 vol distilled water 
to make it l.OM with respect to acidity, was added very rapidly and 
mixed instantly. After 30 min. at 20^ 0 the absorbance of the 
solution at 500nm was read against a blank in which 0,5ml distilled 
water replaced the sample, A calibration plot (Fig, lOB) was
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obtained by subjecting dilutions of a solution of bovine albumin 
in 0.85^  (w/v) NaCl to the assay procedure.
The concentration of NaOH used in this assay effectively 
neutralizes excess and buffers the mixture at pH 10
where colour development is maximal. However, at this pH the 
reactivity of the phenol reagent is only short-lived, due to the 
dissociation of phosphate from molybdate, and it is essential, 
therefore, not to delay mixing once the reagent has been added.
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Extraction of total RHA. DNA and protein from rat gastrocnemius 
muscle and liver
RNA, DNA and protein were extracted from muscle and liver 
tissues using a method based on that described by Schmidt and 
Thannhausser (1945)*
Gastrocnemius muscles were removed rapidly from the animal, 
weighed frozen in liquid nitrogen, and then pulverized into fine 
fragments in a stainless steel mortar cooled with liquid nitrogen. 
The muscle fragments were suspended in 10 vol ice-cold 0.3M KGl 
and homogenised using the Silverson homogeniser (Silverson 
Machines Ltd. Bucks, England) driven at full speed. This 
homogenisation was carried out in two bursts each lasting 30 s.
The homogenate was immersed in ice throughout and a 2-min. interval 
was interposed between each burst in order to maintain the 
temperature of the homogenate between 0° and 4°0. The homogenate 
was mixed with an equal volume of 20^  (w/v) trichloroacetic acid 
and the mixture was kept at 0°G for 20 min.
The liver was also removed rapidly from the animal, washed 
free of blood with ice-cold 0.8^ (w/v) NaOl, weighed and stored 
in a frozen state until required. For extraction it was chopped 
into fine pieces and suspended in 3 vol distilled water. 
Homogenisation was performed as described above for muscle and 
2 vol distilled water were subsequently added to the homogenate.
An equal volume of 20^ (w/v) trichloroacetic acid was added to 
this diluted homogenate which was then allowed to stand at 0°G 
for 20 min.
Subsequent steps in the extraction process were the same for
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both muscle and liver homogenates.
Acid-insoluble material was collected by centrifugation at
' ' * O2000g' ave, for 15 min, at 4 C, The precipitate was washed 3 times 
with 20ml ice-cold 10^ 6 (w/v) trichloroacetic acid to ensure complete 
removal of free nucleotides and other low molecular weight 
contaminants which might interfere with the subsequent estimation 
of nucleic acid content.
The preliminary removal of phospholipids with lipid solvents 
such as ethanol and ethanol/chloroform mixtures was considered 
unnecessary. Furthermore Munro and Downie (1964) have reported 
loss of RNA and protein into cold ethanol following trichloroacetic 
acid precipitation.
The trichloroacetic acid precipitate was treated with 20ml 
0,3M KOH and incubated at 37°C for 18 h during which time RNA was 
completely dissolved and hydrolysed to mononucleotides. Protein 
estimations were performed on aliquots of this alkaline digest.
DNA is not hydrolysed under these conditions because of the absence 
of an hydroxyl group on C^ , resulting in a failure to form cyclic 
nucleoside phosphates on exposure to alkali. In RNA it is this 
obligatory cyclic intermediate that is spontaneously hydrolysed 
to nucleoside or nucleoside 3^ -phosphates (Adams et al, 1976) 
as illustrated in Fig, 11,
The alkaline digest was cooled to 0°C and treated with 0,06ml 
ice-cold lOM perchloric acid per ml of digest to neutralise the 
alkali and acidify the medium sufficiently to cause maximal 
precipitation of protein and DNA, After standing in ice for 5 min. 
the precipitate was sedimented by centrifugation at 2000g ave, for
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B represents a pinzine or pyrimidine base.
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10 min. and washed 2 times with $ml 0.5M perchloric acid. The 
supernatant and washings were pooled and retained as the RNA 
fraction from which suitable aliquots were taken for the orcinol 
test.
The DNA of the precipitate was extracted by hot acid treatment. 
The precipitate was suspended in 10ml l.OM perchloric acid and 
shaken at 70°0 for 20 min. The suspension was cooled to 2°G and 
non-nucleic acid material was sedimented by centrifugation at 
2000g ave, for 10 min. The hot acid treatment was repeated using 
5ml l.OM perchloric acid. The supernatants were pooled and aliquots 
taken for DNA assay by the diphenylamine method.
Isolation of ribosomes from rat gastrocnemius muscle and liver
Ribosomes were isolated from gastrocnemius muscle and liver 
using methods adopted from the procedures described by Chen and 
Young (1968) for muscle ribosomes and by Hirsch and Hiatt (I966) 
for liver ribosomes.
Gastrocnemius muscles from both hind legs of the rats were 
weighed and then frozen in liquid nitrogen to facilitate subsequent 
pulverization. They were pulverised into fine fragments in a 
stainless steel mortar cooled with liquid nitrogen. The fragments 
were suspended in 5 vol medium G (O.OOIM MgGl^ , 0.3M KOI, O.O^M 
Tris~HGl, pH 7*5 (ut 20^ G) and 1 drop of 1^ (w/v) aqueous suspension 
of bentonite was added to protect RNA from enzymic degradation 
(Brovnhill et al. 1959; Littauer and Sela, I962),
Liver tissues were weighed fresh following extensive washings 
in ice-cold 0,8$^ (w/v) NaCl to remove any traces of blood. 
Thereafter, the liver was chopped into fine pieces and suspended
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in 2 vol ice-cold medium C from which KGl had been omitted and 
to which 2 drops of l^o bentonite had been added.
Subsequent steps in the isolation procedure were identical 
for both muscle and liver and were carried out at 0°G unless 
reported otherwise, Homogenates of both tissues were prepared 
using the Silverson homogeniser driven at top speed. All of the 
muscle homogenate and 6,0ml of the liver homogenate were 
centrifuged at 27,000g ave, for 15 min, to sediment nuclei, 
mitochondria and cell debris. The resulting supernatants were 
treated first with 0,2ml lO^ o (w/v) solution of cirassol in medium 
G, with gentle stirring^  and then with 1,0ml 10^ (w/v) solution of 
sodium deoxycholate (Sigma Chemicals Ltd., London, England) in 
water, both detergents serving to dissociate ribosomes from the 
microsomes and other membranous structures. The preparation was
allowed to stand for 1 h before 6,0ml medium G were added and a
crude ribosomal pellet was sedimented by centrifugation at 105,000g 
ave. for 90 min, in an MSB super 65 centrifuge, The ribosomal 
pellet was rinsed with medium D (O.OOIM M^l^, 0.025M KGl, 0.05M 
Tris-HCl, pH 7.5 sit 20°C) and allowed to soften overnight in 4.0ml 
medium D, Thereafter the ribosomes were resuspended in this medium 
using a Potter-Elvehjem homogeniser with a loose-fitting teflon 
pestle. The suspension was centrifuged at 600g ave, for 10 min, 
and an equal volume of medium E (O.IM MgCl^ , 0.05M Tris-HGl, pH
7.5 at 20°C) was added to the supernatant to raise the Mg*^*^
concentration to above 50mM and thus cause an aggregation of the 
ribosomes. The precipitated ribosomes were collected after 1 h by 
centrifugation at 15,000g ave, for 15 min. This treatment with Mg*^*
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frees ribosomes from considerable protein material which remains 
in the supernatant following centrifugation (Hirsch and Hiatt,
1966) • Further purification was achieved by resuspending the 
ribosomes in 4#0ml O.IM KOH, using the Potter-Elvehjem homogeniser 
and centrifuging for 5 min. at 10,000g ave, to clarify the 
suspension and sediment any denatured proteins.
The quantity of ribosomes isolated by this procedure was 
measured by taking optical density readings of the suspension at 
260nra on the basis that a suspension containing 90/*g of ribosomes 
per ml has an of 1,0 (Manchester, 1974) • Yield ranged from 
94 - ll8/*g ribosomes per g of muscle and 2,400 - 3,200/*g ribosomes 
per g of liver.
The purity of the preparation was determined by measuring the 
2^60/^280 This was found to range between 1,51 and 1,67
for muscle preparations and between 1,85 and 1,99 for liver 
preparations. Although an ^ 26c/^280 of 1-51 is considered
indicative of some protein contamination (Dr. G, A, Goodlad,,personal 
communication), ribosomal RNA measurements were carried out on 
perchloric acid extracts of the ribosomal suspension (page 6I) 
which were essentially protein-free. Also it is unlikely that any 
protein present in the ribosomal suspension contributed significally 
to the specific radioactivities obtained from these ribosomes since 
93^ of the tritium label resided in the RNA component of the 
ribosomes (Table 2),
KGl was used at a concentration of 0,3M in medium C to assist 
the solubilisation of muscle myosin, a major protein in this tissue, 
and increase the yield of muscle ribosomes normally closely
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associated with myosin. Ribosomes have been shown to co-precipitate 
with myosin in this tissue (Heywood et al. I967) . This concentration 
of KGl, however, produced gelling of the post-mitachondrial 
supernatant of rat liver more especially in rats given prednisolone. 
This salt was therefore omitted in the preparation of the rat liver 
post-mitochondrial supernatant.
Sucrose has been used extensively in the isolation of ribosomes 
from rat liver since, at a concentration of 0.25M, it conferred 
upon the medium the isotonicity essential for the preservation of 
the morphology of intracellular organelles. However this reagent, 
in the presence of 0.3M KGl and at O^ C, formed a viscous muscle 
homogenate from which ribosomes could not be extracted. Sucrose 
was therefore omitted from medium G,
The protocol for the isolation of ribosomes from rat muscle 
and liver homogenates is presented in Pig, 12,
Estimation of ENA content of rat gastrocnemius muscle and liver 
ribosomes
The procedure for extracting RNA from rat muscle and liver 
ribosomes depended on the alkali lability of ribonucleic acids.
The degraded RNA is soluble in perchloric acid which precipitates 
the protein components of these ribosomes,
1,0ml of a suspension of ribosomes in O.IM KOH was mixed with 
1,0ml 0.5M KOH and incubated at 37°G for 1 h. The alkaline digest 
(Fraction A) was cooled to 2°G and acidified with 0,06ml 10,OM 
perchloric acid per ml of digest. The protein precipitate (Fraction 
B) was sedimented by centrifugation at 600g ave, for 15 rain, at 
0°G and washed with 1,0ml 0.5M perchloric acid. The supernatant
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TISSUE HOMOGENATE
Centrifugation at 27,000g ave.
NUCLEI, MITOCHONDRIA and CELL DEBRIS 
(precipitate)
POST-MITOCHONDRIAL ( supernatant )
detergent treatment 
followed by centrifugation at 105,000g ave.
CYTOSOL ( supernatant) CRUDE RIBOSOMES (precipitate)
SUPERNATANT
Centrifugation of ribosomal suspension at 600g ave.
PRECIPITATE
++Mg concentration raised to 50nM followed by centrifugation at 15000g ave.
SUPERNATANT PRECIPITATE
Suspension in O.IM KOH followed by 
centrifugation at 
10,000g ave.
PRECIPITATERIBOSOME SUSPENSION
Pig, 12 Protocol followed for the isolation of ribosomes from 
rat gastrocnemius muscle and liver. Experimental details are described on page 58 , All procedures were carried out at 0°- 4 G.
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and washing, which contained rihosomal ENA present as acid soluhle
nucleotides, were pooled (Fraction C), The ENA content was
estimated by measuring the absorbance of a suitable dilution of
Fraction C with 0*5M perchloric acid at 260nm. Quantitation was
made on the basis that yeast ENA treated in a similar fashion was 
idofound to have an ^ 260 230 when measured through a light path
of 1.0cm.
Measurement of radioactivity in muscle and liver ribosomes
The radioactivity in the muscle and liver ribosomes were 
measured on the Intertechnique Liquid Scintillation Spectrometer 
(Model SL30) . Samples dissolved in O.IM KOH were layered directly 
onto glass fibre discs (Type GF/A, diameter 2.5cm, Whatman Ltd., 
England) and dried under an infra-red lamp. It was not necessary 
to neutralise the KOH which, in the absence of water, produces no 
chemiluminescenee in toluene (Davies and Hall, I969) .
In initial experiments, the precise location of radioactivity 
in muscle ribosomes was studied by performing radioactivity counts 
of the alkali digest, the protein precipitate, and the perchloric 
acid extract (Fractions A, B and C respectively on page 6l , The 
results obtained are presented on Table 2 and show that 93^ of the 
radioactivity was located in the ENA of the ribosomes.
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TABLE 2 , The radioactivity of ENA and protein components of 
rat gastrocnemius muscle ribosomes
Fraction Radioactivity (cpm/assay)
Alkaline digest 162,4 63.9#Protein precipitate 7.8 6,0
Perchloric acid extract 155.1 58,1
# The protein precipitate was suspended in 1,0ml distilled water, neutralised with a few drops of 2,CM KOH, mixed with 1,0ml 0,3M KOH and incubated at for 2 h. Any precipitate ofpotassium perchlorate was removed by centrifugation at lOOOg for 15 min. The supernatant was counted for radioactivity as described on page 98.
(a) refers to fractions extracted from rat muscle 2 days after the injection of %-Orotic acid into the animals and (B) 
were fractions extracted 10 days after the injection.
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Attempts to isolate tmdegraded ENA from rat gastrocnemius muscle
Most of the current methods for the isolation of ENA from 
mammalian tissues rely on the two-phase partition system introduced 
by Kirby (1956) in which the ENA extracted with phenol/water 
mixtures is re-extracted with 2-methoxyethanol, the nucleic acid 
remaining in the organic layer in the latter extraction. However, 
although this procedure was effective in eliminating water-soluble 
contaminants from phenol-prepared ENA, it does not completely free 
the ENA from ribonucleases (Huppert and Pelmont, I962). The ENA 
isolation attempts described below are modifications of the phenol 
extraction system and were aimed at obtaining uncontaminated and 
undegraded ENA from rat muscle. All ENA isolated by these 
procedures were analysed by sucrose gradient centrifugation as 
described below,
(a) Hot phenol extraction
This method was similar to that used by Manchester (I967) to 
isolate ENA from rat diaphragm muscle.
Gastrocnemius muscle from one hind leg of the rat was excised 
quickly from the animal, frozen in liquid nitrogen and pulverised. 
The pulverised fragments were mixed with 10 vol of medium F (0,3M 
KOI and 0,3M trichloroacetic acid titrated to pH 7*5 with 2,CM 
NaOH) • The mixture was homogenised using a Silverson homogeniser 
and solid SDS was added to the homogenate to a concentration of 
1^ (w/v), this addifiiMv being withheld until after the homogenisation 
step to prevent foaming. The mixture was stirred at 0°C for 10 min, 
and then was treated with 1 vol water-saturated phenol reagent.
The mixture was shaken at 65°G for 20 min, and then cooled to 0^ 0
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by immersion in an ice bucket. The aqueous and phenol phases 
were separated by centrifugation at lOOOg ave. for 20 rain, at 4°G. 
The upper, RNA-contai.ning layer, was carefully withdrawn and the 
phenol layer containing DNA and protein material was re-extracted 
with §  vol medium P. The aqueous layers were pooled and made 2.0M 
with respect to NaCl, by addition of the solid salt, ENA was 
precipitated by mixing the solution with 2 vol absolute ethanol 
and standing overnight at -15. The precipitate was collected by 
centrifugation at lOOOg ave. for 15 min, at 4°0 and washed 6 times 
with 80^  (w/v) ethanol. The material was finally washed in diethyl 
ether and dried over anhydrous GaClg in a desiécator after a brief 
incubation at to remove traces of the ether,
(b) Gold phenol extraction
This method was a slight modification of the procedure 
described by Wool and Munro (1963).
Gastrocnemius muscle, excised, frozen and pulverised was mixed 
with 10 vol ice-cold aqueous 0.3M KGl solution buffàred with 0,05M 
Tris-HGl, pH 7*5 sit 20°C, 0,5ml of an aqueous suspension of
bentonite (50mg/ml) in O.O5M Tris-HGl buffer, pH 7*5 (at 20°G) was 
added quickly to this mixture to inhibit nucleases and the slurry 
was homogenised using a Silverson homogeniser, 0.1 vol SDS (10^  
(w/v) suspension of the solid in distilled water) was added and 
the mixture shaken at 20°G for 10 min. An equal volume of 
freshly-prepared water-saturated phenol reagent was added to this 
mixture and the shaking was continued at 4°C for a further 10 min. 
The phases were separated by centrifugation at lOOOg ave, for 
20 min. at 4°0, The aqueous layer was retained and the phenol
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layer was re-extracted with -J- vol fresh phenol reagent. The pooled 
aqueous phases were treated with I/ 9  vol 20^ (w/v) sodium acetate 
and 3 vol absolute ethanol. ENA was allowed to precipitate from 
this solution overnight at -15^0 and was collected by centrifugation 
at lOOOg ave, for 20 min, at 0°G. The product was washed 
extensively 6 times with QOffo (w/v) ethanol and finally with diethyl 
ether before drying over CaCl^ in a vacuum dessicator.
(c) Cetyltrimethvl ammonium bromide extraction
This method was first described by Ealph and Bellamy (I964) 
and combined Kirby* s 1956 two-phase system with a precipitation 
step where ENA was recovered as the insoluble cetyltrimethyl 
ammonium (CTA) salt.
Gastrocnemius muscle, excised, frozen and pulverised was 
mixed with 10 vol of an aqueous mixture containing 0,5^ (w/v) 
napthalene l,5~disulphonate (sodium salt) and 0,5% (w/v) bentonite. 
An equal volume of water-saturated phenol reagent was added to this 
mixture and the slurry was homogenised using the Silverson 
homogeniser. The homogenate was stirred at 20°G for 30 min, and 
the phases separated by centrifugation at 2000g ave, for 20 min, 
at 4°G. The aqueous phase was carefully withdrawn, treated with 
& vol fresh phenol reagent, shaken at 20°C for 10 min. and 
centrifuged again. The aqueous layer was removed and mixed with 
1/9 vol 20% (w/v) sodium acetate followed by 2 vol absolute ethanol, 
ENA was precipitated from this solution within 90 min at -15^ 0 and 
was recovered by centrifugation at 2,500g ave, for 20 min, at 0^ 0, 
The precipitate was dissolved in 7.0ml O.OIM sodium acetate buffered 
at pH 5.1 with acetic acid, 7.0ml potassium phosphate buffer, pH
. y,.
68
8.1, were added followed by Y.Oml redistilled 2-raethoxyethanol.
The mixture was shaken vigorously for 2 min. and centrifuged at f
lOOOg ave. to separate a clear upper phase which was carefully 
withdrawn. This supernatant fraction was mixed with 1 vol 0.2M 
sodium acetate, 0,5ml of 1% (w/v) cetyl trimethyl ammonium bromide 
was added for every ml of the supernatant fraction and the mixture 4
was chilled at 0*^0 for 10 min, to precipitate the GTAf'ENA complex ''
which was collected by centrifugation at lOOOg ave. for 10 min, 
at 2°G. The complex was washed 3 times with ice-cold 70% (w/v) 
ethanol containing O.IM sodium acetate to precipitate ENA as its 
sodium salt and remove GTA in the supernatant as GTAfacetate, The 
ENA was collected by centrifugation at lOOOg ave, for 10 min, at 
2°G washed 4 times with 80% (w/v) ethanol, then with diethyl ether 
and finally dried over anhydrous GaGl  ^in a vacuum dessicator,
(d) Phenol/chloroform extraction
This method was a modification of the procedure described by =|!
Perry et al (1972).
Gastrocnemius muscle, excised, frozen and pulverised was mixed 
with 10 vol of medium G (O.IM NaGl, 0,0011 EDTA in 0.011 sodium iIacetate buffer, pH 6,0), To inhibit any ribonuclease activity 
which might be present 0.2ml of a 5mg/ml solution of polyvinyl 
sulphate (Sigma Ghemical Go, Ltd., London, England) in medium G 
was added for every 10ml of medium G and the mixture homogenised
using the Silverson homogeniser. As further protection against #
enzymic degradation and to dissociate ENAr^ protein complexes, 0,1 vol 
of 5% (w/v) SDS in medium G was added to the homogenate which was ■'
then shaken at 20^ 0 for 10 min. Protein and cellular debris were %
3
:
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precipitated from the homogenate by the addition of 1 vol of a 
mixture of water-saturated phenol reagent and redistilled 
chloroform (in a 1:1 volume ratio) and shaking for a further 
25 min, at 20^ 0, The mixture was cooled to O^ G and RNA was 
recovered in the aqueous phase following centrifugation at l,500g 
ave, for 20 min, at 2°G. The aqueous phase was re-extracted with 
1 vol fresh phenol/chloroform mixture, made 0.2M with respect to 
NaGl and treated with 2 vol cold absolute ethanol to precipitate 
RNA, The phenol phase from the first extraction was re-extracted 
with 1 vol of fresh medium G and the post-centrifugation aqueous 
phase from this extraction was used to re-extract the phenol phase 
from the second extraction. ENA was precipitated from the final 
aqueous phase with 2 vol cold ethanol and the combined ethanol 
precipitates were kept at -15^ G until required, ENA was recovered 
from the ethanol medium.by centrifugation at 2000g ave. for 15 min. 
at 2°G and was washed twice with 67% (w/v) ethanol.
Isolation of uoly-adenylated RNA from rat gastrocnemius muscle 
The methods employed to obtain poly-adenylated RNA from rat 
gastrocnemius muscle involved, as a first step, phenol extraction 
to isolate all cytoplasmic RNA species from the tissue. These ENA 
species were then fractionated on a column of oligo.(clT)-cellulose 
(Sigma Ghemicals Go, Ltd., London, England) to isolate polyadenylated 
ENA from other RNA species.
(a) The phenol extraction steu
Extraction of RNA by phenol procedures suffers the disadvantage 
that some ENA species, notably poly-adenylate containing ENAs are 
lost to the phenol layer depending on the pH and the cationic
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ooncentration of the aqueous phase as well as on the nature of the 
phenol phase itself (Lee et al, 1971» Perry et al, 1972). To 
overcome this loss various modifications of the phenol procedure, 
as described below, were tried out,
(i) Procedure A
This method was adapted from that described by Neal and 
Florini (1975). O.IM Tris buffer, pH 9.0 at 20°C was used as the 
aqueous phase and water-saturated phenol reagent as the phenol 
phase. The freshly excised muscle was frozen and pulverised before 
it was homogenised in 9 vol of the Tris buffer using a Silverson 
homogeniser. Prior to homogenisation 0,2ml of a 5mg/ml solution 
of polyvinyl sulphate in the Tris buffer was added for every 10ml 
of the homogenisation medium to inhibit any ribonuclease. The 
homogenate was made 0,1% (w/v) with respect to S IB  and shaken 
vigorously for 10 min. at 20^ 0, Thereafter it was treated with 
1 vol phenol reagent and shaken at 20^ 0 for a further 25 min.
After cooling to 0^ 0 the phases were separated by centrifugation 
at 2000g ave. for 15 min. at 4°0. The aqueous phase was carefully 
withdrawn and re-extracted with 1 vol freshly-prepared phenol 
reagent. The two phenol phases were re-extracted with 1 vol of 
the Tris buffer. The combined aqueous phases were made 0.2M with 
respect to NaCl, treated with 2 vol cold ethanol and maintained 
at -15°C overnight to precipitate RNA,
(ii) Procedure B
This method was adapted from the procedure described by 
Mainwaring et al (1974). The aqueous phase was a solution containing 
0.15M NaCl and 0.025M EDTA and the extraction with water-saturated
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phenol was performed at 55^ C in a heated water-hath. Other 
details of this procedure were the same as for procedure A above.
(iii) Procedure C
This method used a phenol/chloroform mixture (1:1 volume 
ratio) in place of water-saturated phenol alone, as recommended by- 
Perry et__al (1972). The aqueous homogenisation medium contained 
O.m NaCl and O.OOIM EDTA in O.OIM Tris-HGl buffer, pH 6.0 at 20°G. 
Procedure 0 was the same as procedure A in all other aspects.
(b) Oligo(cfT)-Cellulose Column Ghromatogra-phy
This procedure fractionates a mix-bare of polynucleotides 
according to the ability of the individual components to form 
base-pairing complexes with complementary oligo deoKythymidylate, 
(01igo(o(T)) , immobilised in the solid state by attachment to 
cellulose. In a medi-ura of high ionic strength the additional 
structural flexibility conferred on poly-adenylate-containing 
nucleotides enco-urages the RNA species to bind selectively to 
Oligo(4t)-cellulose. Upon lowering the ionic strength, the 
contribution of electrostatic forces to this binding is reduced 
and at the slighbly alkaline pH (7.5) identical charges on adjacent 
nucleotides repel each other enabling elution of any poly-adenylated 
RNA.
RNA from the phenol extraction step was collected by 
centrifugation at 2Q00g ave. for 20 min, at 2°G and dissolved in 
5ml O.OIM Tris-HGl buffer, pH 7.5 ut 20°G. This solution was freed 
of any DNA contaminant by incubating it first for 15 min, at 4 ^ 0  
and thereafter for 5 min. at 37°G with an equal volume of a 40/Ug/ml 
solution of ribonuclease-free DNAse (Sigma Ghemical Go, Ltd., London,
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England) in the same buffer. The reaction was stopped by adding 
0.1 vol SDS (1% (w/v) in l.OM Tris-HGl buffer, pH 9.0 (at 20°C)) 
to the medium followed by 1 vol water-saturated phenol reagent.
The mixture was stirred at 20^ G for 10 min. before centrifugation 
to separate the phases. The aqueous phase was withdrawn carefully 
and re-extracted with 1 vol fresh phenol reagent. The aqueous 
phase was then made 0.2M with respect to NaGl and treated with 2 vol 
cold ethanol to precipitate RNA overnight at -15°G. The RNA was 
collected by centrifugation and dissolved in O.OIM Tris-HGl buffer, 
pH 7*5 at 20^ G, containing O.OOIM EDTA to remove any traces of Mg^ "^  
which may cause aggregation of the RNA, The RNA solution was made 
0.5M with respect to KGl and loaded on the column of oligo(dT) 
cellulose. This column contained 0.4mg of the cellulose prepared 
as a suspension in the application buffer (O.OIM Tris-HGl buffer, 
pH 7*5 ut 20°G, containing 0.5M KGl) and packed under gravity in 
a column made from a 2ml-capacity disposable syringe plugged with 
cotton wool. The column was then washed with 20ml of the 
application buffer and effluent and washings were collected.
Material retained on the column was eluted with 10ml O.OIM Tris-HGl 
buffer, pH 7*5 at 20°G and collected as the polyadenylated RNA,
Throughout the operation flow-rate of fluid through the column was
maintained at approximately 2ml per rain, and, at the end, the 
column was regenerated by washing it with 40ml O.IM KOH followed 
by 20ml of the application buffer. The RNA contents: of the different
fractions were measured from their ultraviolet absorbance at 260nm,
Where radioactivity measurements were required the RNA was 
precipitated from the solution with 2 vol cold ethanol. The
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polyadenylated RNA fraction required the addition of l.Omg yeast 
RNA as carrier to aid precipitation. The precipitated material 
was dissolved in 1,0ml of 0,1M KOH before its radioactivity was 
counted,
Separation of RNA species by sucrose gradient centrifugation
The separation of different classes of RNA by sucrose density 
gradient centrifugation relies on the difference in the rates with 
which these macromolecules sediment through centrifugal field in a 
supporting and stabilising medium provided by the sucrose gradient. 
Linear sucrose gradients were always prepared with *Analar* 
grade sucrose and, in the initial experiments, these gradients were 
made 15 - 30% .(^ /^ ) with respect to sucrose. However, contrary to 
the experience of McGohkey (I967), the result obtained using a 
gradient with these sucrose concentrations showed a poor separation 
of RNA species even after 17 hours of centrifugation at 60,000g ave. 
The use of this gradient was, therefore, discontinued in preference 
to a 5 - 20% (w/w) sucrose gradients prepared as follows.
The day before the gradients were required, six aqueous solutions 
containing 5» 8, 11, I4, 17 and 20% (w/w) sucrose respectively were 
prepared in acetate buffer pH 5*1 containing 0,01M sodium acetate 
and O.I5M NaGl, The low pH of this medium minimises nuclease 
activity while the presence of the Na^ ions at this concentration 
counters the charge on the nucleotide phosphate groups conferring 
a more compact structure on the RNA molecules and thus, ensuring a 
better separation of RNA types (McGohkey, I967). Gradients were 
prepared in polypropylene centrifuge tubes by under layering equal 
volumes of all six sucrose solutions sequentially, starting with
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2.5ml of the least concentrated solution and using a syringe fitted 
with a flat-nosed, medium-bore needle to reach the bottom of the 
tube* The gradients prepared in this manner were maintained at 
4°0 for 14 - 18 h before use to permit diffusion and smoothening 
out of any local irregularities of concentration. The linearity 
of this gradient was tested by fractionating it as described below 
and measuring the refractive index of each fraction using a degree 
scale ABBE Type Refractometer (Bellingham and Stanley Ltd,, London, 
England) * This instrument measured the angle of refraction of light 
from a yellow sodium source passing into the sucrose solution and 
the readings obtained on the degrees scale were converted to 
refractive indices using a refractive index table. Since the 
refractive index of a solution at a constant temperature is 
linearly related to concentration, a plot of these indices against 
fraction number should give a straight line if the gradient were 
linear. The results presented on Fig, 13 show that except for 
minor deviations at the top and bottom of the column the gradient 
is essentially linear throughout the system.
The sample to be analysed was dissolved in 2,0ml of the same 
acetate buffer used to prepare the sucrose gradients and the solution 
layered over the sucrose gradient. The concentration of sample used 
never exceeded 0,5mg RNA per ml of the solvent buffer to ensure that 
the sample floated on the 5% (w/w) sucrose solution at the top of the 
gradient. Centrifugation was commenced as quickly as possible after 
sample loading to avoid any tailing of the sample.
For centrifugation the gradient bearing the sample was 
carefully loaded into the buckets of a pre-cooled 3 x 23ml swing-out
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FIG, 13 The linearity of a manually formed 5 - 2Qffo Sucrose Density Gradient;
Gradients were formed manually as described on page 73. Broken lines show the refractive indices of 1,0ml fractions of the gradient after allowing 
14 - 18 h at 4°0 for dispersion of local 
irregularities of concentration.The post-centrifugation sucrose density distribution is shown in unbroken lines. It was obtained by 
layering the gradient with 2,0ml O.O^M sodium acetate buffer pH 5.1 containing O.IM HaCl and centrifuging for 7 hours at 60,000g ave, at Refrantive
indices of 1,0ml fractions were measured as described on page 74W converted to sucrose densities from 
tables (Weast 1974)•
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aluminium rotor (MBE Ltd., England) which was then positioned 
inside an MSE superspeed 65 centrifuge and centrifuged at the 
appropriate speed and temperature for the time desired.
Following centrifugation, 1.0ml fractions of the gradient were 
collected sequentially from the bottom of the tube at using a 
tube piercer (MBE Ltd,, England). The M A  content of each fraction 
was estimated by measuring the absorbance of the solution at 260nm,
To overcome the problem of decreasing radioactivity counting 
efficiency with increasing sucrose concentration (McDowell and 
Copeland, 197l)» M A  was re-precipitated from each fraction overnight 
at -15°C with 2 vol cold ethanol. To aid this precipitation, l.Omg 
yeast M A  in an aqueous solution was added to each fraction before 
the addition of ethanol. The precipitate was dissolved in O.IM KOH 
before radioactivity counts were measured.
Calculation of values of M A  species from data obtained by 
sucrose gradient centrifugation
The sedimentation coefficients ('S' values) associated 
with the various M A  peaks following sucrose density gradient 
centrifugation were calculated as described by McEwen (I967) . This 
calculation assumes that the sucrose concentration distribution does 
not change appreciably during centrifugation and that the 
sedimentation velocity of an M A  particle varies directly with 
density differences between particle and solution and inversely 
with solution viscosity.
The first step in the computation of an ’S * value was the 
estimation of the sucrose concentration corresponding to the 
extrapolation ^of the linear sucrose concentration distribution to
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zero radius
^o " -----------
v/here and Z^  are the sucrose concentrations at the top and "bottom 
of the gradient respectively. Both these expressions are 
dimensionless and, in practice Z  ^= 4.0 and Z  ^= 19.3 (McEwen, 19&7). 
Although the starting sucrose concentration was 5^ (w/w), this 
concentration is lowered somewhat by the diffusion of the sucrose 
into the sample layer above the gradient. Post-centrifugation 
refractive index measurements of 1.0ml fractions of a sucrose 
gradient layered with 2.0ml of the acetate buffer but containing 
no sample showed that 4 .0 and 19.3 were indeed the closest 
approximations of the sucrose concentrations at the top and bottom 
of the gradient (refractive index was converted to sucrose 
concentration from tables compiled by ¥east (1974)*
Z q generally has a negative value.
r is the distance (cm) in the direction of centrifugal force field 
from zero radius to the top (r^ ) and bottom (r^ ) of the gradient.
In practice r  ^was sum of the radius of the rotor and the length of 
the centrifuge tube and was the difference between this sum and 
the height of the gradient.
Using the Z  ^value obtained, and with due regard to the 
temperature of centrifugation (5 C^), sedimentation intergrals (l) 
were computed from the appropriate tables (McEwen, 19&7). 1% is
the sedimentation intergral for the RNA particle for the starting 
sucrose concentration (4.C^  (w/w) due to the diffusion effect 
explained above) and Ig is the sedimentation intergral for the
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sucrose concentration at the position of the RNA peak. The 
sucrose concentration at the position of the RNA peak was read 
off a calibration plot obtained by measuring the refractive 
indices of post-centrifugation 1,0ml fractions of the sucrose 
gradient (Fig, 13) •
Finally the 'S’ value was calculated from the equation
S X 10~13 = (ig _ i^ )
2 w t
where w is the angular velocity in radians per second (l rpra =
2 Ji radians and at 60,000g ave, (29,000 rpm) w = 29000 x 2 x 22 x l)7 60and t is the duration of centrifugation in seconds.
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Attempts to investigate the effect of prednisolone on rates of 
synthesis and degradation of KNA in liver and muscle in rats given 
a single injection of ^H-Orotic Acid
It has been shown by several groups of workers that the rate 
of degradation of liver RNA and of ribosomal RNA in particular 
follows first order kinetics (Ottolenghi and Barnabei, 1970;
Enwonwu and Munro, 1970; Goodlad and Ma, 1975). The rate constant 
for this process can therefore be estimated by labelling the RNA 
by injecting the animal with a suitable radioactive precursor and 
plotting the logarithm of the total radioactivity associated with 
the RNA against a linear time scale* The slope of the resultant 
straight line is equal to kd/2,303 where kd is the RNA degradation 
constant (Fig. I4),
In applying this mathema,tioal formulation to the experimental 
data, it was necessary to assume that during the experimental 
period, a steady-state situation existed in which (a) The rate at 
which labelled precursors appear on the RNA is the rate at which 
they disappear from the macromolecule. Thus a measure of the latter 
will be a measure of the RNA turnover rate; (b) There was a large 
RNA precursor pool available in the tissue which did not change 
significantly during the experimental period. Thus re-utilisation 
of RNA breakdown products was minimal and insignificant; (c) The 
rate of the RNA metabolic process was constant and was not 
complicated by the formation of new cells.
In the present studies, each 'test* and 'control* animal 
received 20/iGi ^ H-Orotic Acid intraperitoneally. Prednisolone 
treatment was started 2 or 4 days after the injection of the orotic
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SLOPE
DAYS AFTER INJECTION OF ^H-OROTIC ACID >
FIG-, 14 Loss of radioactivity from EIiTA with time 
Kinetics of first Order Reaction:
dxdt = kd-x
Thus log X — kd t  ^constant
2.303
Therefore, Slope - M2.303
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aoid and the effect of the steroid on EKA turnover was monitored 
by following the loss of radioactive label from EEA isolated from 
the animals. The biological half-life of the ENA was calculated 
from the value of the degradation constant using the relationship:
0.693ti = ___ ^ kd
Turnover times for ENA and rates of ENA synthesis were calculated 
as described by Bnwonwu et al (l97l)*
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Estimation of *Total* aoid-soluble and aold-soluble mcleotide 
pools in rat gastrocnemius muscle and liver
Each of 9 male rats received 20,0ywCi ^H-orotic acid in 0,i 
(w/v) saline by intraperitoneal injection. Starting 2 days later, 
each of the prednisolone-treated animals received daily 
subcutaneous injections of l.Omg prednisolone acetate per lOOg 
initial body weight while the * control* partner received the same 
volume of saline. One animal was sacrificed 2 days after being 
injected with H^-orotic acid and served as a basal control. A 
pair of animals (one prednisolone-treated and the other its control)
were sacrificed on the 4'tk, 6th, 8th and 10th day after the injection
of %-orotic aoid.
A homogenate of the gastrocnemius muscle was prepared in 5 vol 
aqueous 0.3M KGl solution using the Silverson homogeniser. The 
liver homogenate was prepared in 1 vol of this solution and was then 
diluted 100-fold with distilled water. 2.0ml of each homogenate 
was treated with an equal volume of 0.4M perchloric aoid and, after 
stirring the mixture for 20 min. at 0°0, centrifuged at lOOOg ave. 
for 15 min. at 4°0. The precipitate was washed 2 times with 1.0ml 
0.2M perchloric acid. Each washing was recovered by centrifugation
and pooled v/ith the initial supernatant to make the * Total* acid
soluble pool. This pool was titrated to neutral pH with 0.6M KOH. 
KCIO^ was precipitated from the solution by allowing it to stand 
overnight at 4°C and was removed by centrifugation at lOOOg ave, 
for 15 min. at 4°C.
The nucleotide components of the total acid-soluble pool were 
obtained by passing a 2,0ml aliquot of the perchlorate-free solution
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through a column (9cm by.^ 5om) of Amberlite resin (CG4OO Type II,
200 mesh) as described by Miller and Baggett (1972). This resin 
served as an anion exchanger retaining nucleotides via the 
negatively charged phosphate groups in exchange for chloride ions. 
Unadsorbed material was washed from the column with 20ml distilled 
water at a flow rate of 2ml per min. and the adsorbed nucleotides 
were eluted with 20ml l.OM HCl. The eluent was collected and 
freed of HCl by repeated (5 times) vacuum distillation in a water 
bath maintained at 50°CJ, The dry residue was dissolved in 2.0ml 
O.IM KOH and constituted the acid-soluble nucleotide pool.
In a preliminary experiment 0.5mg cytidine 2^ 3^ - raonophosphoric 
acid dissolved in 1.0ml distilled water was loaded on the resin and 
eluted as described above. A comparison of the absorbances at 
260nm of the eluent with that of sample before the chromatography 
showed that the resin effectively retained and, upon the HCl 
treatment, released 95-97/^ of the cytidine nucleotide.
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Isolation of enzymioally active imolei from rat gastroonemius 
muscle and liver for assay of RNA -polymerase activity
Nuclei were isolated from gastrocnemius muscle using a slight 
modification of the procedure described by Breuer and Florini (1966) 
To obtain sufficient nuclei it v/as necessary to use, in addition 
to the gastrocnemius muscle, the anterior tibial group of muscles 
and quadriceps femoris muscles from both hind limbs, The weight 
of this pool of muscles ranged between 10 and 15g per animal. The 
chilled tissue was out into fine pieces and minced by forcing it 
3 times through a pre-cooled mechanical tissue press/mincer. 
Thereafter the tissue was suspended in 2 vol ice-cold medium H 
(0.375M sucrose, 0.025M KGl, O.OIM MgCl^ in O.O5M Tris-HGl buffer, 
pH 7*6 (at 20^ G)) and homogenised in 5 hursts, each lasting 30 s, 
using the Silverson homogeniser. The tough and fibrous nature of 
the muscle permits such vigorous homogenisation to release nuclei 
without damaging them (Held, 1977)• Throughout the homogenisation 
procedure, the sample was immersed in an ice-bath and 1 .0 min, 
was interposed between each burst to prevent the temperature of 
the homogenate rising. The homogenate was filtered by passing 
through a plastic screen of narrovf mesh fitted to the end of a 
20ml-capacity disposable syringe. This filtration step was 
repeated, after cleaning out the apparatus, to ensure the removal 
of the larger bundles of muscle fibres which would otherwise trap 
nuclei during high-speed centrifugation. The filtrate was divided 
into two aliquots each of which was under-layered with an equal 
volume of aqueous 0.375M sucrose containing O.OOIM MgOl^ , This 
suspension was centrifuged at 600g ave, for 7 min. at 4°0 to
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sediment a crude myofibrillar-nuclear fraction. The sediment was 
resuspended in l6ml of aqueous sucrose containing O.OOIM
MgClg and homogenised gently using a Potter-Elvehjem homogeniser 
with a loose-fitting pestle. Thereafter the mixture was 
centrifuged for 1 h at 29,000g ave. The intense viscosity of the 
medium at lower temperatures necessitated the centrifugation being 
performed at 15^ 0 as recommended by Baieve and Florini (1970). The 
subsequent fraction was discarded along with myofibrils, whole
COim f  Oriirtfs
cells and other non-nuclear subcellular^which formed a plug at the 
top of the tube. The sides of the tubes were wiped clean with 
paper tissue and the nuclear pellet was re-suspended in l6ml of 
aqueous 2.2M sucrose containing O.OOBÆ MgCl^ . Thereafter the 
pellet was homogenised and centrifuged again at 29,000g ave. for 
1 h at 15°G. The final pellet was suspended in 2ml of O.25M 
sucrose containing O.OOIM MgCl^ .
Rat liver nuclei were isolated using a modification of the 
method described by Widnell and Tata (1964). The tissue was 
weighed, minced and homogenised in 3 vol of a solution containing 
0.32M sucrose and 0.003M MgCl^. 25 - 30 upward and downward 
strokes of a tighting-fitting pestle in a Potter-Elvehjem 
homogeniser were sufficient to ensure good cell breakage without 
causing extensive nuclei damage. The homogenate was freed of 
unbroken cells and connective tissue by filtration through 2 layers 
of cheese cloth. The concentration of sucrose in the medium was 
then raised to O.25M by adding solid sucrose and the mixture 
rehomogenised. An equal volume of 0.375M sucrose solution 
containing 0.003M MgCl^ was layered under the mixture and a crude
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nuclear fraction was sediraented by centrifuging the suspension 
for 6 min. at 500g at 4°C, The pediment was suspended in l6ml 
of a 2.4M sucrose solution containing O.OOIM MgCl^ and homogenised 
with the Potter homogeniser using a loose-fitting pestle. The 
mixture was centrifuged at 29,OOOg ave. for 1 h at 4*^C. Mg’*"* was
used at a concentration of O.OOIM to prevent agglutination of 
nuclei (Widnell and Tata, I964). Contamination of the nuclear 
pellet with whole cells was found to occur at higher Mg**^  ^
concentration. 0entrifugation of the nuclear preparation through 
2,4M sucrose was carried out to remove contaminating erythrocytes.
After centrifugation the supernatant was discarded, as was 
the plug of whole cells, blood corpuscles and mitochondria at the 
top of the tube. The sides of the tubes were wiped clean with 
paper tissue and the nuclear pellet re-suspended in 5^ 1 O.25M 
sucrose containing O.OOIM MgOl^.
Both muscle and liver nuclei preparations were examined by 
phase contrast microscopy. Muscle nuclei although undamaged were 
contaminated to a slight extent by myofibrils. Neither the 
inclusion of additional filtration steps nor the adoption of less 
severe homogenisation techniques solved this problem. However the 
myofibrils were observed to settle at the bottom of the tube on 
standing for a few minutes at 4°C and the top portion of the 
preparation was relatively free of the contaminants. This portion 
was retained. Nuclei were counted using a haemocytometer with a 
%homa ruling. The protein contents of the preparations were 
measured by the Folin-Lowry method described on page 52. RNA and 
BNA were precipitated with 1 vol 0.4M perchloric acid and assayed
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as described on pages 43 and 46 respectively, starting with 0.5ml 
of the nuclear preparation. The mean DNA content of muscle nuclei 
was 7*24pg, the RNA/DNA ratio was 0,23 and the protein/UNA was 8.12, 
Corresponding values for liver nuclei were 12.7pg, 0,19 and 4 * 9  
respectively. The results of an analysis of protein RNA and BNA 
contents of the nuclear fractions at various stages in the 
isolation of muscle nuclei are presented on Table 3.
Assay of RNA polymerase activity of isolated nuclei
RNA polymerase catalyses the polymerisation of ribonucleotides 
to RNA as illustrated below:
^ATP
+
nUTP
+
^GTP
+
nCTP
BNA
AMP
UMP
GMP
CMP
The nucleotide composition of the ENA produced depends on the 
nature of the BNA template which in the present studies was derived 
endogeneously from the isolated nuclei. The enzymic activity vfas 
measured by determining the quantity of acid-soluble H-uridine 
incorporated into the acid insoluble polyribonucleotide from 
H^-UTP, The procedure, adapted from Bavies and Griffiths (l973), 
requires dithiothreitol in the incubation mixture to stabilise the 
enzyme during the assay and KCl to stimulate enzymic activity.
For the Mg’*^’*'- activated enzyme assay the incubation mixture
consisted of 0,1ml of solution J (0.025M: MgCl^ * 0.003M NaP,
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TABLE 3. The isolation of nuclei from rat muscle: purity 
of nuclear fractions at key fractionation steps
Fraction
Proteincontent(mg/gmusclej
EBAcontentCmg/gmuscle)
MA
content
(mg/gmuscle)
protein/
M A
ENA/M A
Tissue
homogenate 204 2.1 0.76 269 2.7
Filtered
homogenate 171
1.8 0.65 264 2.7
Myofibrillar-nuclearsediment
28 Q.25 0.18 159 1.4
Final nuclear suspension 0.07
0,002 0,01 8.1 0.23
Experimental details appear on page 84.
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0.002M dithiothreitol and O.I5M KOI in 0.6M Tris-HCl buffer pH 
8.1 (at 20°C)); O.O^ ml of the mixture of nucleotides (prepared by- 
mixing prior to use 0.2ml aqueous 0.0005M ÜTP with 0,8ml aqueous 
0.0075M ATP, O.OO75M GTP and 0.0075M CTP) ; and 0.1ml aqueous 
H^-UTP (pmols).
For the assay of the activated enzyme the incubation
mix-bure was the same as above except that solution J was replaced 
by solution K (O.OI5M MhCl^ , 2.0M(mJg80^, 0.003M NaF, 0.002M 
dithiothreitol and O.I5M KOI all in 0.6M Tris-HCl buffer, pH 8.1 
(at 20°0)).
All solutions were prepared not more than 2 h before use and 
maintained at 0 -
The assay medium was pre-incubated at 37^ C for 3 rain, and the 
enzyme reaction was initiated by the addition of 0.2ml of the 
nuclear suspension. The PNA content in this amount of muscle 
nuclear suspension was S.O/^ g and the corresponding value in the 
liver nuclear suspension, diluted 10-fold before -use, was A-0/ig»
The reaction was allowed to proceed for 5 min, at 37^ 0 and then 
terminated by the addition, with vigorous shaking, of 2,0ml of 
aqueous 10^ (w/v) trichloroacetic acid containing O.OOIM Na^ P^ O .^
A 'blank* assay in which the nuclei preparation was added after the 
trichloroacetic acid was carried through with each test. Test and 
*blank* samples were chilled in an ice-bath and 0.1ml of liver cell 
sap was added to each sample to provide carrier protein required 
to assist the precipitation of acid-insol-iible polynucleotides. This 
precipitation was allowed to proceed for 2 h at 4°C and the sediment 
was collected by centrifugation at 2000g ave, for 10 min, at 4^ 0.
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The precipitate was washed twice with 5*0ml 5^  (w/v) trichloroacetic 
acid, twice with 5*0ml of a mixture of n-propanol diethyl ether (l:l) 
and finally with 5.0ml diethyl ether. The precipitate was dried 
at 37°0 and dissolved in 0.5ml O.IM KOH by incubating at 37°0 for 
1 h. The amount of %-uridine incorporated into RNA was determined 
by counting the radioactivity in a suitable aliquot of the alkaline 
hydrolysates of the test and blank samples and subtracting ‘blank' 
counts from 'test' counts. The BNA in 0.5ml of the nuclear 
preparation was measured and the specific radioactivity of the RNA 
polymerase was expressed as nmols uridine incorporated into ENA 
per mg MA.
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Assay of Ribonuclease Activity in Rat Liver. Muscle and Pancreas
In these experiments prednisolone-treated animals received, 
subcutaneously, l.Omg prednisolone acetate per 10Og body weight 
daily and control animals received the same volume of 0.8^  (w/v) 
saline. After 8 days of such treatment animals were sacrificed 
by stunning and exsanguition. Liver, gastrocnemius muscle from 
both hind limbs and pancreas were excised quickly, washed free of 
any blood with ice-cold saline solution and weighed.
Muscle was frozen in liquid nitrogen and pulverised.
Thereafter it was suspended in 5*0ml of 0.44M sucrose solution and 
homogenised using a Silverson homogeniser. Liver and pancreas 
were minced finely with scissors and each organ was homogenised in 
10.0ml of 0.4#: sucrose.
1.0ml of each homogenate was diluted 5-fold with distilled 
water to render the medium hypotonic in order to disrupt subcellular 
granules containing enzymes. The mixture was then subjected to 
freezing in liquid nitrogen and thawing to ensure maximum release 
of ribonuclease activities from subcellular organelles (Shortman, 
1961), Finally the mixture was centrifuged at lOOOg ave. for 10 min. 
at 4°G to sediment cell debris and nuclei. The supernatant fraction 
was used for the assay of ribonuclease activity.
The ribonuclease assay technique was adapted from that described 
by Shortman (1961) and depended on the measurement of the release of 
acid ethanol-soluble nucleotides by the x’ibonuclease-oatalysed 
hydrolysis of yeast ENA. 'Free* ribonuclease activity refers to the 
enzymic activity measured in the absence of p-chloromercuribenzoate 
and 'Total* ribonuclease activity refers to activity measured in
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the presence of p-chloromercuribenzoate (PCMB) .
(a) Acid ribonuclease assays
For 'free' acid ribonuclease assays the 'test' incubation 
mixture contained 0,2ml of 0.03M veronal acetate buffer, pH 5*8, 
0,1ml distilled water and 0,2ml 1^  (w/v) aqueous solution of 
yeast ENA, A 'tissue/reagent' blank in which 0,2ml distilled 
water replaced the ENA was set up with each test, to correct for 
any absorption due to the reagents and for any ribonuclease 
activity in the absence of added substrate.
For the estimation of 'total' acid ribonuclease the procedure 
was the same as for the free enzyme assay except that 0.1ml of 
0.003M p-chloromercuribenzoate replaced 0.1ml distilled water both 
in the test and in the tissue/reagent blank. The p-chloromercuri­
benzoate suspension was prepared by mixing the material in 0.03M 
veronal acetate buffer, pH 5*8, and titrating the solution to pH 
5.8 with acetic acid before making up to the desired volume with 
the veronal buffer.
For both 'free' and 'total' ribonuclease assays, the reaction 
was started by adding 0.1ml of the tissue supernatant to each 
tube and incubating the tubes at 37°C for 30 min. At the end of 
the incubation period the tubes were cooled in ice for 1,0 min, 
after which the reaction was stopped by the addition of 0,6ml of 
an acid-ethanol reagent prepared by adding 12,0ml HCl to 8,0ml 
distilled water and making the volume up to 100ml with 6^fo (v/v) 
ethanol. Undegraded ENA and protein were removed by centrifugation 
at lOOOg ave, for 15 min. at 2°C and the absorbance of the 
supernatant at 260nm was measured against distilled water.
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For each batch of assays two substrate blanks each containing 
0,2ml of the yeast ENA solution and 0.4ml of the veronal acetate 
buffer were set up. One blank was treated with the acid-ethanol 
reagent without prior incubation and the other was treated with 
the acid-ethanol reagent after a 30 min. incubation at 37^ G, By 
comparing the -^ 260 the supernatants of these blanks after 
centrifugation it was confirmed that there was no breakdown of 
the yeast ENA in the absence of tissue extract.
To calculate the ribonuclease activity in each 'test* sample 
the sum of the absorbance at 260nm of the tissue/reagent blank and 
the substrate blank was subtracted from the absorbance of the 'test' 
at the same wavelength. One unit of ribonuclease activity was the 
enzyme activity which caused an increase of 0,1 in the absorbance 
at 260nm of the acid-ethanol soluble fraction under the 
experimental conditions described above.
(b) Alkaline ribonuclease assays
Experimental conditions for 'free' and 'total* alkaline 
ribonuclease assays were the same as for the acid enzyme assays 
except that the pH of the veronal acetate buffer was 7.8 and that 
p-chloromercuribenzoate was used at a concentration of O.OIM for 
the 'total* alkaline ribonuclease assays as recommended by 
Shortman (I96I),
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Pre-paration and Assay of •predriisolone-reoeptor complexes from 
cytosol of rat muscle and liver
The methods employed to prepare cytosols from rat 
gastrocnemius muscle and liver and to assay the prednisolone-receptor 
complexes from these preparations were adapted from techniques 
described by several workers (Baxter and Tomkins, 1971; Petrovic and 
Markovio, 1975; Mayer and Rosen, 1975; Agawaral, 1977).
Gastrocnemius muscle, perfused in si-tu for 2 min* with ice-cold 
0.85^ (w/v) saline was removed quickly from the animal and minced 
finely* The tissue was suspended in 4 vol ice-cold homogenisation 
buffer (0,00IM sodi-um phosphate buffer, pH 7.4, containing 0*5^  (v/v) 
thiodiglycol to protect sulphydryl groups essential to the stability 
of the receptors) , homogenised using a Silverson homogeniser at 0°C 
and centrifuged at 60,000g ave, for 2 h at 2°G, The 'cytosol 
fraction' was carefully withdrawn with a syringe and stored at 2^ 0,
It was used for prednisolone-binding studies within 24 h of 
preparation and without further purification.
Liver cytosol was prepared as described for muscle cytosol 
after perfusing the tissue in situ for 2 min, with cold 0,855^  (w/v) 
saline through the portal vein*
The protein concentration of each preparation was measured by 
the bi-uret method and appropriate dilutions with the homogenisation 
buffer were made to give a cytosol preparation containing 4*0mg 
protein per ml, 1,0ml of this preparation was further diluted to 
4.0ml with the same buffer and used for the prednisolone-binding 
assays* Prednisolone receptors were exposed to the steroid by 
incubating the dilute cytosol wi'bh a solution of %-prednisolone for
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90 min, at 0°G. Any unadsorbed steroid was removed by adsorption 
on activated charcoal. A determination of the radioactivity 
remaining in supernatant was taken as a measure of prednisolone- 
receptor complexes in the preparation. The steroid solution was 
prepared by mixing 0.1ml of a toluene/ethanol (9:l) solution 
containing 0*36mg unlabelled prednisolone per ml with 0,4ml of a 
solution of %-prednisolone to give a final specific activity of 
173/iwGi per mg prednisolone. The final concentration of the steroid 
in the assay mixture was 9*6#. For use the steroid mixture was 
evaporated to dryness under nitrogen at 20^ 0 and redissolved in 
0,5ml absolute ethanol, 0,2ml of this solution was incubated with 
4.0ml of the cytosol preparation at 0°G.
At the end of the incubation period any unbound prednisolone 
was separated from prednisolone-receptor complex by adsorption on 
activated charcoal. 0,5ml of a suspension of the activated charcoal 
(300mg/ml in O.OOIM sodium phosphate buffer, pH 7.4) was added to 
the incubation mixture which was vigorously agitated on a vortex 
mixer for 1,0 min. The mixture was allowed to stand at O^ G for 
5 min., centrifuged for 5 min. at lOOOg ave, at 2°G, and the 
supernatant filtered through glass wool to remove any traces of 
charcoal.
Fractionation of prednisolone-receptor complexes in rat liver and 
muscle by ion-exchange ohromatogranhv
In order to obtain information on possible ionic differences 
in prednisolone-receptor subpopulations, the final filtrate from 
the preceding section was adsorbed on BE-52 cellulose ion-exchange 
column and eluted with a linear sodium phosphate gradient. The
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cellulose was packed under gravity in a glass tube to give a 
column 25cm high and l,oom in diameter and used at 4^ 0, The 
column was washed with 100ml of the 'initial* buffer (O.OOIM 
sodium phosphate buffer, pH 7.4) before the sample (3.5mg protein 
in 3•5ml) was applied. Sodium phosphate of increasing ionic 
strength was the mobile phase and the fractionation of the receptor 
subpopulations depended on the fact that differences in the 
chemical nature of these macromolecules give rise to differences 
in their ionic changes and behaviour. These differences alter the 
readiness with which the macromolecules are held by the stationary 
phase and the ease with which they are subsequently eluted and 
released from the column by sodium phosphate. As the eluting 
buffer passes through the band containing the mixture of ions to 
be separated, bands of this mixture containing separate components 
are formed and, during their progress down the column, the degree 
of separation between the bands increases making efficient 
fractionation possible.
First, the sample on the column was washed with 70ml of the 
'initial' buffer and 5,0ml fractions of the eluate were collected.
The column was then eluted with a linear sodium phosphate gradient 
prepared by mixing 60ml each of O.OOIM and 0.2M sodium phosphate 
buffer, pH 7*4 in a gradient former and 5*0ml fractions of the 
eluate were again collected, A flow rate of eluant of 1,0ml per 
min, was maintained throughout this procedure with the aid of 
peristaltic pump. Each fraction was assayed for protein by measuring 
its absorbance at 280nm and radioactivity was counted on the 
Interteohnique liquid scintillation spectrometer using NB 250 
liquid scintillator.
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Estimation of molecular sizes of prednisolone-rece-ptor complexes 
in rat liver and muscle cytoplasm
Some information was sought about the molecular sizes of 
prednisolone-receptor complexes in the rat liver and muscle by- 
studying the sedimentation behaviour of these complexes in a 
5 - 209^  (w/w) linear sucrose gradient. The gradient was prepared 
in O.OIM Tris buffer, pH 7*4 at 20^ 0, containing O.OOIM EDTA 
according to the procedure described on page 73 • 1.0ml of the
sample (the final filtrate obtained as described on page 94) was 
layered carefully over the gradient which was then centrifuged at 
60,OOOg ave. for 24 h at 2^ 0. Thereafter 25-drop fractions of the 
gradient were collected sequentially from the bottom of the tube 
using a tube piercer. These fractions were counted for 
radioactivity. As the standard marker, 1.0ml of a solution of 
serum bovine albumin containing 2,0rag albumin per ml in O.OOIM 
sodium phosphate buffer, pH 7.4, containing 0.^ (v/v) thiodiglycol 
was centrifuged concomitantly in an identical gradient. The 
sedimentation profile of this standard was obtained from the 
ultraviolet absorbance at 280nm of the 25-drop fractions collected 
at the end of the centrifugation. Approximate sedimentation 
coefficients and molecular weights were calculated for the 
prednisolone-receptor complexes by comparison with the standard 
(Martin and Ames, I961).
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RADIOACTIVITY MBASUREIMTS
Radioactivity was measured in the present studies by liquid 
scintillation counting on the Intertechnique liquid scintillation 
spectrometer Model SL30. In the scintillation process the 
disintergration of the radioactive sample results in the emission 
of electrons ( j i particles) the energy of which raises the 
surrounding solvent molecules to an excited state, llie energy of 
the electron is thus transferred via the solvent molecules to a 
scintillator molecule which in turn becomes excited and emits its 
energy in the form of photons of light. The emitted light is then 
transmitted through the counter vial to a photomultiplier tube 
inducing an electrical signal which is amplified and counted.
Where glass fibre discs were employed, 0.15ml of the solution 
containing the radioactive sample was layered on the glass 
miorofibre disc (Type GF/A, diameter 2.5cm, Whatman Ltd., England) 
which was then dried under an infra-red lamp for 30 min. The disc 
was transferred into a counting vial containing 5* 0ml, of the 
toluene-based scintillation fluid (NS 233). For a 'blank* count, 
the same volume of the solvent in which the sample was dissolved 
was applied to the disc, dried and counted alongside the sample.
The difference between test and blank counts was the true sample 
count. The duration of counting depended on the radioactivity of 
the sample under assay. Normally at least 4000 counts per sample 
were recorded. V/here necessary, more than one and up to three 
sample-containing discs were loaded into a vial to increase the 
count rate with no significant loss of counting efficiency (Fig, 15) ,
The efficiency with v/hich the samples were counted was determined
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400-1
NUMBER OF DISCS
FIG. 15 The coimt rate of tritium-labelled samples as afunction of the number of discs present in counting vials :
0.15ml of radioactive rat liver ribosomâl nucleotides in O.IM KOH was carried on each disc. Counting v/as performed on the pre-set 3n Channel and background 
counts v/ere obtained for each sample by subjecting the same number of discs, each carrying 0,15ml of O.IM KOH to the assay procedure.
The cpm is the sample count less the background count.
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by internal standardization. The sample on the disc was first
counted. Then a known amount of radioactivity from the same
isotope (internal standard) was added to the sample on the disc
and another count made. The count rate (cpm) of the internal
standard was the difference (h) between these two counts. The
efficiency with which it was counted was calculated by dividing
(D) by the known activity (dpm) of the standard. Since the
standard is assumed to have counted v/ith the same efficiency as
the sample, the result of this calculation is also the counting
efficiency of the sample, -labelled samples dissolved in
O.IM KOH counted with an efficiency averaging 15*6^ and no
significant variation between samples was observed (Table 4) •
In some cases, liquid samples were counted directly in a
dioxane-based scintillation fluid (NE 250), Up to 0.3ml of the
sample was dissolved in scintillation fluid and the counting
efficiency of these samples was obtained from an efficiency
calibration curve (Fig. 16) which was plotted from data obtained
by the external standardization technique. This technique makes
use of the spectral shift towards lower energies as the counting
efficiency of a sample is reduced by a quenching agent. The
117external standard is a gamma source ( 'Os) which generates electrons 
in the scintillator similar to in energy spectrum to a ^ emitter. 
When this external standard is placed in proximity to the sample it 
is counted along with sample and is subject to the same quench 
effect as the sample. These quench effects take the form of 
spectral shifts which are observed as changes in the ratios of 
counts in the lower and upper counting windows (channel ratios) ,
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TABLE 4* The counting efficiency of nucleotide samples on 
the Intertechnique spectrometer (Model SL 30)
cpm dpm Efficiency
.W).......
A Sample X 19.2
B Sample X + 
dpm)(B - A)
Orotic Acid (11190 1794.4 — —
1775.2 11190 15.86
C Sample Y 921.5 - —
D Sample Y + 
dpm)(D - 0)
Orotic Acid (11190 2644.3
1722.8 11190 15.40
E Sample Z 284.5 — —
F Sample Z + dpm)(F - E)
Orotic Acid (III90
2024.5
1740 11190 15.55
Sample X was the acid-soluble extract from the alkaline digest 
of rat gastrocnemius muscle homogenate.
Sample Y was the acid-soluble extract from the alkaline digest of rat liver homogenate.
Sample 2 was the acid-soluble nucleotide pool from rat liver.
Details of the preparation of acid soluble extracts from alkaline digests and the preparation of Total acid soluble pool were described on pages 55 and 82,
All samples were assayed in duplicate and the values presented above are the calculated means.
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Thus the external standard channel ratio can be related to the 
counting efficiency of the sample isotope.
To prepare the calibration curve, 0,3ml of an aqueous 
solution of %-Orotic acid (III90 dpm) was introduced into each 
of 7 vials containing 5.0ml of the scintillation fluid (HE 250).
Increasing quantities of a quenching agent (0.2---> 3.0ml
methanol) were added to each vial and the vials were loaded into 
the spectrometer. Channel C on the spectrometer was switched to 
the factory-set level for and the external standardization 
mode was switched to automatic. On the commencement of counting 
the following sequence of events took place automatically: The
radioactivity in each vial was counted in channel C to give a 
count rate (C^ ) ; The external standard source was positioned 
close to the detection chamber and counted in channels A and B 
to give count rates AI^ and BI^ respectively; finally, with the 
external standard source removed, the sample alone was counted in 
channels A and B to give count rates AI-j^ and BI^,, respectively. 
Dividing 0^  by the activity of the sample (III90 dpm) gave 
the efficiency with which each sample was counted. The channel 
ratio ('^ /B) for each sample was calculated from the relationship
A Alg^ -  Al-y
B BI^ - B%,
where A is the channel with the greater count rate and B is the 
channel with the lesser count rate. The efficiency curve was then 
plotted with efficiency values against the corresponding channel 
ratios. The counting efficiency of a test sample was read off from
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this curve using channel ratios obtained by subjecting the test 
sample (without methanol) to the procedure described above. 
Samples dissolved in O.IM KOH were counted with an efficiency 
of 37*5^  under these conditions.
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CHANNEL RATIO
increasing quench-
FIG. 16 The quench curve for %-Orotic Acid (III90 dpm) 
using the external standard counting mode. 
Experimental details are described on page 102.
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MATHEMATICAL IREATMMT OF RESULTS
Derivation of standard deviation and standard error of mean, and 
tests of statistical significance
The standard deviation and the standard error of mean of a set
of results were calculated following the procedure described by-
Spiegel (1961). To determine "bhe level of statistical significance 
of data obtained from 'test* and 'control* experiments a group or 
paired *t' test was performed as appropriate as described by- 
Spiegel (1961).
Calculation of slopes by method of least squares
If n is the number of points on a graph in which values on the
X axis are plotted against values on the y- axis then the slope, m,
of these points is given by the equation
^x«^y - n ^ xym =
2n ; X
and the y intercept (c) is given by the relationship
> ]  '  -
These values of m and c fit into the equation for a straight 
line (y = mx + c) and a point for x at a fixed value of y can be 
calculated from this equation. The calculated slope is the line 
joining this point to the y intercept (c) •
3. RESULTS
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EFFECT OF PREDHISOLONB TREATMENT ON 
COÏÏCEHTRATIOHS IN RAT LIVER AND MUSCLE
This group of experiments investigated the effect of daily 
injections of prednisolone acetate on ENA, DNA and protein 
concentrations in rat liver and gastrocnemius muscle. The changes 
in the body weight of the animal during the experimental period 
were also measured. Prednisolone acetate was administered daily 
over an eight-day period to male rats by subcutaneous injections 
into the hind limbs at a dose level of l.Omg per lOOg initial 
body weight.
The results presented on Table 5 and Fig. 17 show the changes 
in the overall body weight of the animal over the experimental 
period. There did not appear to be any alteration in body weight 
in prednisolone-treated rats sacrificed on the day after the first 
prednisolone injection (Day 2). During the same period, control 
rats injected with saline gained weight. On subsequent days, 
control animals exhibited a progressive rise in body weight while 
prednisolone-treated rats showed a marked loss of weight.
Over the experimental period, the gastrocnemius muscle of 
prednisolone-treated animals showed a loss of weight (Table 6 and 
Fig. 18). This loss was statistically significant from the fourth 
day, averaging about 20^ when compared with gastrocnemius from the 
control animal and became more pronounced as prednisolone treatment 
progressed. In contrast the liver of prednisolone-treated animals 
gained weight (Table 8 and Pig. l8), The liver of control animals 
treated with saline did not exhibit the same rapid increase in 
weight. This difference was evident as early as two days after the
..-■■ ?:7V-V ’ . H ~  i; •;»’:;;■■'-i 1'
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initial prednisolone injection and persisted all through the 
experimental period with increases averaging "between 155^  and 249^  
of the liver weight of control rats.
The protein content of the gastrocnemius muscle of 
prednisolone«treated animals showed a decrease during the 
experimental period. This decrease was statistically significant 
from the fourth day when protein content of prednisolone-treated 
rats was 75^  of that of the control animals (Table 6). This loss 
of protein from gastrocnemius muscle was still evident when the 
result was expressed per unit weight of the tissue (Table 7 and 
Pig. 19) 9 indicating that the protein loss was disproportionate 
to the overall loss of muscle mass. Total liver, on the other 
hand, increased in prednisclone-treatedrat83: aye^agihgm25p uiore than .g
the control levels on the second day and rising to approximately m
yy/o by Day 8 (Table 8). These changes in the protein concentrations ÿ
in the liver of prednisolone-treated animals parallel the changes f
in the wet weight of the organ as indicated by data on Table 9
gand Pig* 20. ’3
There was also a decrease in the total E M  content of the 
gastrocnemius muscle of prednisolone-treated animals when it was 
compared with the E M  content of the saline-treated control 
animals. This change was apparent two days after the initial 
prednisolone injection and had become statistically significant by 
Day 4. The E M  loss averaged \1 F /o on the second day and reached 
almost 509^  on Day 8 (Table 6) . This ENA loss was disproportionate 
to the overall loss of muscle mass (Table 7) • The EM content in 
the liver of prednisolone-treated animals increased, compared with
,3
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that of controls (Table 8), This increase attained statistical 
significance (P < 0.05) from the second day and by Day 8 the 
ENA concentration in the prednisolone-treated animal was 2(nfo more 
than the concentration in the liver of the control animal.
Throughout the experimental period, the DNA concentration 
in the gastrocnemius muscle of both prednisolone-treated animals 
and their controHs remained constant (Table 6) • There was also no 
significant change in liver DNA content.
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DAYS AFTER COMMENCEIVIENT OF PREDNISOLONE INJECTIONS
PIG. 17 The effect of prednisolone acetate treatment on rat body weight; Prednisolone-treated animals 
received 0.06ral prednisolone acetate (25mg/ml) per 
150g initial body weight daily while control 
animals received the same volume of 0,859^ (w/v) 
saline. Results are mean values from 6 animals - standard deviation.Triangles indicate results obtained with prednisolone-treated animals and circles indicate 
results from control animals.
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FIG* l8 The effect of prednisolone acetate treatment on 
rat gastrocnemius muscle and liver weights; Experimental details were as described on Table 5 Results are mean values from 6 rats - standard 
deviation. Circles indicate controls and triangles indicate results obtained with prednisolone-treated 
animals.
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FIG* 19 The effect of prednisolone treatment on protein and 
Nucleic Acid Concentrations in rat gastrocnemius muscle:
Experimental details were as described on Table 5* Results are mean values from 6 rats - standard deviation.
Circles indicate controls and triangles indicate 
results obtained with prednisolone-treated animals.
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FIG, 20 The effect of prednisolone acetate treatment on 
Protein and EFA concentrations in rat liver. 
Experimental details are as described on Table 5» 
Results are mean values from 4 rats - standard 
deviation.Circles indicate controls and triangles indicate results obtained with prednisolone-treated animals
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STUDIES ON THE TOMOVER OF TOTAL M A  m  LIVER AND MJSCLE 
FOLLOTOG PREDNISOLONE TREATMENT
As early as 48 h after daily injections of prednisolone 
acetate (i.e. on Day 2) alterations were observed in the amounts 
of RDA in rat liver and muscle (Figs* 19 and 20). Reports that 
responses to corticosteroids are prevented by actinomycin D 
(Greengard et al. I963; Garren et al, I964) and that these 
steroids alter the rates of REA breakdown in rat liver (Ottolenghi 
and Barnabei, 1970) suggest that REA synthesis or breakdown may be 
involved in these responses. In this section an investigation of 
the effect of prednisolone treatment on the rates of synthesis and 
breakdown of cytoplasmic REA in the liver and gastrocnemius muscle 
of the rats was undertaken. Since it had been demonstrated in 
this laboratory that maximal labelling of rat liver REA was 
achieved two days after the initial injection of labelled 
Orotic acid (Ma, 1973), this time duration was allowed before the 
coimnencement of prednisolone injections. 2 days after injecting 
20/tCi of %-Orotic acid intraperitoneally into the animals, daily 
subcutaneous injections of prednisolone acetate were administered 
to the 'test* group of animals while the control group received 
the same volume of saline. Every second day a test animal and its 
control partner were sacrificed, liver and muscle were excised and 
the radioactivity and REA content of both tissues were measured 
using techniques described in the 'methods' section.
Table 10 shows the pattern of loss of specific radioactivity 
of the total REA in the liver over the experimental period. Both 
the prednisolone-treated animals and their controls exhibited a
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TABLE 10. EFFECT OF PREDNISOLONE ACETATE TREATMENT ON 
THE LOSS OF RADIOACTIVITY FROM %-LABBLLED 
LIVER RNA
Days after Orotic Acid 
Injection
Specific Activity cpm/mg RNA (x lO” ) Total Activity (opm/liver/lOOg body weight) X 10*"^
Prednisolone-treated
Control Prednisolone Control -treated
2 ^45.0
±0.9
^1701±29.2
4 -0.9 (N/8)
^30.3±1.0
1411 1178 
±40.5 ±31.6 (<0.025)
6 .19.9±0.8
(N/8)
^21.0
±0.8
^1021 ^ 768 
±49.6 ±42.8
(<0.005)
8 15.3±1.1
(N/S)
^15.^±0.9 ^725 ^ 601 ±41.4 ±38.5 (<0.005)
10 11.3±1.1 (N/8)
^9.6±0.8 ,^ 532 ^ 390 ±36.2 • ±45.6
(<0.005)
Each animal received a single dose of H-Orotic acid (20.0/tCi) intraperitonally. Commencing two days after this injection prednisolone-treated animals received 0.06ml prednisolone acetate (25mg/ml) daily subcutaneously. Controls 
received the same volume of (w/v) saline, '
iTotal RNA and radioactivity were measured as described jon pages 55 and 98 respectively. Each result is the mean ]
from 5 animals - standard deviation. Fibres in brackets .jindicate level of statistical si#iifioance@«between prediiidolone- |
treated .rats l and controls; as înalculated iby&groupedoB^ &dtést.
J
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progressive loss of specific radioactivity and although the rate 
of this loss was slightly slower in the prednisolone-treated 
animals than in controls, the difference was not statistically 
significant on any of the days studied. However, when the total 
radioactivity in each tissue was calculated taking into account 
the increase in liver RNA concentrations in the prednisolone- 
treated animals it was evident that the administration of 
prednisolone resulted in a slower decay of RNA radioactivity in 
the treated animals. Statistically significant differences 
between the total radioactivities of the prednisolone-treated 
animals and the control group were observed as early as two days 
after the onset of prednisolone administration. In the control 
animal, total liver RNA radioactivity, after reaching a peak, 
dropped to half of this peak radioactivity in approximately four 
and a half days (Pig. 21 A), At this time, the total liver RNA 
in the prednisolone-treated animal had lost only 40% of the peak 
radioactivity. When data from these experiments were plotted on 
a logarithmic scale against a linear time scale, a strai^t line 
relationship was observed in both control and prednisolone-treated 
animals (Pig. 21 B), an indication that total RNA degradation in 
rat liver followed first order kinetics in both groups of animals. 
From the slope of the lines on Pig. 21 B the biological half-lives 
of total RNA in the liver of the prednisolone-treated and control 
animals were calculated to be 5*85 and 4*26 days respectively.
The corresponding rate constants of RNA degradation were 0.1185 
and 0.1627 respectively. Since no significant alteration occurred 
in the amount of total RNA in the liver of the control animal
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PIG. 21 Loss of radioactivity from total liver RNA following prednisolone treatment.
Experimental details are as described for Table 10.Each point is the mean value from 5 animals. Triangles represent results from pregnisplone-treated animals and circles represent controls." ^ %e slope of each line was plotted by method of 'least Squares'.
Total activity v/as expressed as cpm/liver/lOOg body weight.
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during the experimental period (Table 8), the amount of E M  
synthesised per day was assumed to be the same as the amount 
broken down. Using a rate consfcont of EM degradation of 0.1627, 
the amount of E M  synthesised per day in the control animal was 
calculated to be 6.13mg per liver per lOOg initial body weight.
In the prednisolone-treated animal there was a mean increase of 
24% in the E M  levels during the 8-day experimental period. In 
this animal the amount of ENA synthesised per day will be equal 
to the amount broken down per day plus the daily change in total 
R M  concentration. This value was calculated to be 8,8mg R M  per 
liver per lOOg initial body weight. Prom the biological half-lives 
obtained above, the turnover times for total R M  is 
prednisolone-treated and control rats were 8,5 and 6.15 days 
respectively.
The results of a similar investigation of total RM 
radioactivities in rat gastrocnemius muscle are presented on 
Table 11, The progressive decrease in specific radioactivities 
observed in liver RNA was not evident in muscle where the levels, 
of specific radioactivity remained unchanged or, sometimes, 
tended to show an increase (Pig. 22). This pattern was observed 
in both control and prednisolone-treated animals and is not 
consistent with the general concept of breakdown of RNA, its 
replacement by newly synthesised unlabelled RNA and a consequent 
drop in the specific radioactivity of the macromolecule. To 
investigate this apparent discrepancy, the radioactivities of the 
RNA precursor pools in both groups of animals were examined and 
the turnover of various RNA species in muscle was determined. The 
findings are described in subsequent sections.
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TABLE 11. RADIOACTIVITY LEVELS IN THE TOTAL RNA OF
GASTROCNEMIUS MUSCLE OF PREDNISOLONE-TREATED 
RATS
Days after Orotic Acid Injection Specific Activity (cpm/mg RNA) X 10“"3
Prednisolone
-treated
Control
2 - 0.88
±0.07
4 0.89±0.06
(V s )
0.99±0.06
6 1.14±0.05 (N/8)
1.11
±0.05
8 1.20±0.06
(N/8)
^1.25±0.04
10 _^ 1.33±0.05 (N/S)
1.29±0.05
Each animal received a single dose of %-Orotic acid (20.0/uCi) intraperitoneally. Commencing two days after this injection, each prednisolone-treated animal received 0.06ml prednisolone acetate (25mg/ml) daily subcutaneously. Controls received the same volume of 0.85% (w/v) saline,
RNA and radioactivity were measured as described on pages 55 and 98 respectively. Each result is the mean from 5 animals - standard deviation.
ii
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FIG. 22 Radioactivity of total RNA in rat gastrocnemius muscle following prednisolone treatment: 
Experimental details are as described for Table 11. Each point is the mean value from 5 animals. Triangles represent results obtained from prednisolone-treated animals and circles represent controls. The slope of each line was calculated by method of least squares.
125
TURNOVER OF RIBOSOMES IN LIVER AND MUSCLE OF PREDNISOLQNE- 
TREâTBD RATS
The central role which ribosomes play in cytoplasmic protein 
synthesis is well established and it has been demonstrated that 
hormones can influence the in vitro activity of muscle (Florini 
and Breuer, I966) as well as liver (Rancourt and Litwock, I968) 
ribosomes. Ribosome turnover may therefore be a controlling 
factor in the biological responses observed following prednisolone 
treatment and the translation of genetic information and protein 
synthesis may be regulated by the glucocorticoid at this ribosomal 
level. This series of experiments investigated ribosomal turnover 
in the liver and gastrocnemius muscle of prednisolone-treated 
animals. The RNA component of the ribosome was labelled with 
20 ^ Ci of %-Orotic Acid and the turnover of the ribosomal RNA was 
determined by following the rate of loss of radioactivity. 
Procedures for isolating ribosomes from the liver and muscle are 
described on page 58 RNA and radioactivity measurements were 
performed as described on pages 6l and 98 respectively.
With liver ribosomes, there was a progressive loss of specific 
radioactivities in both the prednisolone-treated animals and their 
controls (Table 12) over the experimental period. This loss of 
specific radioactivity was slightly slower in the prednisolone- 
treated animals than in the control group. The slower rate of 
loss of radioactivity in the prednisolone-treated group became more 
obvious when the total radioactivities in these ribosomes were 
calculated. Statistically significant differences between these 
total radioactivities in the two groups of animals were observed
TABLE 12. LOSS OP RADIOACTIVITY FROM RNA IN RAT LIVER 
RIBOSOMES FOLLOWING PREDNISOLONE TREATMENT
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Days after Orotic Acid Injection
Specific Activity cpm/mg RNA (x 10“3) Total Activity cpn/liver/lOOg body weight (x 10*”^)
Prednisolone -treated . Control Prednisolone Control -treated
2 - , 40.6 
±3.1
^1598
±50.3
4 ,29.8±1.8
(N/s)
30.3±2.6 1323 ^1142 ■"39*6 —41.3
(<0.025)
6 .24.6
±1.3 (N/s)
^26.0±2.1 ^1176 ^ 982 ±50.1 ±48.5 (< 0.010)
8 ^19.3±2.0 (N/s)
^19.4±2.8 892 ^ 727 ±34.5 ±57.8 (< 0.010)
10 .^13.3±2.8 (N/s)
12.5±2.6 631 , 471 —40•0 “ 46 *1 (< 0.010)
Each animal received a single dose of ^-Orotic acid 
(20.0 /MCi) intraperitoneally. Commencing two days later, each prednisolone-treated animal received subcutaneous injections of 0.06ml prednisolone acetate (25mg/ml), Controls received the same volume of 0.85% (w/v) saline.
Ribosomes were isolated as described on page 58 and RNA and radioactivity measurements were performed as described on pages 61 and 98 respectively. Each result is the mean from 
4 animals - standard deviation. Figures in brackets indicate level of statistical significance between prednisolone-treated 
animals and their controls as calculated by Students' grouped *t* test.
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from two days after the onset of prednisolone treatment (Table 
12). The liver of the control animal lost 50% of its ribosomal 
radioactivity in 4.4 days when the prednisolone-treated animal 
still retained 62% of its radioactivity (Fig. 23A). When these 
data were plotted on a logarithmic scale against a linear time 
scale the rate of loss of radioactivity, for both animals, 
followed first order kinetics showing a straight line relationship 
between the total radioactivity and time (Fig, 23B). From the 
slope of these lines, the rate constants of RNA degradation in 
the prednisolone-treated group and in the control group were 
0.1065 and 0.1612 respectively. These constants correspond to 
biological half-lives of 6.51 and 4.3 days for the prednisolone- 
treated and control animals respectively. Ottolenghi and 
Barnabei (l970), from studies of liver microsomal RNA turnover in 
cortisone-treated and control rats reported half-lives of 7.4 and 
4.7 respectively. The amount of ribosomal RNA synthesised per 
day per liver per 10Og initial body weight, in the control group 
was 6,06mg while the corresponding value in the prednisolone-treated 
group was 8.23mg. Turnover time for this RNA was 9.39 days for the 
prednisolone-treated animals and 6.20 days for the control animals.
The results of the investigation of ribosome turnover in the 
rat gastrocnemius muscle are presented on Table 13. Ribosomes from 
the muscle of the control group of animals showed a progressive 
loss of specific radioactivity over the experimental period. Such 
a pattern of loss of radioactivity was not evident in the 
prednisolone-treated animals. If synthesis were occurring during 
the period of predniso3ione treatment, any new RNA formed would be
128
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PIG, 23 Loss of radioactivity from RNA in liver ribosomes following prednisolone treatment;
Experimental details are as described on Table 12, Each point represents the mean result from four 
animals. Triangles indicate results from 
prednisolone-tre^^ed animals and circles represent •the 0 on trois ^ he slope of each line was plotted by the ’least squares’ method.
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TABLE 13. RADIOACTIVITY IN RIBOSOMES OP GASTROCNEMIUS 
MUSCLE OP PREDNISOLONE-TREATED RATS
Days after Orotic Acid Injection
Specific Activity of Ribosomes (cpV/<g RNA) Total Activity of Ribosomes (opni/muscle/ 100g body wei^t) x 10"”^
Prednisolone-treated Control Prednisolone-treated
Control
2 2.7to, 18 - 2.8  to. 11
4 to.07(H/S) —0,16
1.8 2,3
to, 14 to, 24 (<0,025)
6 2.0 to. 11
(H/S) to. 14
.1.5to, 18
(N/8)
1.8 
to, 15
8 1.9 ^1.2io.16 to, 11 
(< 0,025)
1.3to, 14(N/8)
-0,16
10 1.8 ^1.0 to. 12 to. 17 
(< 0.01)
^1.0 
to. 22
(N/8)
1.0 
to.13
Each animal received a single dose of ^-Orotic Acid 
(20.0^ (01) intraperitoneally. Commencing two days later, each prednisolone-treated animal received daily subcutaneous injections of prednisolone acetate (29mg/ml). Control animals received the same volume of 0.855^ (w/v) saline.
Ribosomes were isolated as described on page 58 ; RNA and radioactivity measurements were performed as described on pages 6l and 
98 . Each result is the mean from 4 animals - standarddeviation, Pigures in brackets indicate the level of statistical significance between prednisolone-treated animals and their controls, as determined by students grouped *t* test.
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less radioactive due to loss of radioactivity from the precursor
pool and this would he reflected in a drop of specific radioactivity
throughout the experimental period. Since there was no change in
specific radioactivity it would appear that synthesis of RNA
associated with ribosomes in the prednisolone-treated rats was
depressed. When the total radioactivity in the ribosomes was
Vn.VA.sc lecalculated, taking the total RNA content of the üver-as an 
estimate of the amount of ribosomal RNA, it was found that muscle 
ribosomes from the prednisolone-treated group suffered a progressive 
loss of radioactivity (Table 13). Over the 8-day experimental 
period, muscle ribosomes in both prednisolone-treated and the 
control group of animals lost approximately 62^ of their respective 
total radioactivities (Table 13). Except on Day 4 (two days after 
the commencement of prednisolone injections) when the calculated 
radioactivity was significantly lower than in the control rats, 
there was no significant difference in the calculated radioactivity 
present in control and treated rats. One interpretation of these 
results is that there was a more rapid degradation of this RNA in 
the prednisolone-treated rats during the first 2 days of 
prednisolone administration but that thereafter the amount of RNA 
degraded was similar in both groups of animals.
It is acknowledged that ribosomes may bind to messenger RNA 
and be isolated as polysomes to which, depending on the 
translational state of the cell, various transfer RNAs may also 
be attached, RNA turnover measured from these ribosome preparations 
may, therefore, be reflective of turnover of these various RNA 
species rather than of just ribosomal RNA. A truer measure of
131
ribosomal RNA turnover may be obtained by isolating this ENA 
from the bulk of cytoplasmic RNA, Work aimed at achieving this 
objective will be reported in subsequent sections.
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ISOLATION OF RNA FROM RAT GASTROCNMtnJS MUSCLE ÏÏSING PHENOL 
EXTRACTION METHODS
In the preliminary experiments reported on page ll8 muscle 
ENA was measured in the alkali digests of the tissue as described 
in ’Methods*, This RNA is composed of various RNA species whose 
turnover rates may be different. Furthermore^  the tritium label 
from the orotic acid used in these experiments can be incorporated 
into other cellular constituents (e.g. glycogen). These 
constituents remain in the alkali digest whose radioactivity is 
measured and thus complicate an interpretation of results from 
the experiments. Such considerations prompted attempts to extract 
RNA for the tissue in a purer form and in good yield. Various 
modifications (page 65) of Kirby’s 1956 method were tried and the 
purity and percentage recovery of RNA by each method were 
determined.
When RNA was extracted from the muscle by the Hot Phenol 
method, 6l^  ^of the total RNA present in the tissue was recovered 
(Table I4), This recovery was considerably less than that (75 - 90^ ) 
reported by Manchester (I967). Several repetitions of the 
experiment did not improve the result. It may be significant, 
however, that diagraphm muscle with which Manchester worked is 
more easily homogenised and processed than gastrocnemius muscle.
The ^ 26c/'^ 280 of the RNA isolated by this method was 1,55, a
figure which is lower than the 1,7 reported by Manchester (I967).
Phenol extraction was then carried out at 0°G as recommended 
by Wool and Munro (I963) . The RNA recovered by this method was 
only 58^ of the quantity estimated to be present in the tissue.
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TABLE 14. YIELD AND PURITY OF RNA ISOLATED FROM MUSCLE 
BY VARIOUS PHENOL EXTRACTION TBCHNIQJJES
mg RNA/g Muscle ^ Recovery ^26c/^280
RNA isolated by Hot Phenol Extraction ^61.3t2.3 1.55
Total ENA Content - —
RNA isolated by Cold Phenol Extraction ^1.1 —0,06 .57.9t3.8 1.80
Total RNA Content
-0.11
— -
RNA isolated by CTA extraction
0.80
-0.06 ,43.6±6 .1 1.95
Total RNA Content ^1.81
-0 .07
— —
RNA isolated byPhenol/Chloroformextraction
+1.5-0.03 ,78.9±3.6
1.98
Total RNA Content ^1.90
-0.05
- —
The RNA extracted from the right gastrocnemius muscle was 
dissolved in 3.0ml sodium acetate buffer, pH 5.1 and assayed by the Orcinal method.
•Total RNA content' refers to RNA from the left gastrocnemius muscle of the same animal solubilised by alkali 
digestion as described on page 55 and assayed by the Orcinal method.
'fo Recovery is RNA concentration in extract x 100 Total RNA content
The results are mean values from 3 rats - standard error of mean.
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The •^ 26(/'^ 280 of the material was 1,80, an improvement on
the figure obtained using the Hot Phenol method.
The attempt to extract RNA with CTA involved the 
insolubilisation of an RNA-fOTA complex as described on page 67, 
Only 44% of the total ENA present in the tissue was recovered 
using this method. However, the purity of the isolated RNA was 
an improvement on the two previous methods since the product
gave an -&-26c/'^ 280 °f 1*95.
In an attempt to improve the yield of RNA^  KGl was included 
in the tissue homogenisation medium. This salt solubilises 
muscle proteins, particularly myosin, which are insoluble in 
cytoplasmic extracts when the ionic strength of the medium is 
lowered much below 0.3 (Heywood et al. I967) and with which 
ribosomes will co-precipitate with a resultant dimunition of RNA 
yield. The results of these investigations are presented on 
Table 15. In the presence of O.O5M KGl the recovery of RNA using 
the Gold Phenol method was increased by l6% and further increases 
in KGl concentration did not improve this recovery significantly. 
With the GTA method, the highest yield of RNA was obtained in the 
absence of KGl. It was evident from these investigations that 
the effect of KGl on RNA yield depends on the RNA extraction 
method employed.
The fourth method used to isolate cytoplasmic RNA from 
gastrocnemius muscle required the use of phenol/chloroform 
mixtures as recommended by Perry et al. (1972). Details of this 
RNA extraction technique appear on page 68. As the results on 
Table I4 show, this method yields the most RNA (79% of the total
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RNA present in the tissue). The isolated material contained 
RNA in a purer form than had been achieved with any of the 
other phenol extraction methods (^ 26c/‘^280 ” 1,98).
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EXAMINATION OF RITA ISQLA[EBD BY VARIOUS PHENOL EXTRACTION 
PROCEDURES BY DENSITY GRADIENT CENTRIFUGATION
To determine the inti£.grity and the extent of possible 
degradation of the RNA species isolated by the various phenol 
extraction procedures reported on page 132, the RNA extracts were 
subjected to centrifugation on a linear sucrose gradient as 
described on page 73* The results of these investigations are 
presented in Figs. 24A to 24F and the experimental conditions for 
each experiment appear in the legend below the result.
A 15 - 30^ sucrose density gradient, recommended by McConkey 
(1967), was used in the initial experiments. This gradient, as 
the result on Pig. 24A shows did not fractionate the RNA species 
satisfactorily. In the light of the results obtained by Dr. C.M. 
Goodlad (personal communication) with 5 ~ 20% sucrose gradients, 
subsequent RNA fractionations were carried out using this sucrose 
gradient. More satisfactory results were obtained.
The sucrose gradient profile of RNA isolated by the hot phenol 
method presented on Pig. 24B. The pattern observed differed 
markedly from those of undegraded cytoplasmic RNA reported by Ralph 
and Bellamy (1964). There was some loss of material from the 
presumptive 28^  ribosomal RNA peak, possibly an indication of 
degradation of this RNA species. There was also a steep rise in 
the ultraviolet absorption, at 260n« near the top of the gradient 
presumably due to RNA degradation products (Ralph and Bellamy,
1964), DNA breakdown products (Hayashi et al. 1975)> traces of 
sodium dadecyl sulphate or a combination of these factors.
The RNA extracted by the cold phenol method also gave a
138
profile which suggested that degradation of RFA had occurred 
during the isolation process. Intense absorption at 260 run was 
again observed towards the top of the gradient (Fig. 240).
The sucrose gradient profile of the RFA extracted by the 
OTA method is presented on Pig. 24D, There was no evidence of 
significant degradation of RFA isolated by this method. Three 
RFA peaks were observed. Based on the calculations described on 
page 76, these peaks had sedimentation coefficients of 29, 19 
and 3.85 respectively, corresponding to the two ribosomal RFA 
components and transfer RNA. In an attempt to obtain a better 
separation of the RNA species the duration of the centrifugation 
was extended from 5 to 7 h. This modification, as the results 
on Pig, 24E shoWj gave a more satisfactory distribution of the RNA 
species throughout the gradient. The relative amounts of these 
three RNA species, based on the areas under the peaks were in the 
ratios 3*4 : 1.6 : 1. This result is in good agreement with 
accepted relative proportions of these RNA types in animal tissues 
(Ralph and Bellamy, I964; Sirlin 1972j Adams et al. 1976).
However these results could not be reproduced consistently and the 
OTA method was abandoned.
The results presented on Pig. 24P were obtained with RNA 
extracted using the phenol/chloroform technique described on 
page 68, Here, there was little evidence of significant RNA 
degradation and the sedimentation profile was reproducible with 
several preparations using this RNA extraction technique. The 
proportion of the three RNA species were in the ratios 3.8 : 1.6 : 1. 
Thus, approximately 84% of the RNA isolated from gastrocnemius
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muscle appeared to be ribosomal RNA. This figure is in keeping 
with a value of 80% reported by Manchester (1967) and Young (1970) • 
Since the method employed for the isolation of RNA from muscle 
gave only a 79% recovery (Table I4 ) the data obtained in the 
present work only permit the suggestion that at least 66% of . 
gastrocnemius muscle RNA is ribosomal in origin.
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24A Sucrose gradient profile of rat gastrocnemius muscle ENA isolated by the Hot Phenol Method: l.Omg of ENA extract was dissolved in 2.0ml 0.05M sodium acetate buffer pH 5*1» containing O.IM NaCl and layered over a 15 - 30^  (w/w) sucrose gradient. Centrifugation was performed 
at 5 0 for 17 h at 60,000g ave. using the 3 X 25ml swing-out rotor on the MSE superspeed 
65 centrifuge.
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FIG. 243 Sucrose gradient profile of ENA isolated by the Hot Phenol Method:
Sample was layered over a 5 - 20^  (w/w) sucrose gradient and centrifuged at 60,000g ave. for 7 h at Other experimental details were as
described for Fig. 24A.
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PIG. 24c Sucrose gradient profile of RNA isolated by the Cold Phenol Method.
Sample was layered over a 5 - 20^  (w/w) sucrose gradient and centrifuged at 60,000g ave, for 7 h 
at Other experimental details were asdescribed for Pig. 24A.
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FIG. 24D Sucrose gradient profile of KNA isolated by the OTA Method.
Sample was layered on a 5 20^  (w/w) sucrosegradient and centrifuged at for 5 h at 60,000g ave. Other experimental details were as described in Fig. 24A.
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FIG, 24E Sucrose gradient profile of RNA isolated by the OTA Method.
Sample was layered on a 5 - 20^  sucrose gradient and centrifuged at 5°C for 7 h at 60,000g ave. Other experimental details were as described on Fig. 24A.
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FIG, 24F Sucrose gradient profile of RÎTA isolated by the 
Phenol/Chloroform Method,
Sample v/as layered on a 5 - 20^  sucrose gradient and centrifuged at 5°C for 7 h at 60,000g ave. 
Other experimental details were as described on Fig. 24A.
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CONŒRIHJTION BY FOLYADM YIATED RHA TO MtJSCLE CYITOPIASMIC 
RHA RADIOACTIVITY
Although analysis of the RÎTA extracted from muscle indicated 
that most of cytoplasmic RRA was ribosomal, the data on radioactive 
content of muscle RNA might be influenced to a considerable extent 
by small amounts of heavily labelled RNA species. Messenger RNA 
in particular might be expected to incorporate H^-Orotic acid 
rapidly (Brawerman 1974) and might also be present in ribosomal 
preparation. Most messenger RNA molecules in eukaryotic cells as 
well as some of the heterogeneous nuclear RNA have a poly adenylate 
3^  terminus (Kates and Beeson, 1970» Sheldon et al, 1972), This 
species of RNA can be separated from the rest of the cellular RNA 
by adsorption on an oligo(dT)-cellulose column (Aviv and Leder,
1972), The present series of experiments was carried out with the 
aim of isolating polyadenylated RNA molecules and determining their 
radioactivity. It was also hoped to examine the radioactivity 
present in ribosomal RNA preparations freed from contamination with 
these molecules. The general approach was to (i) maximally extract 
cytoplasmic RNA using the phenol/chloroform procedure described on 
page 71 ; (ii) isolate the polyadenylated RNA from other RNA species 
using the oligo(dT)-cellulose column chromatographic technique 
described on page 7 1; (iii) estimate the specific radioactivity of 
the polyadenylated RNA and the effect of prednisolone treatment on 
this radioactivity; (iv) determine the influence of the 
polyadenylated RNA on the apparent radioactivity levels of other 
muscle RNA species. The results of these investigations are 
presented here. In these experiments administration of prednisolone
147
3acetate was performed 2 days after the injection of H-Orotic 
acid to ensure that maximal labelling of muscle RNA had occurred.
The effectiveness of three RNA isolation techniques, 
described on page 69, in extracting polyadenylated RNA along with 
other RNA species is evident from results presented on Table l6.
The phenol/chloroform method (Procedure O) was the most efficient 
in extracting these RNAs from rat gastrocnemius muscle, RNA 
extracted by this technique was the purest, as determined by 
'^ 260^ '^ 280 ^&tios. It was evident too that although polyadenylated 
RNA constituted only about 3^ (w/w) of the total RNA content of the 
extract, its specific radioactivity was more than three times the 
activity of other RNA species (Table 17). Approximately 10^ of 
muscle RNA radioactivity could thus be attributed to this 
polyadenylated RNA fraction.
The effect of prednisolone treatment on the specific 
radioactivity of polyadenylated RNA is presented on Table 18, 
and shown graphically in Pig. 25. After 8 days of prednisolone 
treatment there was no statistically significant alteration in the 
amount of polyadenylated RNA present in the tissue. The specific 
radioactivity of this RNA was only slightly lower than control 
values (Table 18)• The graphical representation of these results 
shows that the radioactivity associated with polyadenylated RNAs 
from both the prednisolone-treated animals and their controls did 
not decrease over the 10-day experimental period and in fact showed 
a slight rise. The pattern of this increase parallels the results 
obtained from studies of total RNA radioactivities in the 
gastrocnemius muscle (Fig. 22) .
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TABLE 16. EFPECTIVMBSS OF VARIOUS PHENOL PROCEDURES IN THE EXTRACTION OF POLYADENYLATED RNA FROM RAT 
GASTROCNEMIUS MSCLE
Total RNA in tissue PolyA-RNA
(mg/g tissue; ) content
Procedure A 1,1 1,8 ” B 0,8 ' 1,6 
" C 1,5 1.9
2,1  
1.7 3.4 ■
Procedures A, B and C are various modification of phenol extraction methods as described on page 69 . Isolation of polyA-RNA was performed as described on page 71. RNA was measured by the ultraviolet absorption technique (page 44 ).
TABLE 17, DISTRIBUTION OF RADIOACTIVITY IN AND OTHER RNA SPECIES FOLLOWING WITH 3h-0R0TIC ACID
POLY A-RNA TREATACENT
RNA content (mg/g tissue) Specific activity (cpn^ /tg RNA)
Fraction retained by oligo
(dT) column O.O4 0.74
Fraction not retained by 1,38 column 0,23
The animal received a single intraperitoneal injection of 20 Ci ^H~Orotic acid and was sacrificed 48 h later. RNA was extracted by Procedure C as described on page 71 and fractionated on an oligo(dT)-cellulose column using the technique ’ described on page 71.
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TABLE 18. EFFECT OF PREDNISOLONE TREATMENT ON OLIGO(dT)- 
CELLI3L0SE-B0UND RNA RADIOACTIVITY IN RAT 
GASTROCNEMIUS MUSCLE
Days after Orotic Acid 
Injection
PolyA-RNA content (mg/g tissue)
Specific Activity of PolyA-RNA (cpm/ng 
RNA)
Prednisolone-treated Control Prednisolone-treated
Control
2 mm 0.05 - 0.93
4 0.05 0.05 0.81 1.08
6 0.05 0.05 0.97 1.14
8 0.05 0.05 0.88 1.23
10 0.05 0.05 1.12 1.24
Each animal received a single injection of %-Orotic Acid (20/\£i) intraperitoneally. Commencing two days after the Orotic Acid injection animals given prednisolone acetate received 0.06ral of a 25mg/ml suspension of the drug in saline whilst the * controls* each received the same volume of saline, all by subcutaneous 
injeotions,Po(y4-BNA was isolated and measured as described on 
page 71 using Procedure C. Each result is the mean from 2 experiments•
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FIG. 25 Radioactivity in Polyadenylated ERA isolated from 
gastrocnemius muscle of rats given a single dose 
of 3H-0rotic Acid.
Experimental details were as described on Table I8, 
Triangles represent results from prednisolone- 
treated animals and circles represent controls. 
Each point is the mean from two experiments. The 
slope of each line was calculated by the method of 
least squares.
151
The contribution of the radioactivity in polyadenylated RFA 
to the RFA fractions separated by sucrose density gradient 
centrifugation is evident from a comparison of the profiles on 
Figs. 26a and 26B, The removal of polyadenylated RFA did not 
significantly alter the relative ratios of the amounts of RFA in 
the 28s and 1% peaks, as determined by absorbance measurements 
at 260nm, There was however a pronounced change in the 
radioactivity profile of the sample with a general drop of 
radioactivity levels in all three RFA peaks and significant 
alterations in the relative ratios of the specific radioactivities ' 
in these peaks (Table I9) . The 2% RFA fraction lost 18^ of its 
specific radioactivity, the l8S fraction lost Ofo and the 4S RFA 
lost 4^ of its specific radioactivity when polyadenylated RFA 
was removed. These findings suggest that in the rat gastrocnemius 
muscle Lpolyadenylated RFA may have a heterogenous size distribution, 
appearing in all three RFA peaks and making up a large portion of 
the 48 fraction when it may be present as breakdown products of 
heavier polyadenylated RFA molecules. Polyadenylated RFA in this 
tissue thus made a significant contribution to specific 
radioactivities in RFA fractions that are considered to represent 
mainly ribosomal and transfer RFAs. Therefore, any investigations 
that were of ribosomal RFA exclusively required the removal of 
this contaminating RFA fraction as a first step.
À
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FIG, 26a Level of radioactivity of cytoplasmic RNA fromgastrocnemius muscle of normal rats injected with 
20/ACi of 3H_0rotic Acid 48 h before sacrifice.RNA was isolated from the tissue by Procedure G 
on page and centrifuged on a 5 ~ 20^  (w/w) sucrose density gradient at for 7 h at 60,000g 
ave. Radioactivity (-A-A-) was measured as 
described on pagbMm^S and RNA peaks were identified by U.V measurements at 260nm (-#—#-)
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FIG. 26b Level of radioactivity in cytoplasmic M A  
preparations from which polyadenylated MA had been removed.
Experimental details are as for Fig. 26A 
except that the M A  sample was passed through 
an oligo(dT)-cellulose column, as described 
on page 71, before sucrose gradient centrifugation. (“A—A- ) refers to radioactivity and ( )refers to
I
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TABLE 19. EFFECT OF THE REMOVAL OF POLYADENYLATED MA
ON THE SPECIFIC ACTIVITY OF GASTROCMCEUS 
MUSCLE M A  FRACTIONS
SPECIFIC ACTIVITY (cpm/^ #lNA) 
28s ENA 188 ENA 48 RNA
PolyA-RNA present I.04 0*98 I.4I
PolyA-MA removed 0,85 0.92 0.77
M A  was extracted using Procedure C (page 71), from muscle of rats treated with a single injection of 2QwCi of iH-Orotio acid 48 before sacrifice. An aliquot of the M A  in O.OIM Tris-HCl 
buffer pH 6.0 was fractionated by sucrose gradient centrifugation (page 73 ). Another aliquot was freed of polyadenylated M A  by passage through a column of Oligo(dt)-cellulose (page 7I) before sucrose gradient analysis. RNA was measured by ultraviolet absorption at 260nm and a representative fraction from each M A  
peak was measured for radioactivity as described on page 98,
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EFFECT OF PREDNISOLONE ADMINISTRATION ON THE TÜMOVM OF 
RIBOSOMAL RNA IN RAT MUSCLE
Several studies have provided evidence that glucocorticoids 
have a pronounced effect on liver ribosomal RNA (Ottolenghi and 
Barnabei, 1970; Mishra and Felthara, 1973; Schmid and Sekeris,
1975)• These hormones tended to increase the amount of liver 
ribosomal RNA either by causing an increase in its rate of synthesis 
or a decrease in its rate of breakdown. Since, from the results 
quoted on page 133 and also from the finding of other workers 
(Manchester, I967; Young, I970) , ribosomal RNA constitutes the 
major fraction of RNA found in the gastrocnemius muscle, it seemed 
pertinent to investigate the turnover of ribosomal ENA in the 
muscle following prednisolone administration.
Rats were given an injection of ^-Orotic acid and after 4 
days half the animals were injected daily with prednisolone acetate 
and the remainder, the control animals, were given daily injections 
of 0.8g^ (w/v) saline. Intact and undegraded cytoplasmic ENA was 
extracted from the gastrocnemius muscle of control and treated rats 
using the phenol/chloroform procedure described on page 71 . The 
extracted ENA was dissolved in O.OIM sodium acetate buffer pH 6.0 
and passed through a column of oligo(dT)-cellulose, as described 
on page 71 9 to remove polyadenylated species of RNA, The RNA 
recovered in the effluent from this column was subjected to sucrose 
density gradient centrifugation to fractionate the ribosomal RNA 
from lower molecular weight ENA, Finally, the fractions containing 
28s and 18s ENA were pooled, precipitated with ethanol and their 
content of radioactivity measured as described on page 98.
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The results of these investigations are presented in Table 
20 and in Figs. 27 and 28. The specific activity of ribosomal 
RNA in muscles of control rats was found to decrease progressively 
from the 4th to the 12th day after H^-Orotic acid injection. On 
the 12th day the specific activity was 35% of that observed on the 
4th day after the injection of label. There was a marked decrease |
also in the specific activity of muscle ribosomal RNA in rats which 
had received a single injection of prednisolone (i.e. rats killed 
on day 6). At this stage, the specific activity of ribosomal RNA 
in the control and treated animals were not significantly different.
The decrease in specific activity of muscle ribosomal RNA from the 
6th to the 12th day however was much less in the treated animals 
than in the controls.
Over the experimental period gastrocnemius muscles of 
prednisolone-treated rats exhibited a $1% loss of total RNA content 
while in control rats a small increase (4.6%) was found which was 
not statistically significant. Since over 80% of skeletal muscle 
RNA is ribosomal (Manchester, 1967» Young, 1970) alterations in 
total RNA in muscle can be taken to give an indication of the 1
behaviour of ribosomal RNA. In the present work therefore, in
order to obtain an estimate of the effect of prednisolone treatment %
on the turnover of ribosomal RNA, the value of the product of
atotal RNA per muscle per lOOg initial body weight X the specific 1
activity of ribosomal RNA was taken as total muscle ribosomal RNA 
radioactivity and graphed against days of experiment* In the case 
of muscles from control animals the plot of log total muscle %
ribosomal RNA radioactivity decreased in a linear manner with
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TABLE 20. LOSS OP RADIOACTIVITY FROM RIBOSOMAL RNA IN RAT
GASTROCNEMIUS MUSCLE FOLLOWING PREDNISOLONE TREATMENT
Days after Orotic acid Specific Activity (cpnvVg RNA) Total Activity (cpm/ muscle/lOOg initial
Control Prednisolone-treated
Control Prednisolone
-treated
4 1.6io.i — 1811±66 —
6 tii 1.0-0.1 1234±72 .951tii8
8 . tS:î 1.0-0.1 1029±52 ,750±83
10 tS:î tSS .797±105 +659 : ±133
12 0.6-0.1 0^.9 :-0.1 .633±64 ,499—43
Each animal received a single dose (20/uiCi) of H-Orotic 
acid intraperitoneally. Commencing 4 days afterwards each prednisolone-treated animal received 0.06ml prednisolone acetate (25mg/ml in saline) while controls received the same volume of 0.85%(w/v) saline. RNA was isolated as described 
on page 71 and measured for radioactivity as described on page 98 • Each result is the mean from 4 experiments - standard deviation.
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PIG. 27 Loss of radioactivity from rat gastrocnemius muscle ribosomal ENA following prednisolone treatment. 
Experimental details are as described for Table 20. Triangles indicate results from prednisolone-treated 
animals and circles indicate controls. Total activity was the cpm/muscle/lOOg initial body weight.
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PIG. 28 Loss of radioactivity from ribosomal RNA in rat gastrocnemius muscle following prednisolone- treatment;
Experimental details are as described for Table 20. 
Triangles indicate results from prednisolone- 
treated animals and circles denote controls. Each slope was plotted by method of least squares.
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time (Pig. 28)• Assuming that first order kinetics applied, the 
rate constant for the biological degradation and the biological 
half-life for muscle ribosomal RNA in control rats were calculated 
to be 0.1439 and 4*8 days respectively. Since there was no
TloSornill A ItUzA
significant alteration in the muscles of the control rats, it canA
be assumed that the rate of synthesis of muscle ribosomal RNA in 
these animals must also be of the order of their degradation rate. 
This was calculated to be 0.l6mg RNA per day per muscle per lOOg 
initial body weight. When the results obtained from rats given 
prednisolone were treated similarly, a somewhat different picture 
emerged. Rats killed on day 6, i.e. after they had received one 
prednisolone injection, retained significantly less radioactivity 
in muscle ribosomal ENA than did their controls (Table 20; Pig.
27B) . When the logarithm of total muscle ribosomal RNA was plotted 
against time, it became apparent that from day 6, there was a less 
marked depletion of radioactivity from ribosomal RNA of 
prednisolone-treated animals than occurred in control animals. 
During the period from day 6 to day 12 the loss of radioactivity 
from ribosomal ENA in the prednisolone-treated rats followed first 
order kinetics. The rate constant for degradation of ribosomal 
RNA and the biological half-life of ribosomal RNA in these animals 
were calculated to be 0,0978 and 7*08 days respectively. The loss 
of RNA from the muscles of the treated animals during the period 
was equivalent to 0.36mg per muscle per lOOg initial body weight. 
The amount of ribosomal RNA synthesised during this period can be 
calculated from the relationship NET LOSS OP RNA = AMOUNT 
DEGRADED - AMOUNT SYNTHESISED. Using this relationship, the
I6l
amount of ribosomal RNA synthesised per day during this period 
was found to be 0,03mg per muscle per lOOg initial body weight.
The amount of ribosomal RNA synthesised in the control rats per 
day over the same period was 0,l6mg per muscle per lOOg initial 
body weight. There would thus appear to be a marked dimunition 
in ribosomal RNA synthesis as a result of prednisolone treatment.
In the period from day 4 to day 6, when the treated animals 
had received two daily injections of prednisolone, there was a 
net loss of 38% of the specific radioactivity in the muscle 
(Table 20). During the same period, the control rats showed a 
specific radioactivity loss of 25%. This picture would suggest 
an increased synthesis of new ribosomal RNA in the treated animals 
during this period. However, their level of ribosomal RNA had 
been shown to drop during this period (Table 21). Thus, it would 
seem that the initial response of muscle ribosomal RNA metabolism 
to prednisolone is a stimulation of synthesis accompanied by an 
even greater increase in the rate of degradation. This is followed 
by a period when ribosomal RNA synthesis falls to a very low level 
compared to that in untreated animals.
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TABLE 21. effect OF PREDNISOLONE TREATMENT ON RIBOSOMAL RNA 
LEVELS IN THE RAT GASTROCNEMIUS MUSCLE
Days after Orotic acid Injection
Ribosomal RNA content (mg/muscle/lOOg initial body weight)
Control Prednisolone-treated
4 0.73 ~ 0.04
6 0.72 ~ 0.06 0.64 - 0.03
8 0.71 -0.06 0.56 - 0.07
10 0.71 - 0.07 0.49 - 0.05
12 0.72 t  0.05 0.34 - 0.07
Experimental details a x e as described for Table 20.
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EFFECT OF PREDNISOLONE TREATMENT ON THE ACID-SOLUBLE NUCLEOTIDE 
POOL OF RAT LIVER AND MUSCLE
In interpreting the results of the experiments on RNA turnover 
reported on page 118 , consideration must he given to possible 
réutilisation of RNA breakdown products in the nucleic acid 
precursor pool* If there is significant réutilisation, the 
half-lives calculated for the nucleic acid would have been 
overestimated. Furthermore the effects noted with prednisolone on 
RNA turnover may be due to alterations in the free nucleotide pool 
in the tissue rather than a direct effect on RNA synthesis or 
breakdown. These considerations prompted a study of the 
radioactivity in the RNA precursor pool in rat liver and 
gastrocnemius muscle during the experimental period and of the 
effect of prednisolone treatment on these pools. Total acid- 
soluble radioactivity and, more significantly, radioactivity 
present in acid-soluble pyrimidine nucleotides were measured.
Table 22 and Figs. 29A and 29B show the results of assays 
carried out on the rat gastrocnemius muscle. Significant levels 
of radioactivity were still present on the second day after 
%-Orotic acid was injected. Thereafter, radioactivity levels of 
the total acid-soluble pool from the control animals fell by almost 
509^  over the next 4 days. A further loss of radioactivity occurred 
but at a much slower rate over the last 4 days of the experiment 
and, on the tenth day, the radioactivity remaining in the pool was 
still 40^ of that present on the second day. The possibility 
therefore exists that there was some réutilisation of RNA breakdown 
products in new RNA synthesis. The pattern of loss of
164
TABLE 22. EFFECT OF PREDNISOLONE ADMINISTRATION ON THE 
RADIOACTIVITY OF THE TOTAL ACID SOLUBLE POOL AND THE ACID-SOLUBLE NUCLEOTIDE POOL OF RAT 
GASTROCNEMIUS MUSCLE
Days after Orotic Acid Injection
Total acid-soluble pool 
(cpra/g muscle x 10”^ )
Acid-soluble nucleotide 
pool (cpm/g muscle x 10-3)
Prednisolone
-treated
Control Prednisolone
-treated
Control
2 — 2.9 2.2
4 2.0 1.9 1.6 1.4
6 1.7 1.5 1.3 1.2
8 1.5 1.2 1.2 1.0
10 1.6 1.2 1.1 0.9
Bach animal received a single dose of %-Orotic acid ( 20/tCi) intraperitoneally. Commencing 2 days after the orotic acid injection each prednisolone-treated animal received daily 
subcutaneous injections of 0,06ml of prednisolone acetate (25mg/ml in 0,85^ (w/v) saline), while the control received the same volume of 0.85^ (w/v) saline. Total acid soluble pool and acid-soluble 
nucleotide pool were prepared as described on page 82 and 
radioactivity was measured as described on page 9 8. Bach result is the mean value from two experiments.
165
oXjÜoV)3E
O)
E
8-
3-1
2-
1-*
OOCL
aCQD8
I9
<
2-5-1
1-5-
B
0-5-*
10
DAYS AFTER OROTIC ACID INJECTION
FIG. 29 Effect of prednisolone treatment on theradioactivity of the acid-soluble pool in 
rat gastrocnemius muscle.
Experimental details were as described on Table 22.
(a) shows total acid-soluble pool results while (B) shows results with the acid-soluble nucleotide pool.
Triangles represent results obtained with prednisolone-treated animals while circles indicate control values.
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radioactivity from the total acid-soluhle pool from the muscle 
of the prednisolone-treated animals closely paralleled the results 
obtained with the control group, a sharp drop occurring between 
the second and the sixth day after H^-Orotio acid administration 
and a slower fall continuing until the end of the experiment.
The levels of radioactivity in the rat muscle nucleotide 
pool amounted to more than "JCffo of the total acid-soluble pool 
(Table 22), an indication that most of the labelled nucleosides 
were in the phosphorylated form. Radioactivity levels in the 
nucleotide pool, as in the total acid-soluble pool dropped more 
sharply between the 2nd and 6th day and showed a less marked 
decline during the last four days of the experiment. A l\B fo drop 
in radioactivity occurred between days 2 and 6 compared with a 
fall of 2^ over the last four days. Again, prednisolone 
administration caused no significant alteration of this pattern.
The results of similar experiments with rat liver are 
presented on Table 23 and, graphically, in Figs. 30A and 30B. In 
the control group of animals levels of radioactivity in the total 
acid soluble pool fell by over 65^ between the 2nd and 6th day and 
by only a further 35^  in the last four days. Over the entire 
experimental period the total acid soluble pool of the 
prednisolone..-treated animals lost radioactivity at approximately 
the same rate as was observed the control group. This pattern was 
essentially the same when the liver nucleotide pools were examined 
and no significant differences could be found in this pattern of 
loss of radioactivity between control and prednisolone-treated 
animals.
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TABLE 23 EFFECT OF PREDNISOLONE TREATMENT ON THE TOTAL ACID-SOLUBLE POOL AND THE ACID-SOLUBLE POOL IN RAT LIVER
Days after Total Aoid-Soluble pool Acid-Soluble NucleotideOrotic Acid (cpm/g liver x 10""3) pool (cpm/liver x 10“3)
Prednisolone-treated Control Prednisolone-treated Control
2 — 45.1 16.9
4 14.9 19.1 8.7 10.1
6 13.4 15.4 9.4 10.5
8 12.4 10.9 8.3 8.8
10 12.4 9.9 8.1 8.0
Experimental details were as described on Table 22.
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PIG* 30 Effect of prednisolone treatment on theradioactivity of the acid-soluble pool in rat liver.Experimental details were as described on Table 22.(a) refers to total acid-soluble pool while (B) shows results with the acid soluble nucleotide pool.
Triangles indicate results obtained with 
prednisolone-treated animals while circles represent control values.
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In these experiments, the peak level of radioactivity in the 
tissue nucleotide pool due to the injection of H-Orotio acid was 
not estimated. Thus, although the results presented above suggest 
the possibility of some réutilisation of RNA breakdown products, 
it is difficult to assess the significance of the absolute levels 
of radioactivity observed on individual days with respect to the 
labelling of any RNA synthesised during that period. Hirsch and 
Hiatt (1966A) studied the turnover of liver ribosomes, after 
administration radioactivity-labelled orotic acid under conditions 
similar to those carried out here and considered the possible 
effect of réutilisation of label. They also studied ribosome 
turnover in the presence of ] - arginine where the protein
components of the ribosome would be labelled and where 
réutilisation of any label would be minimal since any -arginine 
released by protein broken would be eliminated as urea. Since the 
half-lives of ribosomes obtained with ^ H-Orotic acid or -arginine 
were almost identical these workers concluded that réutilisation of 
the nuclei acid label was not occurring to any great extent. It 
would appear that separate synthetic and catabolic pools for RNA 
exist or alternatively that unlabelled pools may have effectively 
diluted labelled RNA precursors.
It was evident, from the results in both the muscle and liver 
that prednisolone treatment did not cause significant changes in 
RNA precursor pool labelling in either tissue, The alterations 
observed in RNA turnover following prednisolone administration 
might therefore be attributable to more direct effects on RNA 
synthesis and breakdown.
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EFFECT OF ERBMISOLOM! ADMINISTRATION ON RNA POLYMERASE ACTIVITY 
IN NUCLEI ISOLATED FROM RAT LIVER AND MUSCLE
DNA-dependant RNA polymerase (RNA nucleotidyl transferase 
E.C. 2.7*7.6) is the key enayme implicated in the first step of 
genetic information transfer from DNA to RNA (Biswas et al, 1975)* 
Although comparatively little is known about the regulatory role 
of this enzyme in eukaryotic RNA synthesis, there is evidence that 
RNA synthetic capacity of the rat liver nuclei (pogo et al, I966;
Yu and Feigelson, 1971) and rat muscle nuclei (Sobel and Kaufman,
1970; Baieve and Florini, 1970) can be related to alterations in 
the RNA polymerase reaction in these tissues. There is evidence 
also that administration of glucocorticoids causes a decrease in 
RNA polymerase activity in the rat thymus (Drews and Wagner, 1970;
Bell and Borthwick, 1976) and an increase in this activity in 
hepatic nuclei (Barnabei et al. I965; Yu and Feigelson, I971). In 
view of the alterations in RNA metabolism observed in the liver 
and gastrocnemius muscle of rats given prednisolone, the effect of 
this steroid on RNA polymerase activity in these tissues was studied. 
Follov/ing prednisolone administration, nuclei were isolated from 
liver and gastrocnemius muscle as described on page 84 and the 
activities of both the Mn^t activated and the Mg^- activated RNA 
polymerase were measured as described on page 87, The M^- activated 
enzyme has been shown to catalyse the transcription of ribosomal RNA 
genes while the Mh"*~ activated polymerase the transcription of 
messenger RNA (Nair et al. 1967; Drews and Wagner, 1970).
It was shown by Neal and Florini (1975) that differential 
mechanical and DNAse-catalysed damage to DNA during nuclei isolation
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procedures could cause artefactual differences in RNA polymerase 
activities in normal æid dystrophic chick muscle preparations#
Preliminary experiments were therefore performed to establish the |
time course of the system employed to assay RNA polymerase activity 
in muscle of both control and prednisolone-treated animals and to 
ascertain that for both groups of animals there was a linear . j
incorporation of %[ -UTP during the polymerase assay. The results ïj
of these experiments (Fig. 3l) confirmed that over the first 6 min. 
the amount of %  -uridine incorporated into RNA was linearly 
related to the incubation time^ jjh;:huolei:3prëparatlon8 from control and 
prednisolone-treated animals. Therefore, in the experiments 
reported here, the incubation time for muscle RNA polymerase assays 
was always less than 6 min. The incorporation of H -uridine into 
RNA was shown to be linearly related to the number of nuclei up to 
and including 1,25 x 10^  (Fig. 32).
There was a statistically significant decrease of ly fo in the 
activity of the Mg*^ - activated enzyme in muscle nuclei from 
prednisolone-treated animals compared to the levels in the control 
group (Table 24). This alteration in RNA polymerase activity was 
observed after two daily injections of prednisolone into the 
treated animals, a time when cytoplasmic ribosomal ENA levels in 
these animals had also been found to be lower than control levels 
(Table 2l). No significant differences in the levels of the 
Mn*"- activated enzyme activity in the two groups of animals were 
observed. In the liver, there was a two-fold increase in Mg"*"- 
activated RNA polymerase activity as a result of prednisolone 
treatment (Table 24). This observation is in keeping with the
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PIG. 31 Time course of the RNA polymerase-catalysed incorporation of XJTP into RNA.
RNA polymerase was contained in nuclei isolated from rat gastrocnemius muscle as described on page 84 and was assayed as described on page 87 • Circles refer to 
activity of the Mn'**'^ activated enzyme and 
triangles indicate the activity of the Mg*^**" 
activated enzyme. Open symbols refer to 
prednisolone-treated animals and shaded symbols indicate controls.
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FIG. 32 Linearity of ÜTP incorporation into RUA with concentration of gastrocnemius muscle nuclei in incubation medium.
Preparation of nuclei and assay of RNA 
polymerase reaction were carried out as 
described on pages 84 and 87 respectively.
Circles indicate the activity of the Mn*”*“ 
activated enzyme assay and triangles refer to the Mg’^’^-activated assay.
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TABLE 24 OHàNGES IE  RNA POLYMERASE ACTIVITIES FOLLOWING PREDNISOLONE TREATMENT
MÜSCLB LIVER
Control Prednisolone Control Prednisolone -treated -treated
Mg*”- activated enzyme
Mn*^ /(NH ),S0
-activated enzyme
0.83 ^0.72 .0,17 +0.35-0.03 A0.03 AO, 01 -0.01(<0.025) (<0.005)
.0.95 .0.99 .0,33 .0.40AO,06 -0,07 -0,01... . to,02(N.S)
Each prednisolone-treated animal received 2 daily subcutaneous injections of 0.06 ml of a solution containing 2$mg/ml prednisolone acetate in 0.85^ (w/v) saline. Control animals received the same 
volume of 0.85^ (w/v) saline. All animals were sacrificed 24 h after the second injection and nuclei were extracted as described on page 84 . Results are expressed as units of RNA polymerase activity and 1 unit of enzyme activity is the activity, per mg DNA, that incorporated 1 nmole of DTP into RNA under the 
experimental conditions described on page 87 • Results are the mean values of 4 experiments - S.E.M, Figures in brackets indicate statistical significance level between control and 
treated animals, as calculated by the Students paired *t* test.
'"'ÿ
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increase in ENA levels in prednisolone-treated animals and agrees 
with the findings of other workers studying glucocorticoid-induced 
increases in Mg*^ t activated ENA polymerase activity in the liver 
(Barnabei and Ottolenghi, I968; Yu and Feigelson, 1971). The 
activity of the Mn’^t activated enzyme was not significantly 
altered by prednisolone treatment.
It was evident from these results that prednisolone raised 
Mg"^ - activated RNA polymerases in the rat liver and depressed this 
activity in the muscle. The decrease in the Mg*^ - activated RNA 
polymerase activity in muscle and the increase in this activity "in 
liver observed in rats which had been given two injections of 
prednisolone acetate and killed 24 h after the last of these is in 
keeping with the results of the turnover studies of ribosomal RNA 
in these tissues. Thus when the ribosomal RNA synthesis was 
observed to be inhibited in muscle and enhanced in liver by 
prednisolone there were corresponding decreases and increases in 
the RNA polymerase activity believed to be concerned with the 
synthesis of ribosomal RNA. However, it is recognised that RNA 
turnover is regulated by RNA degradative as well as RNA synthetic 
processes and that prednisolone treatment may also affect RNA 
degradation.
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LEVELS OF RIBONIJCLBASE ACTIVITY IF LIVER AND GASTRQCimOlJS MUSCLE 
OF PBEDNISOLONE-TREATEI) RATS
The decreased protein synthetic capacity of cell-free 
preparations from the liver of hypophysectomised rats has been 
attributed to increased levels of alkaline ribonucleases (E.G.
3.1.4-) in these preparations (Brewer et al, I969) and it has been 
suggested that the activities of ribonucleases and ribonuclease 
inhibitors represent a control point in cytoplasmic RNA breakdown 
(Kraft and Shortman, 1970; Rosso et al. 1973; Lorup, 1977)* These 
inhibitors have been shown to be proteins which inhibit hepatic 
alkaline ribonucleases (Shortman, I96I) and it has been suggested 
that corticosteroids may exert their effects by regulating the 
concentration or effectiveness of RNAse inhibitors in rat thymus 
cells (Wiernik and Macleod, I965) . The altered levels of RNA in 
rat liver and muscle following administration of prednisolone could 
therefore have been the result of alterations in ribonuclease 
activities in these tissues. This section reports the results of 
investigations on the activities of the two principal ribonucleases 
in the mammalian cell the acid- (E.G.3.1,4.23) and the alkaline 
ribonucleases, following the administration of prednisolone. The 
influence of the alkaline ribonuclease inhibitor on these enzymic 
activities was also investigated by measuring the latent activities 
of the enzymes. Latent activity refers to the enzyme activity 
liberated by the inactivation of the inhibitor with PGMB which 
breaks the enzymeAinhibitor bond by blocking -SH groups on the 
inhibitor protein. The latent activity discussed here must be 
distinguished from the latent activity released when lysosomal
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membranes are destroyed (De Dwe, I969) • In the experiments 
discussed here all tissue homogenates were taken through cycles of 
freezing and thawing, as described on page 9I » before ribonuclease 
assays were carried out.
Cytoplasmic * supernatants * isolated as described on page 9I 
from control and prednisolone-treated animals were incubated in 
the presence of yeast ENA and the extent of hydrolysis of this ENA 
under defined experimental conditions (page 91) was taken as a 
measure of the activity of the particular ribonuclease. The linear 
relationship (Fig. 33) between the quantity of * supernatant* 
employed for enzyme assay and the observed changes in the extent 
of RNA hydrolysis confirmed that this assay technique is a reliable 
measure of acid and alkaline ribonuclease activities. One unit of 
ribonuclease activity was defined as the enzyme activity that 
caused an increase of 0.1 in the absorption at 260 nm of the 
perchloric acid supernatant under the experimental conditions.
In a preliminary investigation the effect of KOI on 
ribonuclease activities was studied. The addition of KOI to 
homogenising media to a concentration of 0.3M or higher facilitates 
solubilisation of muscle proteins. In the presence of 0.3M KOI, 
there was a complete suppression of both * free' and latent (’Total* 
minus ’free*) muscle acid ribonuclease activity (Table 25). This 
finding is consistent with the inhibition of acid ribonuclease in 
liver homogenates by monovalent cations (Rahman, I966) . Small but 
measurable ’free* and ’latent* ribonuclease activities were observed 
when KOI was omitted from the homogenisation medium. The salt also 
caused some inhibition of alkaline ribonuclease activities.
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PIG. 33 Relationship between ribonuclease concentration and increase in absorbance at 260nm of the acid ethanol-soluble fraction from ribonuclease assays.
The ' supernatant ' was extracted from rat liver as described on page $1 0.1ml of serial dilutions of this supernatant with water was assayed for 
ribonuclease activity as described on page ,91. Triangles represent alkaline ribonuclease activity and Circles represent acid ribonuclease activity.
Shaded symbols refer to ’free' ribonuclease and 
open symbols to ’total’ ribonuclease assays.
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TABLE 25 B M G T  OP KOI (0.3M) ON RIBONUCLEASE ACTIVITY 
IN RAT GASTROCNEMIUS MUSCLE
Acid Ribonuclease (units/g muscle) 'free' 'total’
Alkaline Ribonuclease 
(units/g muscle)' free’ total’
KCl present 
No KCl
0.0
7.0
0.069.6 61.374.4
130
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Enzyme activity measurements were performed as described 
#1 page 91 "U-sing 'supernatants' extracted from gastrocnemius muscle as described on page 9I.
'Pree* activity refers to enzyme activity in the absence of PCM; Total activity was measured in the presence of PCMB, to inactivate the enzyme inhibitor.
One unit of ribonuclease activity was the enzyme activity that caused an increase of 0.1 in the Ag^g of the acid ethanol-soluble fraction under the conditions described on page 91 .
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suppressing the 'free* enzyme activity by 18^ and the 'latent*
activity by 67fo (Table 25). The inclusion of KCl in homogenisation
media was therefore discontinued in these enzyme studies.
The levels of ribonuclease activity in gastrocnemius muscle 
following 8 days of prednisolone administration are shown in 
Table 26. 'Pree* acid ribonuclease activity in treated animals was
only 22^6 of the level;, in controls. 'Latent' acid ribonuclease
was also lowered as a result of prednisolone administration and the 
level in the treated animal was only 12^  of the level in the control 
animal. The observation of 'latent' activity by acid ribonuclease 
was unexpected as this enzyme was believed to be insensitive to 
PCMB (Roth, 1957)* However, 'latent* acid ribonuclease activity 
has been reported in rat liver homogenates by Shortman (196I)* Pree 
alkaline ribonuclease activity in the prednisolone-treated animals 
was only 62^ 6 of the level in the control group. Latent alkaline 
ribonuclease activity also dropped due to prednisolone treatment 
and level in the control animals were about I.4 times higher than 
levels in the treated animals (Table 26) • Since latent ribonuclease 
activity is an indirect measure of the RNAse inhibitor activity, 
the lower latent activity in treated animals, in comparison with 
controls, suggests a lower inhibitor activity in these animals. It 
follows also that the decrease in the free ribonucleases in this 
prednisolone-treated group was not due to an increase in RNAse 
inhibitor activity.
The results of investigations into liver ribonucleases are 
presented in Table 27. Pree acid ribonuclease activity in the 
liver, after 8 days of prednisolone treatment, was only 41/^ of the
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TABLE 26 RIBONUCLEASE ACTIVITY IN GASTROCNEMIUS MUSCLE IN 
RATS GIVEN PREDNISOLONE FOR 8 DAYS
Acid Ribonuclease (units/g muscle)
Alkaline Ribonuclease 
(units/g muscle)'Free* ’Total' 'Free* 'Total*
Prednisolone-treated 1.5 - 0.5 9.0 i 4.2 43.6 t 7.3 192 - 8(< 0.005) (< 0.005) (40.005) (<0.005)
Control 6 .6 t 1 .2 67.3 Î 9.5 70.2 t 8 ,4 278 t 14
Each prednisolone-treated animal received daily subcutaneous injection of 0.06 ml prednisolone aoetate (25mg/ml) over 8 days while the control animal received the same volume of 0. 8$^ ( w/v) saline. All animals were sacrificed on Day 9*
One unit of ribonuclease activity is the enzyme activity that caused an increase of 0 .1 in A under the experimental 
conditions described on page 91*
'Free* ribonuclease activity refers to the activity assayed 
in the absence of PCMB while 'Total* ribonuclease activity was assayed in the presence of PCMB,
Each result is the mean value from 4 experiments - standard 
deviation. The figures in brackets indicate the level of statistical significance between control and prednisolone-treated animals•
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TABLE 27 RIBOMJCLBASB ACTIVITIES IN LIVER IN RATS GIVEN 
PREDNISOLONE FOR 8 DAYS
Acid Ribonuclease 
(units/g liver) 'Free* 'Total'
Alkaline Ribonuclease 
(units/g liver)'Free* 'Total*
Prednisolone 283 “ 40 659 “ 66 268 t 32 1047 - 46-treated
(40.005) (<0.005) (< 0.005) (<0.005)
Control 684 - 69 1473 t 55 782 t 61 1922 t 58
Experimental details were as described on Table 26
TABLE 28 RIBONUCLEASE ACTIVITY IN PANCREAS IN RATS GIVEN 
PREDNISOLONE FOR 8 DAYS
DNA Content(mg/perpancreas)
Acid Ribonuclease (units/mg DNA x 
10"'^ )
Aik. Ribonuclease 
(units/mg DNA x 10-1)
Prednisolone-treated 4 .1 - 0 .1 419 - 31 531 i 29
(N.8) (N.S) (N.S)
Control 4.1 - 0.1 394 -  26 563 - 32
Experimental details were as described on Table 26. DNA was measured as described on page 46.
» T.
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activity in the control animals. The latent activity of this 
enzyme in the treated animals was 4 W  of the activity level in 
the control group. Alkaline ribonuclease activities also decreased 
as a result of prednisolone treatment, the free activity dropping 
by 65^ and the latent activity by 32^ . It was evident from these 
results that in the rat liver, as in the gastrocnemius muscle, 
there was a loss of both acid and alkaline ribonuclease activities 
as a result of the prednisolone therapy. Furthermore, this loss 
was not due to increased ribonuclease inhibitor activity.
It has been suggested (Bai?tholeyns et al. 1975) that liver 
ribonuclease may have an extra-hepatic origin and may be derived *
from the pancreas. The pancreas is a rich source of alkaline
ribonuclease and the enzyme in this gland resembles liver alkaline "J
■‘iribonuclease in its stability to heat and sulphuric acid as well 
as in the effects of salts and buffers (Roth, 1957? Baaiîtholeyns and 
BauRhuin, 1977). It is conceivable, therefore, that any changes 
in ribonuclease activities in the rat liver may be a reflection of /
the changes in the pancreatic enzyme activities. These considerations 
prompted an investigation of ribonuclease activity in the pancreas 
following prednisolone administration. The rat pancreas is a
êdiffuse and lobulated tissue extending from the concavity of the 
duodenum to the spleen and it is interspersed to varying degrees by 
webs of gelatinous connective tissue. This nature of the gland 
makes estimations of its actual weight often inaccurate. Therefore, 
in these studies, units of pancreatic ribonuclease activity have A
been expressed in terras of the IM A content of the gland rather than 
in terms of wet weight.
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The effect of 8 days of prednisolone treatment on total 
pancreatic ribonuclease activity is seen from the results 
presented on Table 28. Small and statistically insignificant 
differences were observed in both the acid and alkaline 
ribonuclease activities in the pancreas of control and 
prednisolone-treated animals. It is unlikely therefore that 
the alteration of ribonuclease activities in the rat liver and 
gastrocnemius muscle are related to the pancreatic enzyme levels.
The reduced ribonuclease activity in the liver of 
prednisolone-treated animals is in keeping with increased RNA 
levels in the liver of these animals and this result is 
consistent with those from the study of RNA turnover vhich 
indicated that prednisolone treatment caused an increased synthesis 
and a reduced breakdown of RNA in rat liver (page 118). The 
finding that ribonuclease activity in the gastrocnemius muscle of 
prednisolone-treated rats was less than that in control animals 
may reflect the tissuefe response to the diminished synthesis of 
new ribosomal RNA as indicated by the decreased RNA polymerase 
activity in the muscles of this group of animals (page 170) •
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COMPARATIVE STUDIES OF PREMISQLQNE-REGEPTOR COMPLEXES FROM RAT 1
LIVER AND MUSCLE CYTOSOLS
It is generally believed that the events which follow steroid |
administration to animals are connected to the transfer of 
cytoplasmic receptorrhormone complexes to the cell nucleus (Beato 
et al, 1970; O'Malley and Means 1974; O'Malley and Duller, 1977).
In particular, it has been shown that cytoplasmic glucocorticoid 
receptors are necessary for the response the hormone produces in 
its rbarget; cells (Baxter and Tomkins, 1970 and 1971» Rousseau 
et al, 1972). It has also been suggested that the biological 
response elicited by a glucocorticoid may depend on the actions of 
the gluoocorticoid-receptor complexes as allosteric effectors 
(Rousseau et al, 1972) and that organ specificity of steroid 
action may be related to qualitative or quantitative differences 
between the steroid binding entities in the target organ (Mayer _et 
al. 1974» Kondo et al, 1975). If indeed glucocorticoid-receptor -g
complexes act as allosteric effectors, possible differences in 
their physico-chemical characteristics may affect their allosteric ?
properties and, consequently, could explain the different responses 
glucocorticoids evoke in different target cells. It was therefore 
of interest to compare some of the properties of prednisolone ^
receptors in the cytoplasm of rat liver and muscle, two tissues in 
which the hormone produced opposite responses. These considerations 
prompted investigations the results of which are presented in this 
section.
Liver and muscle cytosols were prepared as described on page 94 
and the prednisolone-receptor complexes, formed after exposing the
• I
. .. . .. . . . _  ,
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cytosol preparation to tritium-labelled prednisolone, were 
measured using the activated charcoal adsorption technique 
described on page 94. This technique depends on the fact that 
the charcoal will adsorb free but not receptor-bound prednisolone. 
Therefore, determination of the radioactivity in the charcoal-free 
supernatant, after the prednisolone-binding reaction, is a measure 
of the bound steroid and a quantitative monitor of prednisolone 
receptors in the cytosol preparations (Baxter and Tomkins, 1971;
Roth 1974; Agawaral, 1975).
To establish the validity of this assay technique, a series of 
preliminary experiments were performed. The first of these was 
designed to investigate the efficiency of activated charcoal as an 
adsorbent for free prednisolone. An appropriate dilution of the 
cytosol preparations was made to ensure a fixed protein concentration 
of 2.0mg per assay. This diluted cytosol was exposed to 9*6/tM 
prednisolone (specific activity = 173/tCi/mg) and the amount of 
radioactivity remaining in the charcoal-free supernatant following 
the removal of unbound steroid with varying concentrations of the 
activated charcoal was measured. As the results presented in 
Fig, 34 show, the radioactivity levels remaining in the diluted 
liver cytosol preparation after the charcoal treatment decreased 
in a linear manner when the amount of activated charcoal used per 
assay was less than 20mg per ml of the cytosol preparation. 
Thereafter, further increases in the charcoal concentration did 
not significantly alter these radioactivity levels. It would appear, 
therefore, that under the experimental conditions all unbound 
prednisolone was adsorbed when charcoal was added to the assay
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FIG. 34 Effect of charcoal concentration on the measurement of receptor-bound prednisolone in rat liver and 
muscle cytosols. Prednisolone binding was performed 
as described on page 94 and unbound steroid was 
removed using varying concentrations of activated 
charcoal. Prednisolone was in each assay andcytosol concentration was 2.0mg protein per assay. 
The circles indicate liver cytosol assays and the triangles the muscle cytosol assays.
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mixture in any amount greater than 20mg/ml* Similar experiments 
with muscle cytosol preparations showed (Fig. 34) that the 
radioactivity levels remaining in the preparations after charcoal 
treatment also dropped in a linear manner as the amount of charcoal 
used as free steroid adsorbent was increased progressively up to ,;f
30mg per ml of cytosol. Above this concentration, further increases 
in charcoal concentrations per assay did not significantly alter |
these radioactivity levels. Starting with the same concentration 
of liver and muscle cytosol preparations (2,0mg protein) and working 
with a charcoal concentration that effectively removed all unbound 
prednisolone (37*5iag charcoal per ml cytosol preparation), it was 
observed, by comparing radioactivity levels in the two preparations, 
that the muscle cytosol preparation bound only 42^ of the amount of 
prednisolone bound by the liver cytosol preparation. This 
observation may reflect the presence of fewer prednisolone binding 
sites in the muscle.
In the second series of preliminary experiments cytosol 
preparations of varying protein concentrations were incubated with 
a fixed amount (9*6>iM) of prednisolone and, in a subsequent step, 
with a fixed quantity (37*5mg per ml of the cytosol preparation) 
of activated charcoal. Finally, the radioactivity in the 
charcoal-free supernatant was measured. Results obtained with 
liver cytosol preparations are presented in Fig. 35 e*nd show that 
the amount of receptor-bound prednisolone measured by this assay 
technique was linearly related to the protein concentration of the 
cytosol preparation up to a concentration of 4*0mg protein per 
assay. This linearity was lost when cytosol preparations
%
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FIG. 35 Relationship between cytosol concentration and prednisolone binding in rat liver and muscle 
cytosol preparations: Prednisolone binding atvarious cytosol concentrations was measured, 
using 9.6juM prednisolone and activated charcoal at a concentration of 37.5mg per ml of cytosol, 
as described on page 94 . Circles indicate 
results obtained with liver cytosol and triangles represent results obtained with muscle cytosol.
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containing higher protein concentrations were assayed. In 
experiments with muscle cytosol preparations, linearity of 
receptor-bound radioactivity with cytosol concentration was 
maintained up to a cytosol concentration of 8,6mg protein per 
assay, A plateau began to develop when protein in the cytosol 
preparation exceeded this concentration (Pig. 35)•
The results of these preliminary experiments confirmed that 
quantitative measurements of prednisolone receptors in the rat 
liver and muscle cytosol preparations could be obtained using 
the activated charcoal adsorption technique under the experimental 
conditions described on page 94 , Under those conditions, 
activated charcoal should be used at concentrations above 20mg 
per ml of liver cytosol and above 30rag per ml of muscle cytosol 
preparations. As the results in Pig, 35 indicate, the protein 
concentration of the liver cytosol preparation should not exceed 
4.0mg per assay and muscle cytosol should be diluted to give a 
concentration below 8,6mg protein per assay. In subsequent work, 
both liver and muscle cytosols were diluted to the same protein 
concentration (4*0mg per assay) for use. The results obtained in 
these conditions were reproducible and the charcoal adsorption 
technique proved to be a simple and speedy method of measuring 
prednisolone receptors in rat liver and muscle cytosol 
preparations,
Characterization of liver and muscle prednisolone receptors by 
ion-exchange ohromatogranhy
The series of preliminary experiments which were reported in 
the preceding section demonstrated the ability of prednisolone to
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■bind to receptors located in the cytosol of rat gastrocnemius ^
muscle. Those results support earlier suggestions (Simpson and 
White, 1973; Mayer et al, 1974 a.nd 1975) that this tissue, since g
it possesses glucocorticoid binding proteins like the liver, is 
a target tissue for these hormones.
To characterise these prednisolone receptor moitiés with â
respect to heterogeneity and ionic charge the liver and muscle
prednisolone-reoeptor complexes were subjected to ion-exchange %
?chromatography as recommended by Agawaral ( 1976). This technique |
fractionates the receptor subpopulations on the basis that the 
order in which the receptors are eluted from the column by a 
linear ionic gradient depends on each receptor*s overall ionic 
density and the tenacity with which it is held on the column, ?
Following exposure to prednisolone, and charcoal treatment to 
remove unbound steroid, the cytosol preparation was loaded on a |
DE-52 cellulose anion exchange column which had been packed and v
pre-equibrated with O.OOIM sodium phosphate buffer, pH 7.5# After 
an initial prewash with 60ml of the O.OOIM phosphate buffer, 
elution was effected by a linear gradient formed by mixing 60ml 
of this buffer with 60ml of 0.2M phosphate buffer, pH 7*5 in a 
gradient former Radioactivity measurements of the sample before it j
was loaded on column and of the fractions collected after the 
gradient elution confirmed that no significant radioactivity #
remained on the column after the elution.
With the liver sample (Pig, 36) this chromatographic analysis 
resulted in the resolution of two distinct peaks of radioactivity.
The first and larger zone was eluted with the initial wash (O.OOIM
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FIG. 36 DE-52 column chromatography of rat liverprednisolone receptors.
The liver was processed for chromatography 
as described on page 94. 3.5^ 1 of the sample,containing l.Omg protein per ml was applied to the column and, after the initial prewash, 
gradient elution was begun at the arrow. (-#-#-) represents radioactivity and (-0-0-) represents 
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phosphate) and the second eluted at a phosphate concentration of 
O.O69M. A third zone, which was eluted with 0.019M phosphate was 
occasionally observed. This third zone showed extreme variability 
in amount. The results of the experiments with muscle receptors 
are presented in Fig. 37. Two zones of radioactivity were observed 
and their elution profile followed the pattern observed with liver 
samples. There was, however, no indication of a third zone in any %
Jof the experiments with muscle receptors. The first zone of muscle i
receptors was only 43^ of the same zone of liver receptors, in 
terms of their radioactivity levels. This quantitative difference 
was not due to a difference in the cytosol protein concentrations 
which were the same in both preparations. Since it had also been 
confirmed that no radioactivity was retained on the column after 
the elution, this difference may reflect the difference in ability 
or capacity of each tissue to bind prednisolone.
The data in Fig. 36 and Fig. 37 also indicate that the 
prednisolone-binding proteins in both liver and muscle cytosols 
constitute only a very small proportion of the cytoplasmic proteins 
in these tissues. In the liver, two major protein fractions could 
be separated by this chromatographic technique but neither of these 
peaks coincided with the peaks of radioactivity. In the muscle 
cytosol, three major protein fractions were detected at positions 
which did not coincide with the radioactivity peaks.
Characterization of liver and muscle prednisolone receptors by 
ultracentrifugation on a sucrose gradient
To obtain an estimate of the molecular sizes of the '1
prednisolone;-receptor complexes in the muscle and liver cytosol
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FIG. 37 DE~52 column chromatography of rat gastrocnemiusmuscle prednisolone receptors.
The muscle was processed for chromatography as 
described on page 94* 3.5ml of the sample,containing l.Omg protein per ml was applied to 
the column and, after the initial prewash, gradient 
elution was begun at the arrow. ( "# # ) represents radioactivity and (-0-0- ) represents absorbance at 
280nm,
195
preparations, the sedimentation pattern of these complexes on a 
linear 5 - 20^  sucrose gradient was studied using the 
ultracentrifugation technique described on page 73* The sucrose 
gradient served as a supporting medium through which the complexes 
were moved by centrifugal force and fractionated on the basis 
that the rate at vdiich they travelled down the gradient was a 
function of their molecular sizes (Martin and Ames, I96I).
Pre-treatment of the samples consisted of exposing the cytosol 
preparation to ^-prednisolone and, thereafter, to activated 
charcoal to remove unbound steroid. The charcoal-free supernatant 
was loaded on the sucrose gradient and centrifugation was performed 
at for 24 h at 60,000g ave, fractions collected after 
centrifugation were analysed for radioactivity, as described in 
'Methods* section, to locate the prednisoloneireceptor complexes.
The sedimentation coefficients of these complexes were calculated by 
comparing the distance they moved from the meniscus with that 
travelled by the standard (bovine albumin) under identical 
conditions. The molecular weights of these receptor complexes were 
calculated from the sedimentation coefficients as recommended by 
Martin and Ames (I96I)•
Analysis of the fractions of the gradient obtained with the 
liver sample revealed a single peak of radioactivity (Fig. 38) •
The position of this peak in comparison with the bovine albumin 
peak indicated that it had a sedimentation coefficient of 5*9S.
This value is larger than the value of 4S reported by Petrovic and 
Markovic (1975) for cortisol receptors in rat liver but is within 
the range (5S to 8s) reported by Baxter and Tomkins (l97l)j Beato
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FIG. 38 Sedimentation Profile of liver cytosol
prednisolone binding receptors in 59^ - 20^(w/v) sucrose gradients.
1.0ml of the sample, prepared as described on 
page 94 was layered on the gradient and centrifuged at 60,000g ave. for 24 h at 2°C. 
25-drop fractions were collected and assayed for 
radioactivity. - (-0 -0 -) indicates gradients containing no KCl and ( # # ) indicates 
gradients containing 0.3M KCl. The sedimentation peak of bovine albumin ( -A-A- ) was identified 
by ultraviolet absorption measurements at 280nm,
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and Peigelson (1972) and Agawaral et al. (1970). A protein with 
an S value of 5*9 would have a molecular weight of about 97,200.
This peak of radioactivity constitutes only a very small fraction 
of the radioactivity present in the gradient and the rest of this 
radioactivity remained at the top of the gradient (Fig. 38).
This picture suggests that considerable dissociation of the 
hormone-receptor complexes occurred during the lengthy (24 h) 
centrifugation as has been observed by Smart et al. (1970), who 
studied the sedimentation behaviour of corticosterone-binding 
proteins in rat liver. With the muscle prednisolone-receptor 
complexes no reproducible peak could be detected under the existing 
experimental conditions and almost all the radioactivity remained 
at the top of the gradient. Mayer and Rosen (1975) encountered the 
same problem under similar experimental conditions and detected a 
peak only when they included KCl (0.3M) in the sucrose gradient.
It was, therefore, decided to examine the effect of the presence 
of KOI on the gradient analysis of muscle prednisolone-receptor 
complexes. This salt was included, at a concentration of 0.3M, in 
both the homogenisation buffer used in the preparation of the 
cytosol and in the sucrose gradient on which the sample was loaded.
In the presence of 0.3M KCl, a definite peak r: was observed in the 
3.9s region after centrifugation (Fig. 39). This result is in 
good agreement with that obtained by Mayer and Rosen (1975) in 
experiments with dexamethasone receptors in rat gastrocnemius 
muscle cytosol, A sedimentation coefficient of 3*9 indicates a 
molecular weight of about 52,300 for these muscle prednisolone-receptor 
complexes. When the liver cytosol prednisolone-receptor complexes
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were prepared and centrifuged in the presence of 0#3M KCl a 
slightly faster-sedimenting peak (6*98) was obtained. This 
observation contrasts with the findings of Beato and Peigelson 
(1972). These workers found that, in the presence of 0.3M KCl, 
dexamathasone-binding receptors in rat hepatoma cells tended to 
dissociate or were otherwise converted to 4^  forms. The ionic 
environment and the centrifugation process itself may, therefore, 
be critical factors in the results obtained in these experiments.
Possible differences between rat liver and gastrocnemius muscle 
nrednisolone receptors
The results of investigations reported in this section 
indicated that more prednisolone was bound by the liver than was 
bound by the muscle. Since there is a dose-related response to 
glucocorticoids (Locker and de Wever, 1970), the response of rat 
liver and muscle to prednisolone may be related to the different 
amounts of the steroid that is retained by the tissue. The sucrose 
gradient centrifugation experiments indicated that the prednisolone 
receptor in the liver was a bigger molecule than the muscle receptor, 
This liver prednisolone receptor also appeared to be less readily 
dependent on the prevailing ionic environment than the muscle 
receptor. This was evident from the effect of the presence of KCl 
on the sucrose gradient profile of prednisolone receptors in the 
two tissues. The liver prednisolone receptor may, therefore, be 
more stable than the muscle receptors. Such possible difference 
in the relative stabilities of prednisolone receptors in rat liver 
and muscle may also influence the response the steroid elicits in 
the respective tissues.
:
s
I
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The data presented on page 111 clearly indicate that daily 
subcutaneous injections of prednisolone acetate, at a dosage of lOmg 
per kg initial body weight and over an 8-day period, caused a loss of 
protein and RKA in the gastrocnemius muscle of rats as well as a net 
loss in their body weight. Although glucocorticoids are known to 
cause fluid retention (Sayers and Travis, 1970), in these experiments 
no attempt was made to estimate any increase in water content in the 
body as a vfhole or in individual tissues. The depletion of body 
weight observed may thus be an underestimation of the amount of tissue 
wasting which had occurred. These effects of prednisolone 
administration are in agreement with the findings of other workers 
(Mayer et al. 1976; Shoji and Pennington, 1977).
Both prednisolone-treated animals and their controls received and 
consumed the same quantity of food over the experimental period. The 
observed response to prednisolone could not therefore have been 
influenced by the nutritional status of the treated animals. Goodlad 
and Munro (1959) in fact found that cortisol-induced changes in body 
and liver weights in rats were independent of dietary protein and 
energy.
Different muscles vary in their response to the action of  ^
glucocorticoids. Smith (1964), studying the histological and 
histochemical changes in the muscles of rabbits treated with 
trianioinolone, reported more wasting in pale muscle fibres than in 
the dark or red fibres; D'Agostino and Chiga (1966) reported that 
corticosteroids predominantly affected red muscle fibres in rabbits 
and Afifi and Bergman (1969) reported that there was no predilection 
to wasting in any one type of muscle fibre. In more recent studies
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with turaoTor-bearing rats, which also show a depletion of muscle mass 
and muscle protein, it was demonstrated that the ability to resist 
the cachectic effect of the tumour varied with the type of muscle 
involved and that soleus muscle with predominantly dark fibres showed 
a greater resistance to this cachectic effect than the gastrocnemius 
muscle which consists mainly of white fibres (Clark and Goodlad,
1971? Goodlad and Clank, 1972), In the present studies it was shown 
that gastrocnemius was very responsive to the administration of 
prednisolone. This muscle type therefore appeared suitable for a 
study which was concerned primarily with the nature of the response 
to prednisolone rather than with the relative susceptibilities of 
different muscle types to the steroid.
The progressive decrease in protein content in the gastrocnemius 
muscle demonstrated in this study indicates that changes may have 
occurred in protein metabolism in this tissue in response to the 
administration of prednisolone, A net loss of muscle protein could 
be the result of (a) an increased rate of protein breakdovm with no 
change in the rate of protein synthesis, (b) a decrease in the rate of 
protein synthesis with no change in the rate of its breakdown or (c) 
a combination of increased rate of protein breakdown and decreased 
rate of protein synthesis. In the absence of data on the effect of 
prednisolone on the amino-acid pool in muscle or on protein 
metabolism in this tissue, it is not possible in the present work 
to be definitive about the mechanism of protein loss in muscle 
following the administration of prednisolone. However, other workers 
have shown that in response to the administration of cortisol or 
cortisone there was a reduced incorporation of amino-acids into
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muscle protein (ïïanoune et al, 1972; Shoji and Pennington, 1977) as 
well as increased degradation and decreased synthesis of protein 
in the tissue (Goldberg, 1969). Previously, Kaplan and Schimizu (1963) 
had reported that the loss of muscle protein occurred ip. the face of 
increased concentrations of free amino-acids in the tissue and it is 
therefore not due to unavailability of these protein precursors.
The fact that ENA levels also fell during the experimental 
period is a strong hint that prednisolone-mediated changes in protein 
levels may be related to changes in the metabolism of nucleic acids. 
That the effect of steroids on protein metabolism are preceded by 
effects on ENA metabolism was first proposed by Karlson (1963) and 
this view has received considerable support from subsequent related 
studies (Kidson, 1967; Amaral and Moriber, 1967; Young, 1970;
Nakanishi et al. 1977) . Only total cellular ENA levels were 
measured in these investigations and it was not possible to be 
more specific about the ENA species affected by the administration 
of glucocorticoids. However it is probable that the loss of ENA in 
muscle of prednisolone-treated animals involved ribosomal ENA
principally since this ENA species constituted more than 80% of the 
total ENA in skeletal muscle (Manchester, 1967; Young, 1970). This 
probability does not rule out possible accompanying effects of 
prednisolone on other ENA species.
In rat liver there was an increase in mass, protein and ENA as 
prednisolone treatment progressed. These effects in the liver were 
demonstrable two days after the initial prednisolone injection and 
before statistically significant changes were observed in the 
gastrocnemius muscle. It would seem therefore that the protein and
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IENA precursors in the liver were not derived from gastrocnemius %
muscle. The observation that cortisol and triamcinolone bind to î
jdistinct cytoplasmic receptors in rat skeletal muscle (Mayer et al. |
1976) and the presence in liver cytosol of cortisol-specific
receptors (Beato et al. 1971; Eao et al. 1976) support the belief 4Ithat rat liver and gastrocnemius muscle are direct target organs for #
Mthe action of prednisolone and that the steroid-mediated responses 
in both tissues occur independently. |
It is significant that the alterations observed in both the
liver and gastrocnemius muscle occurred without any change in the
amount of DNA present in these tissues. A change in BNA 
concentration is an indication of cell turnover and, conversely, a 
constant BNA level reflects a constant cell population (Enwonwu and 
Sreebny, 1970)• It is evident therefore that the prednisolone-mediated 
changes observed in the rat liver and gastrocnemius muscle were due %
to changes in cellular components rather than to changes in cell number.
In these studies prednisolone acetate was administered at a 
dosage of lOmg per kg initial body weight of the animals. This 
dosage was within the recommended pharmaceutical range for humans 
(Wilson, 1977) and was the basis for any comparison of the effects I
of this steroid in rats and in humans. It should however be pointed 
out that different amounts of a glucocorticoid may elicit quite 
different responses in experimental animals (Loeker and Be Wever,
1970).
The alterations in liver and gastrocnemius muscle ENA following |
prednisolone treatment prompted an investigation of the effect of 
the steroid on ENA turnover in the two tissues. It was found that
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the administration of prednisolone to these animals had an effect 
on the rates at which RNA turned over hut in a somewhat different 
fashion in the two tissues. The result of the investigation of 
total RNA turnover in rat liver (page 118) suggests that in the 
livers of prednisolone-treated rats there was a reduced rate of 
RNA breakdown and an increased rate of RNA synthesis, compared with 
that in the control rats. It would appear therefore that a factor 
in the prednisolone-induced increase in RNA levels in rat liver 
could be a slowing down of the rate at which cellular RNA was being 
degraded together with an increase in the synthetic rate of this 
RNA. Vdien RNA turnover in the ribosomes of rat liver was examined 
in a similar series of experiments a resemblance between the S
turnovers of ribosomal and total RNA was observed. This finding is 
what would be expected since most of liver RNA is ribosomal (Blobel 
and Potter, I967)• Whether or not these changes in RNA metabolism 
involve changes in the activities of ribonucleases and RNA polymerases
in the liver will be discussed in subsequent sections. 4
7Administration of prednisolone appeared to have a more complex ^
effect on the turnover of RNA in the gastrocnemius muscle. The
total radioactivity in the muscle ribosomal RNA of prednisolone- ;•
7’
treated rats was always lower than control levels (page 157) and 4
over the first two days of prednisolone treatment, when the estimated 4
amounts of ribosomal ENA showed only a slight decrease, the specific -7
activity was also lower in the treated animals. RNA turnover in rat 4
gastrocnemius muscle would seem to follow a biphasic pattern during |
prednisolone treatment, the initial event being an increase in ENA
;
synthesis and renewal. If during this first phase ENA was also %
I
i * - - ; ' %, V f  . i-; 'T-./.-vf.- v  r. ' î#
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degraded at a rate exceeding the synthesis rate the net result
would he a lowering of total radioactivity and amount of RNA in the |■jf
tissue. In the absence of precise data on the kinetics of loss of i
radioactivity in vivo from the muscle in the period immediately 
following the first prednisolone injection, this reasoning is 
speculative at the present time. However such a picture would be 
similar to that shown to occur in rabbit lymph node cells under the 
influence of cortisol (Kidson, 196?) • This hormone was found to f
cause a net decrease in the rate of RNA synthesis but the immediate 
response of the cells was to increase RNA synthesis within seconds 
of exposure to the steroid. In the period from the second day of 
prednisolone administration to the end of the experiment a reduced 
rate of RNA synthesis appeared to be occurring. The observed 
reduction in RNA polymerase activity, particularly that believed to it
be responsible for the synthesis of ribosomal RNA (Table 24) supports :il
this view. Thus a possible regulatory site for the action of 
prednisolone in rat gastrocnemius muscle is at the level of ;î
transcription of ribosomal RNA and the alterations observed in 
cytoplasmic RNA may be related to nuclear interactions and/or |
alterations in RNA polymerase activities.
These conclusions about the effect of prednisolone on RNA 
turnover in the liver and gastrocnemius of rats could be subjected 
to one general criticism - the steroid may have altered radioisotope 
uptake into the precursor pool for ENA leading to alterations in ?l
RNA labelling independent of the rate of RNA turnover. In this 
connection it is of interest that the administration of cortisone 
was shown to cause a marked increase in the uptake of glycine for
206
purine biosynthesis in rat liver (Feigelson and Feigelson, 1963) . 
Stimulation of endogeneous synthesis of RNA precursors is thus a 
possibility that could result in dilution of labelled RNA precursors 
in the pool and cause alteration in radioisotope uptake into RNA,
Moreover, any alteration in the re-utilisation of labelled 
nucleotides arising from RNA degradation would lead to apparent 
changes in the half-life of the RNA (Blobel and Rotter, I968),
However, the investigation of the specific activity of ENA precursor 
pools in both rat liver and gastrocnemius muscle carried out in the 
present work shows that prednisolone does not alter these precursor 
pools significantly during the experimental period. The pools of 
labelled precursors in both control and prednisolone-treated rats 
were found to be essentially the same and it would thus appear 
unlikely that any changes in RNA turnover could be related to 
alterations in the ENA precursor pool in the treated animals.
Greenman et al (1965) showed from studies of the action of 
hydrocortisone on rat liver that this steroid altered the synthesis 
of all major ENA species in the tissue. It cannot however be 
concluded that the action of prednisolone on RNA is also indiscriminate, 4: 
Selective alteration of particular ENA species is a possibility that 
would not be detected in the initial experiments which investigated 
total RNA turnover. Subsequent study of polyadenylated and ribosomal 
type ENAs showed that, at least in the rat gastrocnemius muscle the 
administration of prednisolone affected these two RNA species 
differently. It was shown that although polyadenylated RNA 
constituted only a very small proportion by weight of cytoplasmic 
RNA (</ 3%), it was highly labelled and consequently made significant
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contributions to the specific radioactivity of total RNA in 
gastrocnemius muscle. Two days after the injection of the 
radioisotope, the specific radioactivity of polyadenylated RNA 
is more than three times that of other RNA species (Table I7) 
and over a ten-day period this level of radioactivity did not 
fall but rose slightly (Fig. 25). It is a well-documented fact 
that polyadenylate sequences exist covalently bound at the 3^-OH 
end of most eukaryotic messenger RNAs (Sheldon et al. 1972;
Darnell et al. 1973; Brawerman, 1974)* RNA containing these 
sequences are therefore often regarded as messenger RNA (Singer and 
Penman, 1973; Robbins and Heywood, 1978). The presence of these f
sequences in rat muscle messenger ENAs has been demonstrated by 
Kaufmann and Gross (1974) and they have been utilised to provide ^
specific methods for isolating these RNA species from muscle tissue 
(Neal and Florini, 1975; Heywood et al, 1975). There are two points 
of view concerning the regulation of polyadenylated RNA degradation 
in eukaryotic cells. The first is that the degradation of this RNA i
species is not subject to regulation and occurs randomly once 
ribosome initiation sites are empty (Haywood, 1974)* The second 
viewpoint is that the stability of polyadenylated ENA is regulated
by translation. After translation the polyadenylated RNA is
degraded but if translation is inhibited this ENA remains intact 
(Arbuzov 1976 & 1977). A study of the cytoplasmic distribution of 
polyadenylated RNA revealed that transcription products which 
eventually form myosin messenger ENA can be temporarily sequestered 
from activation as messengers and accumulate in the cytoplasm of 
calf muscle cells (Buckingham et al. 1974 & 1976) • This ENA
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presumably retains large portions of polyadenylate segments and 
thus prolongs its biological lifetime (Marbaix et al. 1977). Myosin 
is a major protein component of skeletal muscle myofibrils (Potter, 
1974) and it follows that there may exist in the cytoplasm of rat 
gastrocnemius muscle polyadenylated ENAs which have a much slower 
turnover than other ENA species in the cell. This ENA species may 
have contributed to the specific radioactivity of total ENA in 
gastrocnemius muscle, to the extent observed in Pig. 22.
Another possible explanation for the difference in the observed 
specific radioactivities of polyadenylated RNA and other ENA species 
in the gastrocnemius muscle could be that separate ENA precursor 
pools exist in the muscle cell and that these pools are characterised 
by the species of RNA for which they provide the precursors.
Weigers et al (1976) showed from a study of RNA synthesis in Hela 
cells, in culture, that messenger RNA was formed from precursors 
located in a large pool of pyrimidine nucleotides while a smaller 
pyrimidine pool served to supply ribosomal RNA synthesis. Since the 
bulk of cellular RNA is believed to be ribosomal (Blobel and Potter, 
1967; Manchester, I967; Young, 1970) the small pyrimidine pool would 
have a higher turnover than the pool from which messenger ENA is 
formed. This difference in precursor pool size could thus influence 
the availability of labelled precursors and the overall rate of 
incorporation of these labelled precursors into the various ENA 
species. A compartmentalisation model for RNA precursors has also 
been described by Plagemann (I97I) who examined nucleotide pools 
in rat hepatoma cells and by Goody and Ellem (1975) who studied the 
entry of ENA precursors into nucleotide pools in 6C3HED lymphoma
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cells. However, the difficulty in measuring the absolute size and q
the specific radioactivity of those RNA precursors directly involved %
in new RNA synthesis precludes an accurate assessment of the 
contribution of exogeneous RNA precursors to this pool (Goody and 
Ellem, 1975) • The views on the influence of ENA precursor pools on |
the uptake of labelled nucleotide by cellular RNA species must ,|
therefore remain speculative. ]
IIn summary, the results of the present work suggest that ENA <4
levels in the liver of prednisolone-treated animals rose as a 
result of a reduced degradation and an increased synthesis of #
ribosomal ENA. In the gastrocnemius muscle the picture appears to 4
be more complex but the net result seems to be a reduced synthesis 
of ribosomal RNA. It is not possible to be completely unequivocal -J
about the relationship between prednisolone-mediated alterations 
of ENA turnover and the observed alterations in protein levels in 
the muscle and liver of experimental animals. The two events may 
be unrelated, the prednisolone effect on ENA turnover representing 
a response emanating from a selective steroid effect at the genetic 
level and the effect on cellular protein concentrations reflecting 
an independent action of the steroid on, for example, amino-acid %
pools or the energy requirements for protein synthesis. However, 
available evidence would appear to argue against such a view, |
Protein levels can be related to changes in RNA turnover and 
significant correlation has been observed between the fractional i
rate of protein synthesis and ENA concentration (Garlick et al.
1976; Kaplan and de Nicola, 1976; Carinci et al. 1976; Varga and
Sinitsin, 1978). It has also been demonstrated that the activity É
h
'I
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of the entire protein synthetic machinery is influenced by 
transcriptional events and messenger RNA synthesis (Grieninger and 
Granick, 1975) • Control mechanisms for protein synthesis may also 
involve small RNA molecules acting as promoters of translation 
(Eraser, 1975; Heywood et al, 1975) and the capacity of any tissue 
for protein synthesis depends on the integrity of the RNA in the 
ribosomes (Hirsch and Hiatt, I966; Layman et al, 1976). These 
considerations as well as results which showed alterations in RNA 
levels wherever protein levels were altered lead to the conclusion 
that the means by which prednisolone affects these two processes 
may be closely related.
Considerable difficulty was encountered in isolating cytoplasmic 
RNA species from rat gastrocnemius muscle in the course of this 
work. Firstly, RNA prepared by most of the conventional methods 
was significantly contaminated by other cellular components. From 
inspection of the of the isolated materials these
contaminants were, at least partially, protein in nature. 
Polysaccharides were other possible contaminants since extraction 
with methoxyethanol improved the specific activity of the material. 
Traces of the sodium dodecycl sulphate used in the tissue 
homogenisation medium may also be present as contaminants in the 
isolated material and may account for the high ultraviolet absorption 
at the top of sucrose gradients following the centrifugation of the 
material on these gradients (Fig. 240). This detergent absorbs light 
at 260nm and it is a compound which, once introduced, is not easily 
completely removed from solutions. The second difficulty in this 
series of experiments was in obtaining undegraded RNA consistently by
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some of the methods employed. Enzymic degradation by ribonnoleases 
may acoonnt for this RNA degradation. Contrary to an early report 
(Kirby, 1957) ribonucleases are neither completely removed nor 
permanently inactivated by phenol and several workers (Littauer and 
Eisenberg, 1959> Brownhill et al, 1959» Ralph and Bellamy, I964) 
have reported enzymic degradation of RKA extracted from plant and 
animal sources by phenol methods. Kirby himself noted later (I965) 
that ribonucleases are relatively stable, can survive phenol 
extraction and, on removal of the phenol, can degrade RKA, There 
is evidence also that RFA itself may protect ribonucleases from 
reagents employed to remove the enzymes (Robins and McFutt, 1974) • 
Krechetova et al (1972) held the view that some of the tissue 
ribonucleases are structural proteins of the small ribosomal subunit 
and that the proximity of the larger ribosomal subunit renders the 
enzyme inactive. This inactive state is maintained only as long as 
the ribosome structure is preserved. RFA degradation by 
ribonucleases was therefore always a likely possibility during the 
isolation procedures employed in the course of this work. 
Ribonucleases may be inhibited by several reagents. Sodium dodeoycl 
sulphate (Crestfield et al. 1955)» Polyvinyl sulphate (Feal and 
Plorini, 1975), Zn”*** (Brownhill et al. 1959), Bentonite (Huppert and 
Pelmont, I962) and copolymers of glutamate and tyrosine (Sela, I962) 
have all been employed to inhibit ribonucleases. Diverse mechanisms 
have also been suggested to explain the inhibitory effects of these 
various agents. Thus the acidic copolymers of glutamate and 
tyrosine may inhibit ribonucleases through electrostatic competition 
with the substrate for the enzyme. Such an inhibition will be
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pH-dependent since the ability of the inhibitor to bind enzyme v/ill 
depend on the ionisation of dissociable groups on the enzyme.
Bentonite is a form of aluminium silicate and its ribonuclease 
inhibitory ability has been attributed to its protein adsorbing 
properties (Barrow and Gollowick, I962). Other proteins in the 
environment may therefore affect the efficiency of bentonite as a 
ribonuclease adsorbent by competing for adsorption sites on the 
bentonite, From these considerations, it would seem that the 
effectiveness of a ribonuclease inhibitor depends on the prevailing 
experimental conditions. A medium which favours good yields of RFA 
from a tissue may not be ideal for the action of a particular 
ribonuclease-inhibiting agent. For example, in the presence of a 
high concentration of KGl, the adsorptive capacity of bentonite is 
much reduced (Barrow and Gollowick, I962) and the degradation of 
RFA is increased (ito, 1977)• This is the same experimental condition 
required to cause maximal release of RFA from muscle proteins 
(Manchester, I967) • Furthermore, the action of a ribonuclease 
inhibitor depends on the concentration of inhibitor employed as well 
as on the particular ribonuclease and its source (Littauer and Sela, 
1962; Feal and Florini, 1975)* In the course of the present work, 
the choice of a ribonuclease-inactivating agent was, therefore, 
largely a matter of trial and error. The problems of RFA 
contamination and degradation were however solved by adopting the 
RFA isolation method reported by Perry et al. (1972) and modified 
as described on page 68. This method involves the use of a 
phenol/chloroform mixture which prevents the interaction of specific 
proteins with certain regions of the polynucleotide (Perry et al.
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1972) and ensures a good recovery of undegraded RFA. The RFA 
extraction was performed at pH 6.0 where the activity of the 
so-called alkaline ribonucleases were low, and polyvinyl sulphate 
was included in the tissue homogenisation medium as additional 
protection against ribonuclease degradation. The purity of the 
RFA isolated by this technique was high as indicated by the 
^260/^280 of 1.98 obtained with the isolated material. The
sucrose gradient profile of the material did not show any 
significant RFA contamination by sodium dodecyl sulphate.
After it was established that prednisolone altered RFA 
metabolism in both rat liver and gastrocnemius muscle attention 
was next focussed on two enzyme systems v/hich may be involved in 
the regulation of RFA turnover in these tissues. The effects of 
administration of prednisolone on the activities of RFA polymerases 
and ribonucleases were therefore investigated.
Alterations of RFA polymerase activity in rat liver by 
glucocorticoids have been widely reported (Barnabei et al. 1965;
Jacob et al. I969; Yu and Peigelson, I97I). It has also been .;
demonstrated that, following administration of prednisolone, there 1
was a specific and preferential reduction in the activity of the {
1RFA polymerase responsible for ribosomal RFA synthesis in rat thymus
cells (Drews, 1969; Drews and Wagner, 1970). Data obtained in the ,
.1present work indicate that prednisolone treatment causes a decrease |i
in the activity of Mg^i activated (but not the Mn*"- activated) RFA j
polymerase in rat gastrocnemius muscle. In rat liver this enzymic .j
’■iactivity was increased (Table 24) * The preferential localisation
++ . ^of Mg - activated RFA polymerase in the nucleolus (Maul and Hamilton,
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1967) and reports that this enzyme is responsible for ribosomal-type 
EFl production (Widnell and Tata, I966; Jacob et al, I969) would 
suggest that the changes observed in the present study reflect 
some fundamental alterations in the ribosomal RFA synthetic 
machinery as a result of prednisolone administration. It is not é
clear whether prednisolone altered RFA polymerase activity by (|
Ialtering the DFA template or whether the steroid acted directly on %
the enzyme protein. Several possibilities exist as to how 
prednisolone may alter DFA template activity. These include tf
displacement of chromatin-associated proteins, unwinding of DFA, 
facilitation (or impediment) of movement of RFA polymerase along 
the transcribable regions of DFA or a combination of these changes. 
ÏÏnfortung.tely, these in vivo processes could not be investigated 
in the in vitro studies undertaken in the present work. Factors #
which control RFA synthesis in vivo may have been removed from the 
system by the isolation procedures. Moreover, the osmotic or 
mechanical disruption of nuclei during such isolation procedures f|
may have further complicated the picture (Guzak and Anderson, 1976). %
RFA polymerase activity in the nucleus can be modulated by changing 
the ionic environment (Widnell and Tata, I964 and I966) and it has ÿ
been shown in rat liver that nucleolar RFA polymerase activity is 
very dependent on ions (Grummt and Dindigkelt, 1973; Laval et al. |
1976). It is thus possible that prednisolone treatment altered 
nucleolar RFA polymerase activity by causing alterations in the %
nuclear ionic environment. It is not certain how this could be 
achieved but Laval et al (1976) have suggested that in a high ionic 
environment there is a marked alteration of the ultrastructure of
Æ
I
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rat liver rmoleolus which results in a stimulation of nucleolar =|
RFA polymerase activity.
Prednisolone may have produced the observed changes in RFA 
polymerase activities by altering the concentration of the enzyme in 
the nucleus. It has been demonstrated that the increased activity 
of RFA polymerase observed in the liver of carcinogen-treated rats 
is due to an increase in the amount of enzyme in the nucleus 
(Leonard and Jacob, 1977)* A study by Fakagawa and White (I97l) 
indicated that the decreased RFA polymerase activity in rat thymic 
nuclei exposed to cortisol was the result of an alteration in the 
enzyme itself. These data would appear to rule out the DFA template 
as the prime site of action of the steroid. However, the 
demonstration by the same workers (Fakagawa and V/hite, 1970) that 
the degree of the cortisol effect was different in isolated intact 
nuclei and in aggregate enzyme preparations suggested that the 
action of the steroid may not be explicable solely on the basis of 
alteration of the enzyme concentration.
In view of the different effects which prednisolone treatment 
had on RFA polymerase activities in rat liver and muscle, it is 
difficult to visualise an identical mode of action of this steroid 
in the two tissues. Some effect of prednisolone which precedes 
the change causing alterations in RFA polymerase activity may explain 
the tissue-specificity of the steroid. One such event may be at 
the level of the steroid receptor system. It is conceivable that 
prednisolone-receptor complexes in the rat liver and gastrocnemius 
muscle are different in some way and therefore affect different 
portions of the DFA template. More light will be shed on this
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subject with a better understanding of the regulation of RFA 
synthesis in eukaryotes. All that can be said at the present time 
is that prednisolone would appear to affect rat liver and muscle 
ribosomal RFA at the transcriptional level through alterations of 4IRFA polymerase activities. 1
An interest in ribonucleases in the present work arose from g
suggestions that these enzymes may play a role in the intracellular 
degradation of ribonucleic acids (Shortman, 1962; Kraft and S
Shortman, 1970). The present study showed that following 
administration of prednisolone the activities of acid and alkaline 
ribonucleases were depressed in rat gastrocnemius muscle and liver 
(Tables 26 and 27 respectively). The decrease in ribonuclease 
activity observed in the liver of prednisolone-treated animals is 
in keeping with the increased level of RFA observed in this tissue. 
Barnabei and Ottolenghi (1968), in a study of the response of rat f
liver to cortisone also observed an inverse relationship between 
RFA levels and ribonuclease activity. The changes observed in the 
present work in the activities of acid ribonuclease were unexpected 
since this enzyme is usually associated with RFA digestion in cell 
death or lysis (Be Buve et al, 1955) and not with regulation of j|
cellular RFA levels. However the activities of ribonucleases are
poorly understood at the present time and it is possible that acid 
ribonucleases are involved in the regulation of RFA levels in the 
cell. In this regard it may be significant that the activity of 
acid ribonuclease in rat liver, thymus, heart and brain was observed 
to increase whenever RFA levels were high (Shortman, I962; Kraft 
and Shortman, 1970). The results of investigations of * latent*
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ribonuclease activities in the liver may explain how prednisolone 
reduces ribonuclease activities in this tissue. If prednisolone 
reduced ribonuclease activity by increasing ribonuclease inhibitor 
activity, this reduction would be accounted for by increased 
* latent’ ribonuclease activity. In this work however, ’latent' 
ribonuclease activity decreased as a result of prednisolone 
administration. It would appear therefore that prednisolone 
regulated ribonuclease activity directly rather than at the level 
of the ribonuclease inhibitor. The steroid may exert this control 
by reducing the synthesis or increasing the destruction of these 
enzymes. It has been suggested that liver ribonucleases may have 
a pancreatic origin (Bartholeyns et al. 1975; Bartholeyns and 
Baudhuin, 1977)* Thus the observed prednisolone effects on hepatic 
ribonucleases might reflect the effect of the steroid on these 
enzymes in the pancreas. It was found, however, that pancreatic 
ribonuclease activities were not altered by prednisolone treatment 
(Table 28). It would appear therefore that the steroid had a direct 
effect on liver ribonucleases and that the pancreatic enzyme may be 
quite different as the immunological studies of the enzymes from 
the two tissues had suggested (Zan-Kowalczewska et al. 1974)*
In the gastrocnemius muscle, the administration of prednisolone 
caused a depression of ribonuclease activity. The lower ’latent’ 
ribonuclease activity observed in this tissue suggests that a 
lowering of the amount of ribonuclease inhibitor accompanied the 
reduction in ribonuclease activity. This reduction in ribonuclease 
activity may be an attempt to maintain normal levels of E M  in 
gastrocnemius muscle following prednisolone treatment.
■'I
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In summary it appears that RFA polymerase and ribonucleases 
play a role in bringing about changes in RFA metabolism in rat 
liver and gastrocnemius muscle following administration of 
prednisolone. In the liver of prednisolone-treated animals, the 
observed changes in the activities of the two enzyme systems could 
explain both the increased synthesis and the reduced degradation 
of RFA indicated by studies of turnover of RFA in this tissue 
carried out earlier in the present work. In the gastrocnemius 
muscle, the lowered activity of RFA polymerases would explain the 
fall in RFA levels following prednisolone treatment. The decreased 
activity of ribonucleases in this tissue may reflect an attempt to 
restore to normal the depleting levels of RFA resulting from 
decreased RFA synthesis in the muscle of prednisolone-treated 
animals•
An investigation of prednisolone-receptor complexes in the 
cytosol of rat liver and gastrocnemius muscle was carried out in 
an attempt to explain the different responses which prednisolone 
elicited in the two tissues. The formation of a. steroid-cytosol 
receptor complex is essential for transporting the steroid to the 
nucleus and for its subsequent effect on nuclear transcription 
(Raspe, 1971) . Responses to steroids may be regulated by changes 
in the intracellular concentration of the steroid receptor 
(Kirkpatrick et al. 1972; Rosenau et al. 1972; Cake et al. 1973; 
Lippraan et al, 1973» Chomczynski and Zwierzchowski, 1971) and 
differences in the amount of steroid-receptor complexes which are 
formed in target tissues may therefore be sufficient to determine 
the response of each target tissue to the steroid. In the present
%
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Iwork, it was observed that the amount of prednisolone bound to |
receptors in the rat liver cytosol was more than twice the quantity |
bound in gastrocnemius muscle cytosol of the same protein 
concentration. This finding would suggest that there are fewer 1
prednisolone-binding sites in the muscle than exist in the liver.
A similar conclusion was made by Roth (1974) with regard to 
dexamethasone. It is recognised that differences in quantities |
between steroid-receptor complexes in cytosols from different 
tissues do not necessarily imply the same variation in the amount 
of receptors for the steroid in the cell as a whole. The 
differences observed in the present study could reflect, for %
example, differences in distribution of prednisolone receptors 
between the cytoplasm and the nucleus of the tissues investigated.
However, it is generally accepted that it is the cytoplasmic 
receptor that is transformed and translocated to the nucleus 
(Munck et al. 1972; Litwack et al. 1973; Hondo et al, 1975)* The 
binding to the cytoplasmic receptor enhances the nuclear binding 
of the hormone (Abraham and Sekeris, 1973) and changes in the 
capacity of cytoplasmic receptors to bind a hormone closely J
resemble changes in the nuclear binding capacity (Lipp and Van }
der Muelen, 1977)* The quantity of cytoplasmic prednisolone-receptor ’
complexes formed in the rat liver and gastrocnemius muscle is I
1therefore a relevant consideration in the present study and may be '
significant in the different responses observed in the two tissues. 
Tissue-specific differences in the biological response elicited by 
a steroid may also result from qualitative differences in the 
steroid-receptor complexes formed in each tissue. Such differences
:-ÿ
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may be reflected in the sedimentation properties of the complexes
Jin a sucrose gradient, their elution profiles on an ion-exchange a?
■icolumn or in their stability in particular ionic environments and %
%may affect the capacity of these complexes for transfer to the 4
nucleus (Bird et al, 1976) or their ability to survive cellular
degradative processes (Mayer et al. 1974). In the present study 3
no significant differences in the ionic nature of prednisolone-
receptor complexes in rat liver and gastrocnemius muscle were 
observed from their behaviour on ion-exchange chromatography.
The complexes from each tissue behaved like single proteins when 
analysed by sucrose gradient centrifugation. The detection of two t
peaks of radioactivity by ion-exchange chromatography would seem to 
contradict the view that there was one class of prednisolone 
receptors in the cytosol of rat liver and muscle. However the 
appearance of more than one peak in an ionic gradient elution 
profile has been explained by the gradual disaggregation of 
steroid-receptor complexes as the ionic strength of the eluent
is increased (Lea, 1973). This might occur in the present study |j
if some aggregation of prednisolone-receptor complexes took place 
in the low ionic environment in which the complexes were formed 
and if differently aggregated complexes were differently retained 
on the BE 52-cellulose column. Ficholas and Morishige (1978) have 
also reported the presence of only one class of dexamethasone 
receptors in the cytoplasm of bovine trachealis muscle. The |
sedimentation coefficients calculated for muscle and liver 
prednisolone receptors indicated that these receptors may be 
different proteins. The intergrity of prednisolone-receptor
-t '
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Icomplexes prepared from the cytosol of rat gastrocnemius muscle 
during sucrose gradient centrifugation appeared to depend on the 
presence of 0.3M KCl during both the preparation of the complexes 
and their centrifugation on the gradient. Liver receptor complexes «ï
on the other hand were readily detectable on the gradient in the -3
absence of KGl, This observation suggests that the muscle 
prednisolone-receptor complexes were less stable than the liver 
receptor complexes in a low ionic environment. Glucocorticoid 
receptors depend for their stability on the intergrity of their 
sulphydryl groups (Mayer and Rosen, 1975; Rao et al. 1976;
Granberg and Ballard, 1977) and there is evidence that rat liver 
contains high concentrations of non-protein sulphydryl groups 
(Granberg and Ballard, 1977). The liver may therefore maintain ^
the sulphydryl groups of its prednisolone receptors at the expense 
of these non-protein sulphydryl groups and may thus acquire a 
gx’eater stability than the receptors in the muscle.
In summary, the differences observed in the prednisolone-binding 
capacity of rat muscle and liver cytosols and in the stability of '§
their prednisolone-receptor complexes in a low ionic environment §
may be important in determining the responses of each tissue to 
prednisolone. However, it is difficult without further work to 
relate these responses unequivocally to differences in the 
receptors in the two tissues.
It should be emphasized that consequent upon the administration 
of a glucocorticoid to an animal several responses occur in the 
endocrine system which make it difficult to establish precisely 
those effects attributable to the administered steroid alone. These
i
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responses include a suppression of segments of the 
hypothalmic-pitiutary-adrenal axis; a stunting of growth 
consistent with antagonistic action to growth hormone; a partial 
suppression of the release mechanisms of both the thyroid and the 
melanocyte stimulation hormone; and a potentiating effect on the |
pressor activity of norepinephrine (David et al, 197G; Baxter and ■1Forsham, 1972; Thompson and Lippman, 1974). The effects of the 3
administration of prednisolone to rats may therefore have %
reflected an interaction of hormones as well as the individual 
action of prednisolone. This concept of a system of hormonal 
programming of cellular response is demonstrated in the severe 
hyperinsulinemia induced by the administration of glucocorticoids 
(Owen and Cahill, 1973; Curry and Bennett, 1973; Altszuler et al.
1974; Gunn et al. 1975; Millward et al. 1976). In the skeletal 
muscle insulin enhances protein synthesis, suppressing protein 
breakdown and amino-acid release (Felig and Wharen, 1974) » There 
is also evidence that following the administration of glucocorticoids 3-
to rats the release of amino-acids from skeletal muscle into 3
icirculation was increased while the incorporation of amino-acids g
i'vinto the tissue was decreased (Manchester et al. 1959; Smith and %
Long, 1967). It is likely therefore that following the 
administration of prednisolone to rats there may exist in vivo a j
situation in which a potentially catabolic steroid (prednisolone) 
and a protein synthesis-enhancing hormone (insulin) are present 
simultaneously. It was demonstrated in the present work that in 
the gastrocnemius muscle the net result was decreased protein and 
RFA levels with the catabolic effects of prednisolone prevaü^ing
I223 i
over the effects of any secondary hyperinsulinemia. Tissue 
specificity appears to be an important factor in these responses IIand it has been shown that in cardiac muscle the net result was 
anabolic with insulin completely neutralising the effect of 
hydrocortisone on cardiac protein balance (Griffin and Widenthal, :3f
1978) • In the rat liver where prednisolone treatment resulted in 
higher R M  and protein levels, the induced insulin presumably 
exerts a co-operative effect by promoting conditions which enhance 
protein synthesis (Felig and VRiaren, 1974; Reed and Grisham, 1975).
Any potentially catabolic action of prednisolone in rat liver is 
thus offset by insulin and a new state of homeostasis, in favour 
of anabolism, is established in the tissue*
I
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